{"target_name": "ALK", "paper_count": 79, "paper_count_year": {"1988": [1, 0, 4], "1989": [1, 1, 3], "1993": [1, 1, 2], "1995": [1, 2, 3], "1996": [1, 4, 4], "1997": [1, 2, 3], "1998": [2, 0, 5], "2002": [1, 2, 2], "2004": [1, 1, 6], "2005": [2, 2, 7], "2006": [4, 4, 2], "2007": [2, 4, 1], "2008": [7, 2, 9], "2009": [5, 8, 6], "2010": [9, 5, 14], "2011": [4, 9, 21], "2012": [12, 12, 19], "2013": [7, 12, 34], "2014": [17, 17, 45], "2015": [20, 6, 61], "2016": [24, 15, 64], "2017": [31, 14, 56], "2018": [31, 17, 54], "2019": [29, 13, 38], "2020": [43, 11, 44], "2021": [29, 14, 26], "1910": [0, 1, 0], "1918": [0, 1, 2], "1927": [0, 1, 2], "1930": [0, 1, 2], "1939": [0, 1, 0], "1940": [0, 1, 0], "1951": [0, 1, 1], "1954": [0, 1, 0], "1955": [0, 2, 1], "1956": [0, 1, 1], "1959": [0, 1, 1], "1962": [0, 1, 0], "1963": [0, 1, 0], "1964": [0, 1, 0], "1965": [0, 1, 0], "1966": [0, 1, 1], "1969": [0, 1, 0], "1971": [0, 2, 3], "1973": [0, 1, 1], "1975": [0, 3, 0], "1977": [0, 2, 0], "1978": [0, 1, 0], "1984": [0, 1, 1], "1985": [0, 4, 1], "1986": [0, 1, 0], "1987": [0, 1, 0], "1990": [0, 2, 4], "1994": [0, 5, 2], "1999": [0, 1, 3], "2000": [0, 1, 5], "2001": [0, 1, 9], "2003": [0, 1, 10], "1825": [0, 0, 1], "1827": [0, 0, 1], "1829": [0, 0, 1], "1832": [0, 0, 1], "1836": [0, 0, 1], "1844": [0, 0, 1], "1853": [0, 0, 1], "1862": [0, 0, 1], "1868": [0, 0, 1], "1873": [0, 0, 1], "1883": [0, 0, 1], "1884": [0, 0, 2], "1885": [0, 0, 3], "1886": [0, 0, 1], "1889": [0, 0, 2], "1892": [0, 0, 1], "1893": [0, 0, 3], "1896": [0, 0, 1], "1898": [0, 0, 1], "1899": [0, 0, 4], "1900": [0, 0, 2], "1903": [0, 0, 1], "1904": [0, 0, 3], "1905": [0, 0, 1], "1906": [0, 0, 1], "1907": [0, 0, 1], "1909": [0, 0, 2], "1911": [0, 0, 2], "1912": [0, 0, 1], "1913": [0, 0, 3], "1914": [0, 0, 1], "1915": [0, 0, 2], "1916": [0, 0, 1], "1917": [0, 0, 1], "1920": [0, 0, 3], "1921": [0, 0, 1], "1922": [0, 0, 6], "1926": [0, 0, 1], "1929": [0, 0, 3], "1933": [0, 0, 1], "1934": [0, 0, 2], "1935": [0, 0, 1], "1937": [0, 0, 1], "1938": [0, 0, 2], "1941": [0, 0, 2], "1943": [0, 0, 3], "1948": [0, 0, 2], "1953": [0, 0, 2], "1957": [0, 0, 1], "1960": [0, 0, 3], "1972": [0, 0, 1], "1974": [0, 0, 1], "1980": [0, 0, 2], "1982": [0, 0, 1], "1983": [0, 0, 1], "1992": [0, 0, 1]}, "drug_molecule_count": 66, "drug_molecule_paper": [{"id": 0, "paper_title": "Drug Discovery Targeting Anaplastic Lymphoma Kinase (ALK)", "paper_author": ["Xiaotian Kong", "Peichen Pan", "Huiyong Sun", "Hongguang Xia", "Xuwen Wang", "Youyong Li", "Tingjun Hou"], "paper_year": 2019, "paper_institution": "", "paper_cited": 22, "doi": "10.1021/acs.jmedchem.9b00446", "paper_journal": "Journal of Medicinal Chemistry", "paper_abstract_image": "https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00446/20191219/images/large/jm9b00446_0028.jpeg", "compound_count": 65, "compound_name": "1", "compound_name_drug": "", "compound_smiles": "", "medicinal_chemistry_metrics": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "selectivity": 0}, "pharm_metrics_vitro": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "EC50": 0.0, "selectivity": 0, "hERG": 0.0, "solubility": 0.0}, "pharm_metrics_vivo": {"ED50": 0.0, "AUC": 0.0, "solubility": 0.0, "t_half": 0.0, "bioavailability": 0.0}, "clinical_statistics": {}}, {"id": 1, "paper_title": "Development of Alectinib-Based PROTACs as Novel Potent Degraders of Anaplastic Lymphoma Kinase (ALK)", "paper_author": ["Shaowen Xie", "Yuan Sun", "Yulin Liu", "Xinnan Li", "Xinuo Li", "Wenyi Zhong", "Feiyan Zhan", "Jingjie Zhu", "Hong Yao", "Dong-Hua Yang", "Zhe-Sheng Chen", "Jinyi Xu", "Shengtao Xu"], "paper_year": 2021, "paper_institution": "", "paper_cited": -1, "doi": "10.1021/acs.jmedchem.1c00270", "paper_journal": "Journal of Medicinal Chemistry", "paper_abstract_image": "https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00270/20210629/images/large/jm1c00270_0024.jpeg", "compound_count": 55, "compound_name": "17", "compound_name_drug": "", "compound_smiles": "", "medicinal_chemistry_metrics": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "selectivity": 0}, "pharm_metrics_vitro": {"Ki": 0.0, "Kd": 0.0, "IC50": 13.63, "EC50": 0.0, "selectivity": 0, "hERG": 0.0, "solubility": 0.0}, "pharm_metrics_vivo": {"ED50": 0.0, "AUC": 0.0, "solubility": 0.0, "t_half": 0.0, "bioavailability": 0.0}, "clinical_statistics": {}}, {"id": 2, "paper_title": "Discovery of (10R)-7-Amino-12-fluoro-2,10,16-trimethyl-15-oxo-10,15,16,17-tetrahydro-2H-8,4-(metheno)pyrazolo[4,3-h][2,5,11]-benzoxadiazacyclotetradecine-3-carbonitrile (PF-06463922), a Macrocyclic Inhibitor of Anaplastic Lymphoma Kinase (ALK) and c-ros Oncogene 1 (ROS1) with Preclinical Brain Exposure and Broad-Spectrum Potency against ALK-Resistant Mutations", "paper_author": ["Ted W. Johnson", "Paul F. Richardson", "Simon Bailey", "Alexei Brooun", "Benjamin J. Burke", "Michael R. Collins", "J. Jean Cui", "Judith G. Deal", "Ya-Li Deng", "Dac Dinh", "Lars D. Engstrom", "Mingying He", "Jacqui Hoffman", "Robert L. Hoffman", "Qinhua Huang", "Robert S. Kania", "John C. Kath", "Hieu Lam", "Justine L. Lam", "Phuong T. Le", "Laura Lingardo", "Wei Liu", "Michele McTigue", "Cynthia L. Palmer", "Neal W. Sach", "Tod Smeal", "Graham L. Smith", "Albert E. Stewart", "Sergei Timofeevski", "Huichun Zhu", "Jinjiang Zhu", "Helen Y. Zou", "Martin P. Edwards"], "paper_year": 2014, "paper_institution": "La Jolla Laboratories, Pfizer Worldwide Research and Development, 10770 Science Center Drive, San Diego, California 92121, United States", "paper_cited": 265, "doi": "10.1021/jm500261q", "paper_journal": "Journal of Medicinal Chemistry", "paper_abstract_image": "https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500261q/production/images/large/jm-2014-00261q_0018.jpeg", "compound_count": 102, "compound_name": "8k", "compound_name_drug": "PF-06463922", "compound_smiles": "", "medicinal_chemistry_metrics": {"Ki": 0.0, "Kd": 0.0, "IC50": 1.3, "selectivity": 0}, "pharm_metrics_vitro": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "EC50": 0.0, "selectivity": 0, "hERG": 0.0, "solubility": 0.0}, "pharm_metrics_vivo": {"ED50": 0.0, "AUC": 0.0, "solubility": 0.0, "t_half": 0.0, "bioavailability": 0.0}, "clinical_statistics": {"p1_company_num": 11, "p1_stat_company_num": [0, 2, 0, 0, 0, 0, 9, 0, 0], "p1_company": [[], ["OHSU Knight Cancer Institute", "Children's Hospital of Philadelphia"], [], [], [], [], ["National Cancer Center", "Pfizer", "The Netherlands Cancer Institute", "University of Milano Bicocca", "NRG Oncology", "Grenoble - CHU", "Erasmus MC, Rotterdam, Netherlands", "Massachusetts General Hospital", "Lyon - URCOT"], [], []], "p1_terminate_reason": {}, "p1_withdraw_reason": {}, "p1_adverse_event": {"Pfizer": 0.0}, "p2_company_num": 9, "p2_stat_company_num": [0, 7, 0, 1, 0, 0, 1, 0, 0], "p2_company": [[], ["Erasmus MC, Rotterdam, Netherlands", "National Cancer Center", "The Netherlands Cancer Institute", "Massachusetts General Hospital", "University of Milano Bicocca", "Grenoble - CHU", "Lyon - URCOT"], [], ["NRG Oncology"], [], [], ["Pfizer"], [], []], "p2_terminate_reason": {}, "p2_withdraw_reason": {}, "p2_adverse_event": {}, "p3_company_num": 1, "p3_stat_company_num": [0, 0, 0, 1, 0, 0, 0, 0, 0], "p3_company": [[], [], [], ["Pfizer"], [], [], [], [], []], "p3_terminate_reason": {}, "p3_withdraw_reason": {}, "p3_adverse_event": {}}}, {"id": 3, "paper_title": "Pyrazolylamine Derivatives Reveal the Conformational Switching between Type I and Type II Binding Modes of Anaplastic Lymphoma Kinase (ALK)", "paper_author": ["Chih-Hsiang Tu", "Wen-Hsing Lin", "Yi-Hui Peng", "Tsu Hsu", "Jian-Sung Wu", "Chun-Yu Chang", "Cheng-Tai Lu", "Ping-Chiang Lyu", "Chuan Shih", "Weir-Torn Jiaang", "Su-Ying Wu"], "paper_year": 2016, "paper_institution": "Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes, 35 Keyan Road, Zhunan Town, Miaoli County 350, Taiwan, ROC", "paper_cited": 18, "doi": "10.1021/acs.jmedchem.6b00106", "paper_journal": "Journal of Medicinal Chemistry", "paper_abstract_image": "https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.6b00106/20160422/images/large/jm-2016-00106d_0011.jpeg", "compound_count": 15, "compound_name": "5a", "compound_name_drug": "", "compound_smiles": "", "medicinal_chemistry_metrics": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "selectivity": 0}, "pharm_metrics_vitro": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "EC50": 0.0, "selectivity": 0, "hERG": 0.0, "solubility": 0.0}, "pharm_metrics_vivo": {"ED50": 0.0, "AUC": 0.0, "solubility": 0.0, "t_half": 0.0, "bioavailability": 0.0}, "clinical_statistics": {}}, {"id": 4, "paper_title": "Chemically Induced Degradation of Anaplastic Lymphoma Kinase (ALK)", "paper_author": ["Chelsea E. Powell", "Yang Gao", "Li Tan", "Katherine A. Donovan", "Radosław P. Nowak", "Amanda Loehr", "Magda Bahcall", "Eric S. Fischer", "Pasi A. Jänne", "Rani E. George", "Nathanael S. Gray"], "paper_year": 2018, "paper_institution": "", "paper_cited": 73, "doi": "10.1021/acs.jmedchem.7b01655", "paper_journal": "Journal of Medicinal Chemistry", "paper_abstract_image": "https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01655/20180504/images/large/jm-2017-01655v_0007.jpeg", "compound_count": 12, "compound_name": "11", "compound_name_drug": "", "compound_smiles": "", "medicinal_chemistry_metrics": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "selectivity": 0}, "pharm_metrics_vitro": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "EC50": 0.0, "selectivity": 0, "hERG": 0.0, "solubility": 0.0}, "pharm_metrics_vivo": {"ED50": 0.0, "AUC": 0.0, "solubility": 0.0, "t_half": 0.0, "bioavailability": 0.0}, "clinical_statistics": {}}, {"id": 5, "paper_title": "Discovery of Entrectinib: A New 3-Aminoindazole As a Potent Anaplastic Lymphoma Kinase (ALK), c-ros Oncogene 1 Kinase (ROS1), and Pan-Tropomyosin Receptor Kinases (Pan-TRKs) inhibitor", "paper_author": ["Maria Menichincheri", "Elena Ardini", "Paola Magnaghi", "Nilla Avanzi", "Patrizia Banfi", "Roberto Bossi", "Laura Buffa", "Giulia Canevari", "Lucio Ceriani", "Maristella Colombo", "Luca Corti", "Daniele Donati", "Marina Fasolini", "Eduard Felder", "Claudio Fiorelli", "Francesco Fiorentini", "Arturo Galvani", "Antonella Isacchi", "Andrea Lombardi Borgia", "Chiara Marchionni", "Marcella Nesi", "Christian Orrenius", "Achille Panzeri", "Enrico Pesenti", "Luisa Rusconi", "Maria Beatrice Saccardo", "Ermes Vanotti", "Ettore Perrone", "Paolo Orsini"], "paper_year": 2016, "paper_institution": "Oncology, Nerviano Medical Sciences Srl, Viale Pasteur 10, 20014 Nerviano, Milan, Italy", "paper_cited": 107, "doi": "10.1021/acs.jmedchem.6b00064", "paper_journal": "Journal of Medicinal Chemistry", "paper_abstract_image": "https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00064/20160414/images/large/jm-2016-000643_0008.jpeg", "compound_count": 34, "compound_name": "1", "compound_name_drug": "", "compound_smiles": "", "medicinal_chemistry_metrics": {"Ki": 0.0, "Kd": 0.0, "IC50": 12.0, "selectivity": 0}, "pharm_metrics_vitro": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "EC50": 0.0, "selectivity": 0, "hERG": 0.0, "solubility": 0.0}, "pharm_metrics_vivo": {"ED50": 0.0, "AUC": 13.1, "solubility": 0.0, "t_half": 3.01, "bioavailability": 7.3}, "clinical_statistics": {}}, {"id": 6, "paper_title": "Discovery of Potent, Selective, and Brain-Penetrant 1H-Pyrazol-5-yl-1H-pyrrolo[2,3-b]pyridines as Anaplastic Lymphoma Kinase (ALK) Inhibitors", "paper_author": ["Makoto Fushimi", "Ikuo Fujimori", "Takeshi Wakabayashi", "Tomoaki Hasui", "Youichi Kawakita", "Keisuke Imamura", "Tomoko Kato", "Morio Murakami", "Tsuyoshi Ishii", "Yorifumi Kikko", "Maki Kasahara", "Atsushi Nakatani", "Yuto Hiura", "Maki Miyamoto", "Kumar Saikatendu", "Hua Zou", "Scott Weston Lane", "J. David Lawson", "Hiroshi Imoto"], "paper_year": 2019, "paper_institution": "", "paper_cited": 5, "doi": "10.1021/acs.jmedchem.8b01630", "paper_journal": "Journal of Medicinal Chemistry", "paper_abstract_image": "https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01630/20190516/images/large/jm-2018-01630m_0020.jpeg", "compound_count": 59, "compound_name": "1", "compound_name_drug": "", "compound_smiles": "[C@H](c1c(F)cc(F)cc1)(Nc1nn2c(ncc2c2[nH]nc(C)c2)cc1)C", "medicinal_chemistry_metrics": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "selectivity": 0}, "pharm_metrics_vitro": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "EC50": 0.0, "selectivity": 0, "hERG": 0.0, "solubility": 0.0}, "pharm_metrics_vivo": {"ED50": 0.0, "AUC": 0.0, "solubility": 0.0, "t_half": 0.0, "bioavailability": 0.0}, "clinical_statistics": {}}, {"id": 7, "paper_title": "Discovery of Novel 2,4-Diarylaminopyrimidine Analogues (DAAPalogues) Showing Potent Inhibitory Activities against Both Wild-type and Mutant ALK Kinases", "paper_author": ["Zilan Song", "Yanhong Yang", "Zhiqing Liu", "Xia Peng", "Junfeng Guo", "Xinying Yang", "Kui Wu", "Jing Ai", "Jian Ding", "Meiyu Geng", "Ao Zhang"], "paper_year": 2014, "paper_institution": "CAS Key Laboratory of Receptor Research, Synthetic Organic & Medicinal Chemistry Laboratory, Shanghai Institute of Materia Medica (SIMM), Chinese Academy of Sciences, Shanghai 201203, China", "paper_cited": 33, "doi": "10.1021/jm5005144", "paper_journal": "Journal of Medicinal Chemistry", "paper_abstract_image": "https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm5005144/20150106/images/large/jm-2014-005144_0011.jpeg", "compound_count": 48, "compound_name": "15", "compound_name_drug": "", "compound_smiles": "c1c(F)c(Nc2nc(NC3=C[C]4(=[I](C(C[C@@H]5C(=[O][C@@H]5N(C(=O)N5CCCC5)$C)N4)(C)C[C@H](I)C)C=C3)C)ncc2Cl)c(C(=O)NC)cc1", "medicinal_chemistry_metrics": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "selectivity": 0}, "pharm_metrics_vitro": {"Ki": 0.0, "Kd": 0.0, "IC50": 15300.0, "EC50": 0.0, "selectivity": 0, "hERG": 0.0, "solubility": 0.0}, "pharm_metrics_vivo": {"ED50": 0.0, "AUC": 0.0, "solubility": 0.0, "t_half": 0.0, "bioavailability": 0.0}, "clinical_statistics": {}}, {"id": 8, "paper_title": "Discovery of Clinical Candidate CEP-37440, a Selective Inhibitor of Focal Adhesion Kinase (FAK) and Anaplastic Lymphoma Kinase (ALK)", "paper_author": ["Gregory R. Ott", "Mangeng Cheng", "Keith S. Learn", "Jason Wagner", "Diane E. Gingrich", "Joseph G. Lisko", "Matthew Curry", "Eugen F. Mesaros", "Arup K. Ghose", "Matthew R. Quail", "Weihua Wan", "Lihui Lu", "Pawel Dobrzanski", "Mark S. Albom", "Thelma S. Angeles", "Kevin Wells-Knecht", "Zeqi Huang", "Lisa D. Aimone", "Elizabeth Bruckheimer", "Nathan Anderson", "Jay Friedman", "Sandra V. Fernandez", "Mark A. Ator", "Bruce A. Ruggeri", "Bruce D. Dorsey"], "paper_year": 2016, "paper_institution": "Teva Branded Pharmaceutical Products R&D, 145 Brandywine Parkway, West Chester, Pennsylvania 19380, United States", "paper_cited": 43, "doi": "10.1021/acs.jmedchem.6b00487", "paper_journal": "Journal of Medicinal Chemistry", "paper_abstract_image": "https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00487/20160819/images/large/jm-2016-004872_0023.jpeg", "compound_count": 62, "compound_name": "27b", "compound_name_drug": "", "compound_smiles": "C1CCc2c(C)c(C)ccc2CC1", "medicinal_chemistry_metrics": {"Ki": 0.0, "Kd": 0.0, "IC50": 3.1, "selectivity": 0}, "pharm_metrics_vitro": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "EC50": 0.0, "selectivity": 0, "hERG": 0.0, "solubility": 0.0}, "pharm_metrics_vivo": {"ED50": 0.0, "AUC": 0.0, "solubility": 0.0, "t_half": 0.0, "bioavailability": 0.0}, "clinical_statistics": {}}, {"id": 9, "paper_title": "Strategies to Mitigate the Bioactivation of 2-Anilino-7-Aryl-Pyrrolo[2,1-f][1,2,4]triazines: Identification of Orally Bioavailable, Efficacious ALK Inhibitors", "paper_author": ["Eugen F. Mesaros", "Tho V. Thieu", "Gregory J. Wells", "Craig A. Zificsak", "Jason C. Wagner", "Henry J. Breslin", "Rabindranath Tripathy", "James L. Diebold", "Robert J. McHugh", "Ashley T. Wohler", "Matthew R. Quail", "Weihua Wan", "Lihui Lu", "Zeqi Huang", "Mark S. Albom", "Thelma S. Angeles", "Kevin J. Wells-Knecht", "Lisa D. Aimone", "Mangeng Cheng", "Mark A. Ator", "Gregory R. Ott", "Bruce D. Dorsey"], "paper_year": 2011, "paper_institution": "Worldwide Discovery Research, Cephalon, Inc., 145 Brandywine Parkway, West Chester, Pennsylvania 19380, United States ", "paper_cited": 20, "doi": "10.1021/jm2010767", "paper_journal": "Journal of Medicinal Chemistry", "paper_abstract_image": "https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm2010767/production/images/large/jm-2011-010767_0013.jpeg", "compound_count": 42, "compound_name": "32", "compound_name_drug": "", "compound_smiles": "c1c(c(ccc1C(CCC)CCC)N)O", "medicinal_chemistry_metrics": {"Ki": 0.0, "Kd": 0.0, "IC50": 6.0, "selectivity": 0}, "pharm_metrics_vitro": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "EC50": 0.0, "selectivity": 0, "hERG": 0.0, "solubility": 0.0}, "pharm_metrics_vivo": {"ED50": 0.0, "AUC": 0.0, "solubility": 0.0, "t_half": 0.0, "bioavailability": 0.0}, "clinical_statistics": {}}, {"id": 10, "paper_title": "Designing Dual Inhibitors of Anaplastic Lymphoma Kinase (ALK) and Bromodomain-4 (BRD4) by Tuning Kinase Selectivity", "paper_author": ["Ellen Watts", "David Heidenreich", "Elizabeth Tucker", "Monika Raab", "Klaus Strebhardt", "Louis Chesler", "Stefan Knapp", "Benjamin Bellenie", "Swen Hoelder"], "paper_year": 2019, "paper_institution": "", "paper_cited": 22, "doi": "10.1021/acs.jmedchem.8b01947", "paper_journal": "Journal of Medicinal Chemistry", "paper_abstract_image": "https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01947/20190308/images/large/jm-2018-01947q_0015.jpeg", "compound_count": 84, "compound_name": "16k", "compound_name_drug": "BRD4", "compound_smiles": "c1c(csc1CN1[C@@H](C(=O)N(c2c1nc(Nc1c(cc(C3CCN(CC3)C)cc1)OCC)nc2)C)CC)C", "medicinal_chemistry_metrics": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "selectivity": 0}, "pharm_metrics_vitro": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "EC50": 0.0, "selectivity": 0, "hERG": 0.0, "solubility": 0.0}, "pharm_metrics_vivo": {"ED50": 0.0, "AUC": 0.0, "solubility": 0.0, "t_half": 0.0, "bioavailability": 0.0}, "clinical_statistics": {"p1_company_num": 9, "p1_stat_company_num": [1, 2, 0, 0, 0, 0, 6, 0, 0], "p1_company": [["University of Pittsburgh Cancer Institute LAO"], ["M.D. Anderson Cancer Center", "Dana-Farber Cancer Institute"], [], [], [], [], ["IUCPQ-UL", "Sarah Cannon", "GlaxoSmithKline", "Dana-Farber - Harvard Cancer Center LAO", "Tennessee Oncology", "Ohio State University Comprehensive Cancer Center"], [], []], "p1_terminate_reason": {}, "p1_withdraw_reason": {}, "p1_adverse_event": {}, "p2_company_num": 3, "p2_stat_company_num": [2, 0, 0, 0, 0, 0, 0, 1, 0], "p2_company": [["IUCPQ-UL", "Ohio State University Comprehensive Cancer Center"], [], [], [], [], [], [], ["Dana-Farber - Harvard Cancer Center LAO"], []], "p2_terminate_reason": {}, "p2_withdraw_reason": {}, "p2_adverse_event": {}, "p3_company_num": 0, "p3_stat_company_num": [0, 0, 0, 0, 0, 0, 0, 0, 0], "p3_company": [[], [], [], [], [], [], [], [], []], "p3_terminate_reason": {}, "p3_withdraw_reason": {}, "p3_adverse_event": {}}}, {"id": 11, "paper_title": "The Discovery and Optimization of a Novel Class of Potent, Selective, and Orally Bioavailable Anaplastic Lymphoma Kinase (ALK) Inhibitors with Potential Utility for the Treatment of Cancer", "paper_author": ["Richard T. Lewis", "Christiane M. Bode", "Deborah M. Choquette", "Michele Potashman", "Karina Romero", "John C. Stellwagen", "Yohannes Teffera", "Earl Moore", "Douglas A. Whittington", "Hao Chen", "Linda F. Epstein", "Renee Emkey", "Paul S. Andrews", "Violeta L. Yu", "Douglas C. Saffran", "Man Xu", "Allison Drew", "Patricia Merkel", "Steven Szilvassy", "Rachael L. Brake"], "paper_year": 2012, "paper_institution": "Amgen Inc., 360 Binney Street, Cambridge Massachusetts 02142, United States", "paper_cited": 30, "doi": "10.1021/jm3005866", "paper_journal": "Journal of Medicinal Chemistry", "paper_abstract_image": "https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3005866/production/images/large/jm-2012-005866_0013.jpeg", "compound_count": 60, "compound_name": "49", "compound_name_drug": "", "compound_smiles": "", "medicinal_chemistry_metrics": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "selectivity": 0}, "pharm_metrics_vitro": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "EC50": 0.0, "selectivity": 0, "hERG": 0.0, "solubility": 0.0}, "pharm_metrics_vivo": {"ED50": 0.0, "AUC": 0.0, "solubility": 0.0, "t_half": 0.0, "bioavailability": 0.0}, "clinical_statistics": {}}, {"id": 12, "paper_title": "Design, Synthesis, and Anaplastic Lymphoma Kinase (ALK) Inhibitory Activity for a Novel Series of 2,4,8,22-Tetraazatetracyclo[14.3.1.13,7.19,13]docosa-1(20),3(22),4,6,9(21),10,12,16,18-nonaene Macrocycles", "paper_author": ["Henry J. Breslin", "Brandon M. Lane", "Gregory R. Ott", "Arup K. Ghose", "Thelma S. Angeles", "Mark S. Albom", "Mangeng Cheng", "Weihua Wan", "R. Curtis Haltiwanger", "Kevin J. Wells-Knecht", "Bruce D. Dorsey"], "paper_year": 2011, "paper_institution": "Cephalon, Inc., 145 Brandywine Parkway, West Chester, Pennsylvania 19380-4245, United States", "paper_cited": 28, "doi": "10.1021/jm201333e", "paper_journal": "Journal of Medicinal Chemistry", "paper_abstract_image": "https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201333e/production/images/large/jm-2011-01333e_0008.jpeg", "compound_count": 96, "compound_name": "2m", "compound_name_drug": "", "compound_smiles": "", "medicinal_chemistry_metrics": {"Ki": 0.0, "Kd": 0.0, "IC50": 510.0, "selectivity": 0}, "pharm_metrics_vitro": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "EC50": 0.0, "selectivity": 0, "hERG": 0.0, "solubility": 0.0}, "pharm_metrics_vivo": {"ED50": 0.0, "AUC": 0.0, "solubility": 0.0, "t_half": 0.0, "bioavailability": 0.0}, "clinical_statistics": {}}, {"id": 13, "paper_title": "2,7-Disubstituted-pyrrolo[2,1-f][1,2,4]triazines: New Variant of an Old Template and Application to the Discovery of Anaplastic Lymphoma Kinase (ALK) Inhibitors with in Vivo Antitumor Activity", "paper_author": ["Gregory R. Ott", "Gregory J. Wells", "Tho V. Thieu", "Matthew R. Quail", "Joseph G. Lisko", "Eugen F. Mesaros", "Diane E. Gingrich", "Arup K. Ghose", "Weihua Wan", "Lihui Lu", "Mangeng Cheng", "Mark S. Albom", "Thelma S. Angeles", "Zeqi Huang", "Lisa D. Aimone", "Mark A. Ator", "Bruce A. Ruggeri", "Bruce D. Dorsey"], "paper_year": 2011, "paper_institution": "Worldwide Discovery Research, Cephalon, Inc., 145 Brandywine Parkway, West Chester, Pennsylvania 19380, United States", "paper_cited": 33, "doi": "10.1021/jm200758k", "paper_journal": "Journal of Medicinal Chemistry", "paper_abstract_image": "https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-18/jm200758k/production/images/large/jm-2011-00758k_0007.jpeg", "compound_count": 38, "compound_name": "30", "compound_name_drug": "", "compound_smiles": "c1c(c(ccc1C)N)O", "medicinal_chemistry_metrics": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "selectivity": 0}, "pharm_metrics_vitro": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "EC50": 0.0, "selectivity": 0, "hERG": 0.0, "solubility": 0.0}, "pharm_metrics_vivo": {"ED50": 0.0, "AUC": 0.0, "solubility": 0.0, "t_half": 0.0, "bioavailability": 0.0}, "clinical_statistics": {}}, {"id": 14, "paper_title": "Structure Based Drug Design of Crizotinib (PF-02341066), a Potent and Selective Dual Inhibitor of Mesenchymal–Epithelial Transition Factor (c-MET) Kinase and Anaplastic Lymphoma Kinase (ALK)", "paper_author": ["J. Jean Cui", "Michelle Tran-Dubé", "Hong Shen", "Mitchell Nambu", "Pei-Pei Kung", "Mason Pairish", "Lei Jia", "Jerry Meng", "Lee Funk", "Iriny Botrous", "Michele McTigue", "Neil Grodsky", "Kevin Ryan", "Ellen Padrique", "Gordon Alton", "Sergei Timofeevski", "Shinji Yamazaki", "Qiuhua Li", "Helen Zou", "James Christensen", "Barbara Mroczkowski", "Steve Bender", "Robert S. Kania", "Martin P. Edwards"], "paper_year": 2011, "paper_institution": "La Jolla Laboratories, Pfizer Worldwide Research and Development, 10770 Science Center Drive, San Diego, California 92121, United States", "paper_cited": 539, "doi": "10.1021/jm2007613", "paper_journal": "Journal of Medicinal Chemistry", "paper_abstract_image": "https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-18/jm2007613/production/images/large/jm-2011-007613_0019.jpeg", "compound_count": 73, "compound_name": "3", "compound_name_drug": "PF-02341066", "compound_smiles": "c1c(S(=O)(=O)Cc2c(cccc2Cl)Cl)cc2/C(=C/c3c(C)c(C(=O)N4[C@@H](CN5CCCC5)CCC4)c(C)[nH]3)/C(=O)Nc2c1", "medicinal_chemistry_metrics": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "selectivity": 0}, "pharm_metrics_vitro": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "EC50": 0.0, "selectivity": 0, "hERG": 0.0, "solubility": 0.0}, "pharm_metrics_vivo": {"ED50": 0.0, "AUC": 0.0, "solubility": 0.0, "t_half": 0.0, "bioavailability": 0.0}, "clinical_statistics": {"p1_company_num": 51, "p1_stat_company_num": [0, 3, 0, 2, 0, 1, 44, 0, 1], "p1_company": [[], ["M.D. Anderson Cancer Center", "Shanghai Eastern Hospital", "Children's Hospital of Philadelphia"], [], ["Dana-Farber Cancer Institute", "Hospital 12 de Octubre"], [], ["Baylor College of Medicine"], ["Memorial Sloan Kettering Cancer Center", "University of Colorado, Denver", "Sun Yat-sen University", "University of Alabama at Birmingham", "National Cancer Institute (NCI)", "St Bart's Hospital", "Princess Margaret Cancer Centre", "Lyon - URCOT", "Cancer Institute and Hospital, Chinese Academy of Medical Sciences", "Children's Oncology Group", "Gustave Roussy, Cancer Campus, Grand Paris", "Hoffmann-La Roche", "Takeda", "NRG Oncology", "Department of Oncology, Herlev and Gentofte Hospital", "Oslo University Hospital", "Uniklinik Köln, Department I for Internal Medicine, LCGC", "ECOG-ACRIN Cancer Research Group", "Universitaire Ziekenhuizen Leuven", "Univ. Health Network-OCI/Princess Margaret Hospital, Toronto, ON Canada", "Ospedale Santa Maria della Misericordia - Azienda Ospedaliera di Perugia", "Atrium Health (formerly Carolinas HealthCare System)", "Bristol-Myers Squibb", "Pfizer", "Samsung Medical Center", "Grenoble - CHU", "Oxford University Hospital NHS Trust", "Shanghai Pulmonary Hospital, Shanghai, China", "COG Phase I Consortium", "Southwest Oncology Group", "National Cheng-Kung University Hospital", "Massachusetts General Hospital", "Xinhua Hospital, Shanghai Jiao Tong University School of Medicine", "University of California, San Francisco", "The Netherlands Cancer Institute", "University of Milano Bicocca", "Associate Professor of Medicine at the Columbia University Medical Center", "Novartis Pharmaceuticals", "Hunan Province Tumor Hospital", "Gustave Roussy, Villejuif", "St. Jude Children's Research Hospital", "University of Birmingham", "Second Affiliated Hospital of Nanchang University", "Guangdong Association of Clinical Trials"], [], ["Cancer Hospital of Chines Academy of Medical Sciences"]], "p1_terminate_reason": {"Pfizer": "Death"}, "p1_withdraw_reason": {}, "p1_adverse_event": {"Pfizer": 0.0}, "p2_company_num": 41, "p2_stat_company_num": [3, 17, 0, 5, 0, 2, 12, 0, 2], "p2_company": [["Second Affiliated Hospital of Nanchang University", "Cancer Institute and Hospital, Chinese Academy of Medical Sciences", "National Cheng-Kung University Hospital"], ["Guangdong Association of Clinical Trials", "Samsung Medical Center", "Grenoble - CHU", "St Bart's Hospital", "Princess Margaret Cancer Centre", "Shanghai Pulmonary Hospital, Shanghai, China", "Massachusetts General Hospital", "Xinhua Hospital, Shanghai Jiao Tong University School of Medicine", "Lyon - URCOT", "University of California, San Francisco", "The Netherlands Cancer Institute", "Department of Oncology, Herlev and Gentofte Hospital", "Hunan Province Tumor Hospital", "University of Birmingham", "ECOG-ACRIN Cancer Research Group", "Univ. Health Network-OCI/Princess Margaret Hospital, Toronto, ON Canada", "University of Alabama at Birmingham"], [], ["University of Milano Bicocca", "NRG Oncology", "Associate Professor of Medicine at the Columbia University Medical Center", "Gustave Roussy, Villejuif", "Universitaire Ziekenhuizen Leuven"], [], ["Atrium Health (formerly Carolinas HealthCare System)", "Southwest Oncology Group"], ["Bristol-Myers Squibb", "Pfizer", "Children's Oncology Group", "Gustave Roussy, Cancer Campus, Grand Paris", "Hoffmann-La Roche", "Takeda", "University of Colorado, Denver", "Novartis Pharmaceuticals", "Sun Yat-sen University", "Oslo University Hospital", "National Cancer Institute (NCI)", "COG Phase I Consortium"], [], ["Uniklinik Köln, Department I for Internal Medicine, LCGC", "Ospedale Santa Maria della Misericordia - Azienda Ospedaliera di Perugia"]], "p2_terminate_reason": {"Atrium Health (formerly Carolinas HealthCare System)": "Death", "NRG Oncology": "Protocol Violation"}, "p2_withdraw_reason": {}, "p2_adverse_event": {"Pfizer": 0.5056285178236398, "COG Phase I Consortium": 0.5, "Atrium Health (formerly Carolinas HealthCare System)": 0.3333333333333333, "NRG Oncology": 0.07142857142857142, "Novartis Pharmaceuticals": 0.4032258064516129, "Takeda": 0.5321100917431193, "Hoffmann-La Roche": 0.2826086956521739, "Massachusetts General Hospital": 0.3333333333333333, "Bristol-Myers Squibb": 0.46153846153846156, "National Cancer Institute (NCI)": 1.0}, "p3_company_num": 6, "p3_stat_company_num": [1, 3, 0, 2, 0, 0, 0, 0, 0], "p3_company": [["Hoffmann-La Roche"], ["Takeda", "Sun Yat-sen University", "Children's Oncology Group"], [], ["Novartis Pharmaceuticals", "Pfizer"], [], [], [], [], []], "p3_terminate_reason": {}, "p3_withdraw_reason": {}, "p3_adverse_event": {"Pfizer": 0.4423076923076923}}}, {"id": 15, "paper_title": "Synthesis, Structure–Activity Relationships, and in Vivo Efficacy of the Novel Potent and Selective Anaplastic Lymphoma Kinase (ALK) Inhibitor 5-Chloro-N2-(2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl)-N4-(2-(isopropylsulfonyl)phenyl)pyrimidine-2,4-diamine (LDK378) Currently in Phase 1 and Phase 2 Clinical Trials", "paper_author": ["Thomas H. Marsilje", "Wei Pei", "Bei Chen", "Wenshuo Lu", "Tetsuo Uno", "Yunho Jin", "Tao Jiang", "Sungjoon Kim", "Nanxin Li", "Markus Warmuth", "Yelena Sarkisova", "Frank Sun", "Auzon Steffy", "AnneMarie C. Pferdekamper", "Allen G. Li", "Sean B. Joseph", "Young Kim", "Bo Liu", "Tove Tuntland", "Xiaoming Cui", "Nathanael S. Gray", "Ruo Steensma", "Yongqin Wan", "Jiqing Jiang", "Greg Chopiuk", "Jie Li", "W. Perry Gordon", "Wendy Richmond", "Kevin Johnson", "Jonathan Chang", "Todd Groessl", "You-Qun He", "Andrew Phimister", "Alex Aycinena", "Christian C. Lee", "Badry Bursulaya", "Donald S. Karanewsky", "H. Martin Seidel", "Jennifer L. Harris", "Pierre-Yves Michellys"], "paper_year": 2013, "paper_institution": "Genomics Institute of the Novartis Research Foundation, 10675 John Jay Hopkins Drive, San Diego, California 92121, United States", "paper_cited": 249, "doi": "10.1021/jm400402q", "paper_journal": "Journal of Medicinal Chemistry", "paper_abstract_image": "https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400402q/production/images/large/jm-2013-00402q_0010.jpeg", "compound_count": 56, "compound_name": "15b", "compound_name_drug": "", "compound_smiles": "c1(C2CCNCC2)c(C)cc(Nc2ncc(Cl)c(Nc3c(S(=O)(=O)C(C)C)cccc3)n2)c(OC(C)C)c1", "medicinal_chemistry_metrics": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "selectivity": 0}, "pharm_metrics_vitro": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "EC50": 0.0, "selectivity": 0, "hERG": 0.0, "solubility": 0.0}, "pharm_metrics_vivo": {"ED50": 0.0, "AUC": 0.0, "solubility": 0.0, "t_half": 0.0, "bioavailability": 0.0}, "clinical_statistics": {}}, {"id": 16, "paper_title": "Structural Insights into the ATP Binding Pocket of the Anaplastic Lymphoma Kinase by Site-Directed Mutagenesis, Inhibitor Binding Analysis, and Homology Modeling", "paper_author": ["Rosalind H. Gunby", "Shaheen Ahmed", "Roberta Sottocornola", "Marc Gasser", "Sara Redaelli", "Luca Mologni", "Carmen J Tartari", "Valentina Belloni", "Carlo Gambacorti-Passerini", "Leonardo Scapozza"], "paper_year": 2006, "paper_institution": "Department of Clinical Medicine, Via Cadore 48, University of Milano-Bicocca, Monza, 20052, Italy, Pharmaceutical Biochemistry Group, School of Pharmaceutical Sciences, University of Geneva, University of Lausanne, Quai Ernest-Ansermet 30, CH-1211 Geneva 4, Switzerland, Department of Experimental Oncology, Istituto Nazionale dei Tumori, Via Venezian 1, Milan, 20133, Italy, and Department of Oncology, McGill University, Montreal, Canada ", "paper_cited": 26, "doi": "10.1021/jm060380k", "paper_journal": "Journal of Medicinal Chemistry", "paper_abstract_image": "https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-19/jm060380k/production/images/large/jm060380kn00001.jpeg", "compound_count": 13, "compound_name": "+", "compound_name_drug": "", "compound_smiles": "", "medicinal_chemistry_metrics": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "selectivity": 0}, "pharm_metrics_vitro": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "EC50": 0.0, "selectivity": 0, "hERG": 0.0, "solubility": 0.0}, "pharm_metrics_vivo": {"ED50": 0.0, "AUC": 0.0, "solubility": 0.0, "t_half": 0.0, "bioavailability": 0.0}, "clinical_statistics": {}}, {"id": 17, "paper_title": "Discovery of an Orally Efficacious Inhibitor of Anaplastic Lymphoma Kinase", "paper_author": ["Diane E. Gingrich", "Joseph G. Lisko", "Matthew A. Curry", "Mangeng Cheng", "Matthew Quail", "Lihui Lu", "Weihua Wan", "Mark S. Albom", "Thelma S. Angeles", "Lisa D. Aimone", "R. Curtis Haltiwanger", "Kevin Wells-Knecht", "Gregory R. Ott", "Arup K. Ghose", "Mark A. Ator", "Bruce Ruggeri", "Bruce D. Dorsey"], "paper_year": 2012, "paper_institution": "Worldwide Discovery Research, Cephalon, Inc., 145 Brandywine Parkway, West Chester, Pennsylvania 19380, United States", "paper_cited": 25, "doi": "10.1021/jm201550q", "paper_journal": "Journal of Medicinal Chemistry", "paper_abstract_image": "https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-10/jm201550q/production/images/large/jm-2011-01550q_0006.jpeg", "compound_count": 38, "compound_name": "25b", "compound_name_drug": "", "compound_smiles": "O=C(N)[C@H]1C2C=C[C@H]([C@H]1Nc1nc(Nc3c(c4CC[C@@H](N5CCOCC5)CCc4cc3)OC)ncc1Cl)C2", "medicinal_chemistry_metrics": {"Ki": 0.0, "Kd": 0.0, "IC50": 1.9, "selectivity": 0}, "pharm_metrics_vitro": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "EC50": 0.0, "selectivity": 0, "hERG": 0.0, "solubility": 0.0}, "pharm_metrics_vivo": {"ED50": 0.0, "AUC": 0.0, "solubility": 0.0, "t_half": 0.0, "bioavailability": 0.0}, "clinical_statistics": {}}, {"id": 18, "paper_title": "Design and Synthesis of 5-Aryl-pyridone-carboxamides as Inhibitors of Anaplastic Lymphoma Kinase", "paper_author": ["Rongshi Li", "Liquan Xue", "Tong Zhu", "Qin Jiang", "Xiaoli Cui", "Zheng Yan", "Danny McGee", "Jian Wang", "Vidyasagar Reddy Gantla", "Jason C. Pickens", "Doug McGrath", "Alexander Chucholowski", "Stephan W. Morris", "Thomas R. Webb"], "paper_year": 2006, "paper_institution": "ChemBridge Research Laboratories and ChemBridge Corporation, 16981 Via Tazon, Suites K and G, San Diego, California 92127, and Departments of Pathology and Hematology-Oncology, St. Jude Children's Research Hospital, 332 N. Lauderdale Street, Memphis, Tennessee 38105 ", "paper_cited": 41, "doi": "10.1021/jm050824x", "paper_journal": "Journal of Medicinal Chemistry", "paper_abstract_image": "https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-3/jm050824x/production/images/large/jm050824xn00001.jpeg", "compound_count": 72, "compound_name": "9c", "compound_name_drug": "", "compound_smiles": "", "medicinal_chemistry_metrics": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "selectivity": 0}, "pharm_metrics_vitro": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "EC50": 0.0, "selectivity": 0, "hERG": 0.0, "solubility": 0.0}, "pharm_metrics_vivo": {"ED50": 0.0, "AUC": 0.0, "solubility": 0.0, "t_half": 0.0, "bioavailability": 0.0}, "clinical_statistics": {}}, {"id": 19, "paper_title": "Rapid Development of Piperidine Carboxamides as Potent and Selective Anaplastic Lymphoma Kinase Inhibitors", "paper_author": ["Marian C. Bryan", "Douglas A. Whittington", "Elizabeth M. Doherty", "James R. Falsey", "Alan C. Cheng", "Renee Emkey", "Rachael L. Brake", "Richard T. Lewis"], "paper_year": 2012, "paper_institution": "Medicinal Chemistry Research Technologies, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320, United States", "paper_cited": 24, "doi": "10.1021/jm201565s", "paper_journal": "Journal of Medicinal Chemistry", "paper_abstract_image": "https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-4/jm201565s/production/images/large/jm-2011-01565s_0004.jpeg", "compound_count": 46, "compound_name": "1", "compound_name_drug": "", "compound_smiles": "O(c1c(OC)c(OC)cc(Nc2nc(ccn2)N2CCC[C@@H](C2)C(=O)NCc2ccc(cc2)C)c1)C", "medicinal_chemistry_metrics": {"Ki": 0.0, "Kd": 0.0, "IC50": 174.0, "selectivity": 0}, "pharm_metrics_vitro": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "EC50": 0.0, "selectivity": 0, "hERG": 0.0, "solubility": 0.0}, "pharm_metrics_vivo": {"ED50": 0.0, "AUC": 0.0, "solubility": 0.0, "t_half": 0.0, "bioavailability": 0.0}, "clinical_statistics": {}}, {"id": 20, "paper_title": "Discovery of CJ-2360 as a Potent and Orally Active Inhibitor of Anaplastic Lymphoma Kinase Capable of Achieving Complete Tumor Regression", "paper_author": ["Jianyong Chen", "Yunlong Zhou", "Xuyuan Dong", "Liu Liu", "Longchuan Bai", "Donna McEachern", "Sally Przybranowski", "Chao-Yie Yang", "Jeanne Stuckey", "Xiaoqin Li", "Bo Wen", "Ting Zhao", "Siwei Sun", "Duxin Sun", "Lingling Jiao", "Yu Jing", "Ming Guo", "Dajun Yang", "Shaomeng Wang"], "paper_year": 2020, "paper_institution": "", "paper_cited": 1, "doi": "10.1021/acs.jmedchem.0c01550", "paper_journal": "Journal of Medicinal Chemistry", "paper_abstract_image": "https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01550/20201120/images/large/jm0c01550_0020.jpeg", "compound_count": 57, "compound_name": "7d", "compound_name_drug": "", "compound_smiles": "N1(C[C@@H](N([C@@H](C1)C)C)C)c1c(OC)cc2c(=O)c3c4ccc(C#N)cc4[nH]c3n(C(C)C)c2c1F", "medicinal_chemistry_metrics": {"Ki": 0.0, "Kd": 0.0, "IC50": 2.2, "selectivity": 0}, "pharm_metrics_vitro": {"Ki": 0.0, "Kd": 0.0, "IC50": 21.3, "EC50": 0.0, "selectivity": 0, "hERG": 0.0, "solubility": 0.0}, "pharm_metrics_vivo": {"ED50": 0.0, "AUC": 0.0, "solubility": 0.0, "t_half": 0.0, "bioavailability": 0.0}, "clinical_statistics": {}}, {"id": 21, "paper_title": "Discovery of Inhibitors That Overcome the G1202R Anaplastic Lymphoma Kinase Resistance Mutation", "paper_author": ["John M. Hatcher", "Magda Bahcall", "Hwan Geun Choi", "Yang Gao", "Taebo Sim", "Rani George", "Pasi A. Jänne", "Nathanael S. Gray"], "paper_year": 2015, "paper_institution": "†Department of Cancer Biology, ‡Lowe Center for Thoracic Oncology, and §Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, Massachusetts 02115, United States", "paper_cited": 25, "doi": "10.1021/acs.jmedchem.5b01136", "paper_journal": "Journal of Medicinal Chemistry", "paper_abstract_image": "https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b01136/20151204/images/large/jm-2015-01136d_0015.jpeg", "compound_count": 36, "compound_name": "6", "compound_name_drug": "", "compound_smiles": "", "medicinal_chemistry_metrics": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "selectivity": 0}, "pharm_metrics_vitro": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "EC50": 0.0, "selectivity": 0, "hERG": 0.0, "solubility": 0.0}, "pharm_metrics_vivo": {"ED50": 0.0, "AUC": 150478.0, "solubility": 0.0, "t_half": 0.0, "bioavailability": 0.0}, "clinical_statistics": {}}, {"id": 22, "paper_title": "Discovery of Brigatinib (AP26113), a Phosphine Oxide-Containing, Potent, Orally Active Inhibitor of Anaplastic Lymphoma Kinase", "paper_author": ["Wei-Sheng Huang", "Shuangying Liu", "Dong Zou", "Mathew Thomas", "Yihan Wang", "Tianjun Zhou", "Jan Romero", "Anna Kohlmann", "Feng Li", "Jiwei Qi", "Lisi Cai", "Timothy A. Dwight", "Yongjin Xu", "Rongsong Xu", "Rory Dodd", "Angela Toms", "Lois Parillon", "Xiaohui Lu", "Rana Anjum", "Sen Zhang", "Frank Wang", "Jeffrey Keats", "Scott D. Wardwell", "Yaoyu Ning", "Qihong Xu", "Lauren E. Moran", "Qurish K. Mohemmad", "Hyun Gyung Jang", "Tim Clackson", "Narayana I. Narasimhan", "Victor M. Rivera", "Xiaotian Zhu", "David Dalgarno", "William C. Shakespeare"], "paper_year": 2016, "paper_institution": "ARIAD Pharmaceuticals, Inc., 26 Landsdowne Street, Cambridge, Massachusetts 02139, United States", "paper_cited": 155, "doi": "10.1021/acs.jmedchem.6b00306", "paper_journal": "Journal of Medicinal Chemistry", "paper_abstract_image": "https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-10/acs.jmedchem.6b00306/20160520/images/large/jm-2016-00306u_0005.jpeg", "compound_count": 58, "compound_name": "11q", "compound_name_drug": "AP26113", "compound_smiles": "C1CN(CCN1C)C1CCN(CC1)c1ccc(c(OC)c1)Nc1nc(Nc2ccccc2P(O)(C)C)c(cn1)Cl", "medicinal_chemistry_metrics": {"Ki": 0.0, "Kd": 0.0, "IC50": 370.0, "selectivity": 0}, "pharm_metrics_vitro": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "EC50": 0.0, "selectivity": 0, "hERG": 0.0, "solubility": 0.0}, "pharm_metrics_vivo": {"ED50": 0.0, "AUC": 2268.0, "solubility": 0.0, "t_half": 4.8, "bioavailability": 52.0}, "clinical_statistics": {"p1_company_num": 12, "p1_stat_company_num": [0, 1, 0, 0, 0, 0, 11, 0, 0], "p1_company": [[], ["Northwestern University"], [], [], [], [], ["Massachusetts General Hospital", "Institut für Klinische Krebsforschung IKF GmbH", "Takeda", "NRG Oncology", "Princess Maxima Center for Pediatric Oncology in The Netherlands", "Ohio State University Comprehensive Cancer Center", "Ariad Pharmaceuticals", "Fondazione per la Medicina Personalizzata", "Duke University", "University of California, San Francisco", "Lyon - URCOT"], [], []], "p1_terminate_reason": {}, "p1_withdraw_reason": {}, "p1_adverse_event": {}, "p2_company_num": 11, "p2_stat_company_num": [1, 7, 0, 2, 0, 0, 1, 0, 0], "p2_company": [["Princess Maxima Center for Pediatric Oncology in The Netherlands"], ["Massachusetts General Hospital", "Institut für Klinische Krebsforschung IKF GmbH", "Ohio State University Comprehensive Cancer Center", "Fondazione per la Medicina Personalizzata", "Duke University", "University of California, San Francisco", "Lyon - URCOT"], [], ["Ariad Pharmaceuticals", "NRG Oncology"], [], [], ["Takeda"], [], []], "p2_terminate_reason": {}, "p2_withdraw_reason": {}, "p2_adverse_event": {"Takeda": 0.5321100917431193}, "p3_company_num": 1, "p3_stat_company_num": [0, 1, 0, 0, 0, 0, 0, 0, 0], "p3_company": [[], ["Takeda"], [], [], [], [], [], [], []], "p3_terminate_reason": {}, "p3_withdraw_reason": {}, "p3_adverse_event": {}}}, {"id": 23, "paper_title": "9-Substituted 6,6-Dimethyl-11-oxo-6,11-dihydro-5H-benzo[b]carbazoles as Highly Selective and Potent Anaplastic Lymphoma Kinase Inhibitors", "paper_author": ["Kazutomo Kinoshita", "Takamitsu Kobayashi", "Kohsuke Asoh", "Noriyuki Furuichi", "Toshiya Ito", "Hatsuo Kawada", "Sousuke Hara", "Jun Ohwada", "Kazuo Hattori", "Takuho Miyagi", "Woo-Sang Hong", "Min-Jeong Park", "Kenji Takanashi", "Toshiyuki Tsukaguchi", "Hiroshi Sakamoto", "Takuo Tsukuda", "Nobuhiro Oikawa"], "paper_year": 2011, "paper_institution": "Research Division, Chugai Pharmaceutical Co., Ltd., 200 Kajiwara, Kamakura, Kanagawa 247-8530, Japan", "paper_cited": 53, "doi": "10.1021/jm200652u", "paper_journal": "Journal of Medicinal Chemistry", "paper_abstract_image": "https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-18/jm200652u/production/images/large/jm-2011-00652u_0009.jpeg", "compound_count": 24, "compound_name": "13d", "compound_name_drug": "", "compound_smiles": "", "medicinal_chemistry_metrics": {"Ki": 0.0, "Kd": 0.0, "IC50": 5000.0, "selectivity": 0}, "pharm_metrics_vitro": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "EC50": 0.0, "selectivity": 0, "hERG": 0.0, "solubility": 0.0}, "pharm_metrics_vivo": {"ED50": 0.0, "AUC": 0.0, "solubility": 0.0, "t_half": 0.0, "bioavailability": 0.0}, "clinical_statistics": {}}, {"id": 24, "paper_title": "Design of Potent and Selective Inhibitors to Overcome Clinical Anaplastic Lymphoma Kinase Mutations Resistant to Crizotinib", "paper_author": ["Qinhua Huang", "Ted W. Johnson", "Simon Bailey", "Alexei Brooun", "Kevin D. Bunker", "Benjamin J. Burke", "Michael R. Collins", "Andrew S. Cook", "J. Jean Cui", "Kevin N. Dack", "Judith G. Deal", "Ya-Li Deng", "Dac Dinh", "Lars D. Engstrom", "Mingying He", "Jacqui Hoffman", "Robert L. Hoffman", "Patrick S. Johnson", "Robert S. Kania", "Hieu Lam", "Justine L. Lam", "Phuong T. Le", "Qiuhua Li", "Laura Lingardo", "Wei Liu", "Melissa West Lu", "Michele McTigue", "Cynthia L. Palmer", "Paul F. Richardson", "Neal W. Sach", "Hong Shen", "Tod Smeal", "Graham L. Smith", "Albert E. Stewart", "Sergei Timofeevski", "Konstantinos Tsaparikos", "Hui Wang", "Huichun Zhu", "Jinjiang Zhu", "Helen Y. Zou", "Martin P. Edwards"], "paper_year": 2014, "paper_institution": "La Jolla Laboratories, Pfizer Worldwide Research and Development, 10770 Science Center Drive, San Diego, California 92121, United States", "paper_cited": 67, "doi": "10.1021/jm401805h", "paper_journal": "Journal of Medicinal Chemistry", "paper_abstract_image": "https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401805h/production/images/large/jm-2013-01805h_0021.jpeg", "compound_count": 53, "compound_name": "1", "compound_name_drug": "", "compound_smiles": "", "medicinal_chemistry_metrics": {"Ki": 0.0, "Kd": 0.0, "IC50": 800.0, "selectivity": 0}, "pharm_metrics_vitro": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "EC50": 0.0, "selectivity": 0, "hERG": 0.0, "solubility": 0.0}, "pharm_metrics_vivo": {"ED50": 0.0, "AUC": 0.0, "solubility": 0.0, "t_half": 0.0, "bioavailability": 0.0}, "clinical_statistics": {}}, {"id": 25, "paper_title": "Identification of 4-Phenoxyquinoline Based Inhibitors for L1196M Mutant of Anaplastic Lymphoma Kinase by Structure-Based Design", "paper_author": ["Shinmee Mah", "Jung Hee Park", "Hoi-Yun Jung", "Kukcheol Ahn", "Soyeon Choi", "Hyun Seop Tae", "Kyung Hee Jung", "Jin Kyung Rho", "Jae Cheol Lee", "Soon-Sun Hong", "Sungwoo Hong"], "paper_year": 2017, "paper_institution": "Department of Chemistry, Korea Advanced Institute of Science and Technology (KAIST), Daejeon 34141, Korea", "paper_cited": 12, "doi": "10.1021/acs.jmedchem.7b01039", "paper_journal": "Journal of Medicinal Chemistry", "paper_abstract_image": "https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b01039/20171117/images/large/jm-2017-01039t_0016.jpeg", "compound_count": 33, "compound_name": "30", "compound_name_drug": "", "compound_smiles": "", "medicinal_chemistry_metrics": {"Ki": 0.0, "Kd": 0.0, "IC50": 7.1000000000000005, "selectivity": 0}, "pharm_metrics_vitro": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "EC50": 0.0, "selectivity": 0, "hERG": 0.0, "solubility": 0.0}, "pharm_metrics_vivo": {"ED50": 0.0, "AUC": 155.1, "solubility": 0.0, "t_half": 3.5, "bioavailability": 0.0}, "clinical_statistics": {}}, {"id": 26, "paper_title": "Targeting Cysteine Located Outside the Active Site: An Effective Strategy for Covalent ALKi Design", "paper_author": ["Guoyi Yan", "Xinxin Zhong", "Chunlan Pu", "Lin Yue", "Huifang Shan", "Suke Lan", "Meng Zhou", "Xueyan Hou", "Jie Yang", "Deyu Li", "Shilong Fan", "Rui Li"], "paper_year": 2021, "paper_institution": "", "paper_cited": 1, "doi": "10.1021/acs.jmedchem.0c01707", "paper_journal": "Journal of Medicinal Chemistry", "paper_abstract_image": "https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01707/20210204/images/large/jm0c01707_0013.jpeg", "compound_count": 24, "compound_name": "Con B-1", "compound_name_drug": "", "compound_smiles": "", "medicinal_chemistry_metrics": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "selectivity": 0}, "pharm_metrics_vitro": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "EC50": 0.0, "selectivity": 0, "hERG": 0.0, "solubility": 0.0}, "pharm_metrics_vivo": {"ED50": 0.0, "AUC": 0.0, "solubility": 0.0, "t_half": 0.0, "bioavailability": 0.0}, "clinical_statistics": {}}, {"id": 27, "paper_title": "Identification of the First Selective Activin Receptor-Like Kinase 1 Inhibitor, a Reversible Version of L-783277", "paper_author": ["Hanna Cho", "Sandip Sengupta", "Sean S. H. Jeon", "Wooyoung Hur", "Hwan Geun Choi", "Hong-Seog Seo", "Byung Joo Lee", "Jeong Hun Kim", "Minhwan Chung", "Noo Li Jeon", "Nam Doo Kim", "Taebo Sim"], "paper_year": 2017, "paper_institution": "KU-KIST Graduate School of Converging Science and Technology, Korea University, 145 Anam-ro, Seongbuk-gu, Seoul 02841, Republic of Korea", "paper_cited": 3, "doi": "10.1021/acs.jmedchem.6b01679", "paper_journal": "Journal of Medicinal Chemistry", "paper_abstract_image": "https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-4/acs.jmedchem.6b01679/20170216/images/large/jm-2016-01679v_0008.jpeg", "compound_count": 28, "compound_name": "1", "compound_name_drug": "L-783277", "compound_smiles": "", "medicinal_chemistry_metrics": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "selectivity": 0}, "pharm_metrics_vitro": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "EC50": 0.0, "selectivity": 0, "hERG": 0.0, "solubility": 0.0}, "pharm_metrics_vivo": {"ED50": 0.0, "AUC": 0.0, "solubility": 0.0, "t_half": 0.0, "bioavailability": 0.0}, "clinical_statistics": {}}, {"id": 28, "paper_title": "Discovery of a Brigatinib Degrader SIAIS164018 with Destroying Metastasis-Related Oncoproteins and a Reshuffling Kinome Profile", "paper_author": ["Chaowei Ren", "Ning Sun", "Haixia Liu", "Ying Kong", "Renhong Sun", "Xing Qiu", "Jinju Chen", "Yan Li", "Jianshui Zhang", "Yuedong Zhou", "Hui Zhong", "Qianqian Yin", "Xiaoling Song", "Xiaobao Yang", "Biao Jiang"], "paper_year": 2021, "paper_institution": "", "paper_cited": -1, "doi": "10.1021/acs.jmedchem.1c00373", "paper_journal": "Journal of Medicinal Chemistry", "paper_abstract_image": "https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00373/20210629/images/large/jm1c00373_0012.jpeg", "compound_count": 6, "compound_name": "1–11", "compound_name_drug": "Brigatinib Degrader SIAIS164018", "compound_smiles": "", "medicinal_chemistry_metrics": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "selectivity": 0}, "pharm_metrics_vitro": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "EC50": 0.0, "selectivity": 0, "hERG": 0.0, "solubility": 0.0}, "pharm_metrics_vivo": {"ED50": 0.0, "AUC": 0.0, "solubility": 0.0, "t_half": 0.0, "bioavailability": 0.0}, "clinical_statistics": {}}, {"id": 29, "paper_title": "Medicinal Chemistry Strategies for the Development of Kinase Inhibitors Targeting Point Mutations", "paper_author": ["Xiaoyun Lu", "Jeff B. Smaill", "Ke Ding"], "paper_year": 2020, "paper_institution": "", "paper_cited": 7, "doi": "10.1021/acs.jmedchem.0c00507", "paper_journal": "Journal of Medicinal Chemistry", "paper_abstract_image": "https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c00507/20201019/images/large/jm0c00507_0013.jpeg", "compound_count": 29, "compound_name": "19", "compound_name_drug": "", "compound_smiles": "", "medicinal_chemistry_metrics": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "selectivity": 0}, "pharm_metrics_vitro": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "EC50": 0.0, "selectivity": 0, "hERG": 0.0, "solubility": 0.0}, "pharm_metrics_vivo": {"ED50": 0.0, "AUC": 0.0, "solubility": 0.0, "t_half": 0.0, "bioavailability": 0.0}, "clinical_statistics": {}}, {"id": 30, "paper_title": "Design, Synthesis, and Pharmacological Evaluation of Novel Multisubstituted Pyridin-3-amine Derivatives as Multitargeted Protein Kinase Inhibitors for the Treatment of Non-Small Cell Lung Cancer", "paper_author": ["Wei Zhu", "Hui Chen", "Yulan Wang", "Jiang Wang", "Xia Peng", "Xianjie Chen", "Yinglei Gao", "Chunpu Li", "Yulong He", "Jing Ai", "Meiyu Geng", "Mingyue Zheng", "Hong Liu"], "paper_year": 2017, "paper_institution": "†State Key Laboratory of Drug Research and ‡CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai, 201203, China", "paper_cited": 14, "doi": "10.1021/acs.jmedchem.7b00076", "paper_journal": "Journal of Medicinal Chemistry", "paper_abstract_image": "https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00076/20170721/images/large/jm-2017-00076u_0015.jpeg", "compound_count": 73, "compound_name": "3m", "compound_name_drug": "", "compound_smiles": "", "medicinal_chemistry_metrics": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "selectivity": 0}, "pharm_metrics_vitro": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "EC50": 0.0, "selectivity": 0, "hERG": 0.0, "solubility": 0.0}, "pharm_metrics_vivo": {"ED50": 0.0, "AUC": 0.0, "solubility": 0.0, "t_half": 0.0, "bioavailability": 0.0}, "clinical_statistics": {}}, {"id": 31, "paper_title": "Identification of 1,5-Naphthyridine Derivatives as a Novel Series of Potent and Selective TGF-β Type I Receptor Inhibitors", "paper_author": ["Françoise Gellibert", "James Woolven", "Marie-Hélène Fouchet", "Neil Mathews", "Helen Goodland", "Victoria Lovegrove", "Alain Laroze", "Van-Loc Nguyen", "Stéphane Sautet", "Ruolan Wang", "Cheryl Janson", "Ward Smith", "Gaël Krysa", "Valérie Boullay", "Anne-Charlotte de Gouville", "Stéphane Huet", "David Hartley"], "paper_year": 2004, "paper_institution": "Departments of Medicinal Chemistry and Biology, GlaxoSmithKline, 25-27 Avenue du Québec, 91951 Les Ulis, France, Discovery Research, Computational and Structural Science, and Department of Medicinal Chemistry, GlaxoSmithKline, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, United Kingdom, Discovery Research, Assay Development and Compound Profiling, GlaxoSmithKline, Five Moore Drive, P.O. Box 13398, Research Triangle Park, North Carolina 27709, and Discovery Research, GlaxoSmithKline, 709 Swedeland Road, King of Prussia, Pennsylvania 19406 ", "paper_cited": 126, "doi": "10.1021/jm0400247", "paper_journal": "Journal of Medicinal Chemistry", "paper_abstract_image": "https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2004/jmcmar.2004.47.issue-18/jm0400247/production/images/large/jm0400247n00001.jpeg", "compound_count": 105, "compound_name": "1", "compound_name_drug": "", "compound_smiles": "c1cc2nc(ccc2nc1)/C(=C(/N=C(/N)\\C)\\C(=C\\C=C/C(=C)C)\\C)/C", "medicinal_chemistry_metrics": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "selectivity": 0}, "pharm_metrics_vitro": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "EC50": 0.0, "selectivity": 0, "hERG": 0.0, "solubility": 0.0}, "pharm_metrics_vivo": {"ED50": 0.0, "AUC": 0.0, "solubility": 0.0, "t_half": 0.0, "bioavailability": 0.0}, "clinical_statistics": {}}, {"id": 32, "paper_title": "Discovery of N-((4-([1,2,4]Triazolo[1,5-a]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1H-imidazol-2-yl)methyl)-2-fluoroaniline (EW-7197): A Highly Potent, Selective, and Orally Bioavailable Inhibitor of TGF-β Type I Receptor Kinase as Cancer Immunotherapeutic/Antifibrotic Agent", "paper_author": ["Cheng Hua Jin", "Maddeboina Krishnaiah", "Domalapally Sreenu", "Vura B. Subrahmanyam", "Kota S. Rao", "Hwa Jeong Lee", "So-Jung Park", "Hyun-Ju Park", "Kiho Lee", "Yhun Yhong Sheen", "Dae-Kee Kim"], "paper_year": 2014, "paper_institution": "Graduate School of Pharmaceutical Sciences, College of Pharmacy, Ewha Womans University, 11-1 Daehyun-dong, Seodaemun-gu, Seoul 120-750, Korea", "paper_cited": 64, "doi": "10.1021/jm500115w", "paper_journal": "Journal of Medicinal Chemistry", "paper_abstract_image": "https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm500115w/20160122/images/large/jm-2014-00115w_0012.jpeg", "compound_count": 51, "compound_name": "12b", "compound_name_drug": "", "compound_smiles": "", "medicinal_chemistry_metrics": {"Ki": 0.0, "Kd": 0.0, "IC50": 9.0, "selectivity": 1}, "pharm_metrics_vitro": {"Ki": 0.0, "Kd": 0.0, "IC50": 31040.0, "EC50": 0.0, "selectivity": 0, "hERG": 0.0, "solubility": 0.0}, "pharm_metrics_vivo": {"ED50": 0.0, "AUC": 0.0, "solubility": 0.0, "t_half": 0.0, "bioavailability": 0.0}, "clinical_statistics": {}}, {"id": 33, "paper_title": "Novel Quinazolinone Inhibitors of ALK2 Flip between Alternate Binding Modes: Structure–Activity Relationship, Structural Characterization, Kinase Profiling, and Cellular Proof of Concept", "paper_author": ["Liam Hudson", "James Mui", "Santiago Vázquez", "Diana M. Carvalho", "Eleanor Williams", "Chris Jones", "Alex N. Bullock", "Swen Hoelder"], "paper_year": 2018, "paper_institution": "", "paper_cited": 21, "doi": "10.1021/acs.jmedchem.8b00782", "paper_journal": "Journal of Medicinal Chemistry", "paper_abstract_image": "https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00782/20180816/images/large/jm-2018-00782w_0014.jpeg", "compound_count": 35, "compound_name": "16", "compound_name_drug": "", "compound_smiles": "", "medicinal_chemistry_metrics": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "selectivity": 0}, "pharm_metrics_vitro": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "EC50": 0.0, "selectivity": 0, "hERG": 0.0, "solubility": 0.0}, "pharm_metrics_vivo": {"ED50": 0.0, "AUC": 0.0, "solubility": 0.0, "t_half": 0.0, "bioavailability": 0.0}, "clinical_statistics": {}}, {"id": 34, "paper_title": "Identification of Novel Inhibitors of the Transforming Growth Factor β1 (TGF-β1) Type 1 Receptor (ALK5)", "paper_author": ["James F. Callahan", "Joelle L. Burgess", "James A. Fornwald", "Laramie M. Gaster", "John D. Harling", "Frank P. Harrington", "Jag Heer", "Chet Kwon", "Ruth Lehr", "A. Mathur", "Barbara A. Olson", "Joseph Weinstock", "Nicholas J. Laping"], "paper_year": 2002, "paper_institution": "Department of Medicinal Chemistry, GlaxoSmithKline Pharmaceuticals, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426, Departments of Medicinal Chemistry, Renal Pharmacology, Protein Biochemistry, and Gene Expression Sciences, GlaxoSmithKline Pharmaceuticals, 709 Swedeland Road, King of Prussia, Pennsylvania 19406, and Department of Medicinal Chemistry, New Frontiers Science Park (North), Coldharbour Road, Harlow, Essex CM19 5AD, England ", "paper_cited": 237, "doi": "10.1021/jm010493y", "paper_journal": "Journal of Medicinal Chemistry", "paper_abstract_image": "https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-5/jm010493y/production/images/large/jm010493yn00001.jpeg", "compound_count": 14, "compound_name": "14", "compound_name_drug": "", "compound_smiles": "", "medicinal_chemistry_metrics": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "selectivity": 0}, "pharm_metrics_vitro": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "EC50": 0.0, "selectivity": 0, "hERG": 0.0, "solubility": 0.0}, "pharm_metrics_vivo": {"ED50": 0.0, "AUC": 0.0, "solubility": 0.0, "t_half": 0.0, "bioavailability": 0.0}, "clinical_statistics": {}}, {"id": 35, "paper_title": "Rapid Generation of a High Quality Lead for Transforming Growth Factor-β (TGF-β) Type I Receptor (ALK5)†", "paper_author": ["Frederick W. Goldberg", "Richard A. Ward", "Steven J. Powell", "Judit É. Debreczeni", "Richard A. Norman", "Nicola J. Roberts", "Allan P. Dishington", "Helen J. Gingell", "Kate F. Wickson", "Andrew L. Roberts"], "paper_year": 2009, "paper_institution": "AstraZeneca, Mereside, Alderley Park, Macclesfield SK10 4TG, U.K.", "paper_cited": 25, "doi": "10.1021/jm900807w", "paper_journal": "Journal of Medicinal Chemistry", "paper_abstract_image": "https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-23/jm900807w/production/images/large/jm-2009-00807w_0006.jpeg", "compound_count": 15, "compound_name": "19", "compound_name_drug": "", "compound_smiles": "", "medicinal_chemistry_metrics": {"Ki": 0.0, "Kd": 0.0, "IC50": 72.0, "selectivity": 0}, "pharm_metrics_vitro": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "EC50": 0.0, "selectivity": 0, "hERG": 0.0, "solubility": 0.0}, "pharm_metrics_vivo": {"ED50": 0.0, "AUC": 75.0, "solubility": 0.0, "t_half": 0.0, "bioavailability": 0.0}, "clinical_statistics": {}}, {"id": 36, "paper_title": "Discovery of 4-{4-[3-(Pyridin-2-yl)-1H-pyrazol-4-yl]pyridin-2-yl}-N-(tetrahydro-2H- pyran-4-yl)benzamide (GW788388):  A Potent, Selective, and Orally Active Transforming Growth Factor-β Type I Receptor Inhibitor", "paper_author": ["Françoise Gellibert", "Anne-Charlotte de Gouville", "James Woolven", "Neil Mathews", "Van-Loc Nguyen", "Cécile Bertho-Ruault", "Angela Patikis", "Eugene T. Grygielko", "Nicholas J. Laping", "Stéphane Huet"], "paper_year": 2006, "paper_institution": "Department of Medicinal Chemistry and Biology, GlaxoSmithKline, 25−27 Avenue du Québec, 91951 Les Ulis, France, Computational and Structural Sciences, Department of Drug Metabolism and Pharmacokinetics, GlaxoSmithKline, GunnelsWood Road, Stevenage, Hertfordshire SG1 2NY, United Kingdom, Department of Medicinal Chemistry, GlaxoSmithKline, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, United Kingdom, and Departments of Renal and Urology Research, GlaxoSmithKline Pharmaceuticals, King of Prussia, Pennsylvania ", "paper_cited": 76, "doi": "10.1021/jm0509905", "paper_journal": "Journal of Medicinal Chemistry", "paper_abstract_image": "https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-7/jm0509905/production/images/large/jm0509905n00001.jpeg", "compound_count": 175, "compound_name": "13d", "compound_name_drug": "GW788388", "compound_smiles": "C=C(c1ccc(c2cc(c3c[nH]nc3c3ncccc3)ccn2)cc1)C", "medicinal_chemistry_metrics": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "selectivity": 0}, "pharm_metrics_vitro": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "EC50": 0.0, "selectivity": 0, "hERG": 0.0, "solubility": 0.0}, "pharm_metrics_vivo": {"ED50": 0.0, "AUC": 0.0, "solubility": 0.0, "t_half": 0.0, "bioavailability": 0.0}, "clinical_statistics": {}}, {"id": 37, "paper_title": "Leveraging an Open Science Drug Discovery Model to Develop CNS-Penetrant ALK2 Inhibitors for the Treatment of Diffuse Intrinsic Pontine Glioma", "paper_author": ["David Smil", "Jong Fu Wong", "Eleanor P. Williams", "Roslin J. Adamson", "Alison Howarth", "David A. McLeod", "Ahmed Mamai", "Soyoung Kim", "Brian J. Wilson", "Taira Kiyota", "Ahmed Aman", "Julie Owen", "Gennady Poda", "Kurumi Y. Horiuchi", "Ekaterina Kuznetsova", "Haiching Ma", "J. Nicole Hamblin", "Sue Cramp", "Owen G. Roberts", "Aled M. Edwards", "David Uehling", "Rima Al-awar", "Alex N. Bullock", "Jeff A. O’Meara", "Methvin B. Isaac"], "paper_year": 2020, "paper_institution": "", "paper_cited": 2, "doi": "10.1021/acs.jmedchem.0c01199", "paper_journal": "Journal of Medicinal Chemistry", "paper_abstract_image": "https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01199/20200915/images/large/jm0c01199_0017.jpeg", "compound_count": 96, "compound_name": "6a", "compound_name_drug": "", "compound_smiles": "C1CN(CCN1)c1ccc(c2cncc(c3cc(OC)c(OC)c(OC)c3)c2C)cc1", "medicinal_chemistry_metrics": {"Ki": 0.0, "Kd": 0.0, "IC50": 19.0, "selectivity": 0}, "pharm_metrics_vitro": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "EC50": 0.0, "selectivity": 0, "hERG": 0.0, "solubility": 0.0}, "pharm_metrics_vivo": {"ED50": 0.0, "AUC": 0.0, "solubility": 0.0, "t_half": 0.0, "bioavailability": 0.0}, "clinical_statistics": {}}, {"id": 38, "paper_title": "Synthesis and Biological Evaluation of 4(5)-(6-Alkylpyridin-2-yl)imidazoles as Transforming Growth Factor-β Type 1 Receptor Kinase Inhibitors", "paper_author": ["Dae-Kee Kim", "Yoojeung Jang", "Ho Soon Lee", "Hyun-Ju Park", "Jakyung Yoo"], "paper_year": 2007, "paper_institution": "College of Pharmacy, Ewha Womans University, 11-1 Daehyun-dong, Seodaemun-gu, Seoul 120-750, Korea, In2Gen Co., Ltd., 608 Daerung Posttower II Building, 182-13 Guro-dong, Guro-gu, Seoul 152-050, Korea, and College of Pharmacy, Sungkyunkwan University, Suwon 440-746, Korea ", "paper_cited": 39, "doi": "10.1021/jm070129k", "paper_journal": "Journal of Medicinal Chemistry", "paper_abstract_image": "https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-13/jm070129k/production/images/large/jm070129kn00001.jpeg", "compound_count": 63, "compound_name": "13e", "compound_name_drug": "", "compound_smiles": "c1c(nc(cc1)c1c(c2cc3OCOc3cc2)nc([nH]1)NCC1=CC=[C](#N)(C=C1)C)C", "medicinal_chemistry_metrics": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "selectivity": 0}, "pharm_metrics_vitro": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "EC50": 0.0, "selectivity": 0, "hERG": 0.0, "solubility": 0.0}, "pharm_metrics_vivo": {"ED50": 0.0, "AUC": 0.0, "solubility": 0.0, "t_half": 0.0, "bioavailability": 0.0}, "clinical_statistics": {}}, {"id": 39, "paper_title": "Discovery of 2,4-pyrimidinediamine derivatives as potent dual inhibitors of ALK and HDAC", "paper_author": ["Tao Pan", "Yanrong Dan", "Dafeng Guo", "Junhao Jiang", "Dongzhi Ran", "Lin Zhang", "Binghua Tian", "Jianyong Yuan", "Yu Yu", "Zongjie Gan"], "paper_year": 2021, "paper_institution": "Department of Medicinal Chemistry, College of Pharmacy, Chongqing Medical University, Chongqing 400016, PR China", "paper_cited": 0, "doi": "10.1016/j.ejmech.2021.113672", "paper_journal": "European Journal of Medicinal Chemistry", "paper_abstract_image": "https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421005213-ga1_lrg.jpg", "compound_count": 58, "compound_name": "10f", "compound_name_drug": "", "compound_smiles": "CC(S(=O)(=O)c1ccccc1Nc1c(Cl)cnc(Nc2c(OC(C)C)cc(c(c2)CI)C2CCNCC2)n1)C", "medicinal_chemistry_metrics": {"Ki": 0.0, "Kd": 0.0, "IC50": 7.9, "selectivity": 0}, "pharm_metrics_vitro": {"Ki": 0.0, "Kd": 0.0, "IC50": 640.0, "EC50": 0.0, "selectivity": 20, "hERG": 0.0, "solubility": 0.0}, "pharm_metrics_vivo": {"ED50": 0.0, "AUC": 205.1, "solubility": 0.0, "t_half": 0.42, "bioavailability": 0.0}, "clinical_statistics": {}}, {"id": 40, "paper_title": "Structure-based optimization identified novel furyl-containing 2,4-diarylaminopyrimidine analogues as ALK/ROS1 dual inhibitors with anti-mutation effects", "paper_author": ["Ming Guo", "Daiying Zuo", "Tianming Zhao", "Xiangyu Li", "Jianshuang Cao", "Yuxuan Qiu", "Shangfei Wei", "Xin Zhai"], "paper_year": 2021, "paper_institution": "Key Laboratory of Structure-Based Drug Design and Discovery, Ministry of Education, Shenyang Pharmaceutical University, Shenyang, 110016, China", "paper_cited": 0, "doi": "10.1016/j.ejmech.2021.113259", "paper_journal": "European Journal of Medicinal Chemistry", "paper_abstract_image": "https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421001082-fx1_lrg.jpg", "compound_count": 39, "compound_name": "16", "compound_name_drug": "", "compound_smiles": "", "medicinal_chemistry_metrics": {"Ki": 0.0, "Kd": 0.0, "IC50": 2.8, "selectivity": 0}, "pharm_metrics_vitro": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "EC50": 0.0, "selectivity": 0, "hERG": 0.0, "solubility": 0.0}, "pharm_metrics_vivo": {"ED50": 0.0, "AUC": 0.0, "solubility": 0.0, "t_half": 0.0, "bioavailability": 0.0}, "clinical_statistics": {}}, {"id": 41, "paper_title": " activity", "paper_author": ["Guoyi Yan", "Xinxin Zhong", "Lin Yue", "Chunlan Pu", "Huifang Shan", "Suke Lan", "Meng Zhou", "Xueyan Hou", "Jie Yang", "Rui Li"], "paper_year": 2021, "paper_institution": "State Key Laboratory of Biotherapy, Collaborative Innovation Center of Biotherapy and Cancer Center, West China Hospital of Sichuan University, Chengdu, China", "paper_cited": 2, "doi": "10.1016/j.ejmech.2020.113150", "paper_journal": "European Journal of Medicinal Chemistry", "paper_abstract_image": "https://api.elsevier.com/content/object/eid/1-s2.0-S0223523420311223-fx1_lrg.jpg", "compound_count": 10, "compound_name": "B3", "compound_name_drug": "", "compound_smiles": "S(=O)(=O)(C(C)C)c1c(Nc2nc(Nc3c(cc(C4CCN(CC4)CCC(=O)NCCOCCOCCOCCNc4cccc5C(=O)N(C6CCC(=O)NC6=O)C(=O)c45)c(c3)C)OC(C)C)ncc2Cl)cccc1", "medicinal_chemistry_metrics": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "selectivity": 0}, "pharm_metrics_vitro": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "EC50": 0.0, "selectivity": 0, "hERG": 0.0, "solubility": 0.0}, "pharm_metrics_vivo": {"ED50": 0.0, "AUC": 0.0, "solubility": 0.0, "t_half": 0.0, "bioavailability": 0.0}, "clinical_statistics": {"p1_company_num": 127, "p1_stat_company_num": [0, 8, 0, 3, 0, 4, 111, 0, 1], "p1_company": [[], ["Y-Biologics", "University of Illinois at Chicago College of Medicine", "InteRNA", "CSL Behring", "LundbeckClinicalTrials@Lundbeck.com", "Idorsia Pharmaceuticals Ltd.", "University of Minnesota", "The Medicines Evaluation Unit"], [], ["UCSD Morres Cancer Center", "Washington University School of Medicine", "City of Hope Comprehensive Cancer Center"], [], ["Abbott", "AstraZeneca", "Karyopharm Therapeutics Inc", "Center for Human Drug Research"], ["M.D. Anderson Cancer Center", "McGill University Health Centre/Research Institute of the McGill University Health Centre", "Beijing Friendship Hospital", "Amphastar Pharmaceuticals, Inc.", "University of Colorado, Denver", "Ipsen", "Johns Hopkins University", "Roswell Park Cancer Institute", "michel.willemsen@radboudumc.nl", "Eisai Inc.", "National Heart, Lung, and Blood Institute (NHLBI)", "University of Kansas Medical Center", "Fondazione IRCCS Istituto Nazionale dei Tumori, Milano", "Oregon Health and Science University", "Hoffmann-La Roche", "Janssen R&D Ireland", "Takeda", "AstraZeneca Molndal, Sweden", "Universitätsklinikum Hamburg-Eppendorf", "Avid Radiopharmaceuticals, Inc.", "Haydom Lutheran Hospital", "Associate Professor of Psychiatry and Human Behavior", "Senior Medical Research Director, Quintiles", "Daiichi Sankyo, Inc.", "Celgene", "Duke Cancer Institute", "Amgen", "A/Z Clinical", "RAND", "University of Calgary", "NYU Langone Medical Center", "University of Miami", "Nouvo Policlinico \"LE SCOTTE'", "Regents of the University of California", "Bristol-Myers Squibb", "Hamilton Health Sciences Corporation", "Pfizer", "Angion Biomedica", "UCSD Medical Center", "Medical Mission Institute, Würzburg, Germany", "Northwestern University", "Millennium Pharmaceuticals, Inc.", "BioNTech SE", "Novartis Pharmaceuticals", "Wayne State University", "Actelion", "Sponsor Chief Investigator, Imperial College London", "St. Jude Children's Research Hospital", "Section of Pediatric Infectious Diseases, Boston Medical Center", "Imperial College London", "University of Maryland, College Park", "Amphastar Pharmeceuticals, Inc.", "Merck Sharp & Dohme Corp.", "HM-CIOCC, Hospital HM Delfos, HM Hospitales, Barcelona (Spain)", "Institut Curie, Paris, France", "Tom Baker Cancer Centre", "Janssen Research & Development, LLC", "SUNY at Stony Brook", "Quintiles Phase I unit 6700 w 115th st Overland Park, Ks 66211", "PROFESSOR OF MEDICINE", "Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center", "UConn Health", "Fudan University", "Brigham and Women's Hospital", "Swinburne University", "National Cancer Institute (NCI)", "Novo Nordisk A/S", "Eli Lilly and Company", "Bayer", "Usona Institute", "OHSU Knight Cancer Institute", "Shanghai Children's Medical Center", "Peking University First Hospital", "General Faculty Hospital, Charles University", "NIDDK, NIH", "Sanofi Pasteur Inc.", "Floyd & Delores Jones Cancer Institute at Virginia Mason Medical Center", "Department of Clinical Pharmacology", "Center for Human Drug Research (The Netherlands)", "Fujian Medical University Union Hospital", "Covance Clinical Research Unit", "Tennessee Oncology", "AbbVie", "University of Pennsylvania", "Novartis Vaccines", "Princess Margaret Hospital, Canada", "Medpace, Inc.", "Samsung Medical Center", "Melbourne Health", "Wyeth is now a wholly owned subsidiary of Pfizer", "University of North Carolina, Chapel Hill", "BBB Therapeutics", "Jiangsu Provincal Center for Disease Control and Prevention", "Virobay Inc.", "Dana-Farber Cancer Institute", "Scottsdale Clinical Research Institute, USA", "Istituto Clinico Humanitas", "Shanghai Zhongshan Hospital", "Nuvisan GmbH", "urology and nephrology center", "NKI-AvL", "Stanford University", "Robert H. Lurie Cancer Center", "Avid Radiopharmaceuticals", "GlaxoSmithKline", "Central Institute of Mental Health, Mannheim", "Adelaide, SA 5000 Australia", "South East Dermatology, South East Dermatology, Carina QLD 4152, Australia", "University Hospital of Basel", "University of Aarhus", "Institute of Tropical Medicine, University of Tuebingen"], [], ["The Netherlands Cancer Institute"]], "p1_terminate_reason": {}, "p1_withdraw_reason": {}, "p1_adverse_event": {}, "p2_company_num": 88, "p2_stat_company_num": [4, 16, 0, 5, 0, 5, 54, 0, 4], "p2_company": [["Bristol-Myers Squibb", "HM-CIOCC, Hospital HM Delfos, HM Hospitales, Barcelona (Spain)", "Tennessee Oncology", "Roswell Park Cancer Institute"], ["M.D. Anderson Cancer Center", "National Heart, Lung, and Blood Institute (NHLBI)", "Fondazione IRCCS Istituto Nazionale dei Tumori, Milano", "Institut Curie, Paris, France", "University of Colorado, Denver", "University of Miami", "Brigham and Women's Hospital", "Central Institute of Mental Health, Mannheim", "National Cancer Institute (NCI)", "Associate Professor of Psychiatry and Human Behavior", "St. Jude Children's Research Hospital", "Jiangsu Provincal Center for Disease Control and Prevention", "Celgene", "University of Aarhus", "Usona Institute", "Tom Baker Cancer Centre"], [], ["Janssen Research & Development, LLC", "BioNTech SE", "Samsung Medical Center", "Daiichi Sankyo, Inc.", "Istituto Clinico Humanitas"], [], ["Takeda", "GlaxoSmithKline", "Scottsdale Clinical Research Institute, USA", "Bayer", "OHSU Knight Cancer Institute"], ["McGill University Health Centre/Research Institute of the McGill University Health Centre", "Beijing Friendship Hospital", "SUNY at Stony Brook", "PROFESSOR OF MEDICINE", "Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center", "UConn Health", "Amphastar Pharmaceuticals, Inc.", "Fudan University", "Ipsen", "Swinburne University", "Novo Nordisk A/S", "Eli Lilly and Company", "Johns Hopkins University", "Eisai Inc.", "University of Kansas Medical Center", "Oregon Health and Science University", "Shanghai Children's Medical Center", "General Faculty Hospital, Charles University", "Hoffmann-La Roche", "AstraZeneca Molndal, Sweden", "Universitätsklinikum Hamburg-Eppendorf", "NIDDK, NIH", "Avid Radiopharmaceuticals, Inc.", "Floyd & Delores Jones Cancer Institute at Virginia Mason Medical Center", "Sanofi Pasteur Inc.", "Haydom Lutheran Hospital", "A/Z Clinical", "RAND", "Fujian Medical University Union Hospital", "NYU Langone Medical Center", "University of Calgary", "Nouvo Policlinico \"LE SCOTTE'", "Regents of the University of California", "AbbVie", "Hamilton Health Sciences Corporation", "Pfizer", "Novartis Vaccines", "Princess Margaret Hospital, Canada", "Melbourne Health", "Wyeth is now a wholly owned subsidiary of Pfizer", "BBB Therapeutics", "Dana-Farber Cancer Institute", "UCSD Medical Center", "Medical Mission Institute, Würzburg, Germany", "Shanghai Zhongshan Hospital", "Northwestern University", "Stanford University", "Robert H. Lurie Cancer Center", "Novartis Pharmaceuticals", "Avid Radiopharmaceuticals", "Wayne State University", "University of Maryland, College Park", "Amphastar Pharmeceuticals, Inc.", "Merck Sharp & Dohme Corp."], [], ["Imperial College London", "michel.willemsen@radboudumc.nl", "urology and nephrology center", "NKI-AvL"]], "p2_terminate_reason": {"National Cancer Institute (NCI)": "Death", "Scottsdale Clinical Research Institute, USA": "Death", "Bayer": "Death"}, "p2_withdraw_reason": {}, "p2_adverse_event": {"NIDDK, NIH": 0.0, "Nouvo Policlinico \"LE SCOTTE'": 0.0, "Dana-Farber Cancer Institute": 0.65, "National Heart, Lung, and Blood Institute (NHLBI)": 0.0, "National Cancer Institute (NCI)": 0.4666666666666667, "Scottsdale Clinical Research Institute, USA": 0.3055555555555556, "M.D. Anderson Cancer Center": 0.1, "OHSU Knight Cancer Institute": 0.25, "Oregon Health and Science University": 0.14285714285714285, "RAND": 0.0, "Eisai Inc.": 0.0, "Johns Hopkins University": 0.0, "Merck Sharp & Dohme Corp.": 0.03333333333333333, "Northwestern University": 0.0967741935483871, "Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center": 0.0, "Novartis Vaccines": 0.13725490196078433, "Bayer": 0.058823529411764705, "GlaxoSmithKline": 0.0, "Ipsen": 0.043478260869565216}, "p3_company_num": 26, "p3_stat_company_num": [1, 5, 0, 2, 0, 2, 14, 0, 2], "p3_company": [["Shanghai Zhongshan Hospital"], ["Shanghai Children's Medical Center", "Novartis Pharmaceuticals", "University of Calgary", "Fujian Medical University Union Hospital", "Merck Sharp & Dohme Corp."], [], ["Hoffmann-La Roche", "Melbourne Health"], [], ["University of Maryland, College Park", "SUNY at Stony Brook"], ["Beijing Friendship Hospital", "AbbVie", "Stanford University", "Pfizer", "UConn Health", "AstraZeneca Molndal, Sweden", "Universitätsklinikum Hamburg-Eppendorf", "Fudan University", "Avid Radiopharmaceuticals, Inc.", "Avid Radiopharmaceuticals", "Sanofi Pasteur Inc.", "Wyeth is now a wholly owned subsidiary of Pfizer", "Haydom Lutheran Hospital", "Eli Lilly and Company"], [], ["A/Z Clinical", "PROFESSOR OF MEDICINE"]], "p3_terminate_reason": {"SUNY at Stony Brook": "Adverse Event"}, "p3_withdraw_reason": {}, "p3_adverse_event": {"SUNY at Stony Brook": 0.17942583732057416, "Wyeth is now a wholly owned subsidiary of Pfizer": 0.015503875968992248, "Eli Lilly and Company": 0.1, "Hoffmann-La Roche": 0.1298283261802575}}}, {"id": 42, "paper_title": "Structure-based discovery of SIAIS001 as an oral bioavailability ALK degrader constructed from Alectinib", "paper_author": ["Chaowei Ren", "Ning Sun", "Ying Kong", "Xiaojuan Qu", "Haixia Liu", "Hui Zhong", "Xiaoling Song", "Xiaobao Yang", "Biao Jiang"], "paper_year": 2021, "paper_institution": "Shanghai Institute for Advanced Immunochemical Studies, ShanghaiTech University, 393 Middle Huaxia Road, Shanghai, 201210, China", "paper_cited": 2, "doi": "10.1016/j.ejmech.2021.113335", "paper_journal": "European Journal of Medicinal Chemistry", "paper_abstract_image": "https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421001847-ga1_lrg.jpg", "compound_count": 37, "compound_name": "1", "compound_name_drug": "SIAIS001", "compound_smiles": "C[C@@H]1CC[C@@H](C)C1", "medicinal_chemistry_metrics": {"Ki": 0.0, "Kd": 0.0, "IC50": 900.0, "selectivity": 0}, "pharm_metrics_vitro": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "EC50": 0.0, "selectivity": 0, "hERG": 0.0, "solubility": 0.0}, "pharm_metrics_vivo": {"ED50": 0.0, "AUC": 0.0, "solubility": 0.0, "t_half": 0.0, "bioavailability": 0.0}, "clinical_statistics": {}}, {"id": 43, "paper_title": "Development of a Brigatinib degrader (SIAIS117) as a potential treatment for ALK positive cancer resistance", "paper_author": ["Ning Sun", "Chaowei Ren", "Ying Kong", "Hui Zhong", "Jinju Chen", "Yan Li", "Jianshui Zhang", "Yuedong Zhou", "Xing Qiu", "Haifan Lin", "Xiaoling Song", "Xiaobao Yang", "Biao Jiang"], "paper_year": 2020, "paper_institution": "Shanghai Institute for Advanced Immunochemical Studies, ShanghaiTech University, 393 Middle Huaxia Road, Shanghai, 201210, China", "paper_cited": 13, "doi": "10.1016/j.ejmech.2020.112190", "paper_journal": "European Journal of Medicinal Chemistry", "paper_abstract_image": "https://api.elsevier.com/content/object/eid/1-s2.0-S0223523420301574-fx1_lrg.jpg", "compound_count": 74, "compound_name": "1–3", "compound_name_drug": "SIAIS117", "compound_smiles": "", "medicinal_chemistry_metrics": {"Ki": 0.0, "Kd": 0.0, "IC50": 1.7, "selectivity": 0}, "pharm_metrics_vitro": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "EC50": 0.0, "selectivity": 0, "hERG": 0.0, "solubility": 0.0}, "pharm_metrics_vivo": {"ED50": 0.0, "AUC": 0.0, "solubility": 0.0, "t_half": 0.0, "bioavailability": 0.0}, "clinical_statistics": {}}, {"id": 44, "paper_title": "Discovery of 2-aminopyridines bearing a pyridone moiety as potent ALK inhibitors to overcome the crizotinib-resistant mutants", "paper_author": ["Wenteng Chen", "Xiao Guo", "Can Zhang", "Di Ke", "Guolin Zhang", "Yongping Yu"], "paper_year": 2019, "paper_institution": "Zhejiang Province Key Laboratory of Anti-Cancer Research, College of Pharmaceutical Sciences, Zhejiang University, 310058, China", "paper_cited": 4, "doi": "10.1016/j.ejmech.2019.111734", "paper_journal": "European Journal of Medicinal Chemistry", "paper_abstract_image": "https://api.elsevier.com/content/object/eid/1-s2.0-S0223523419308864-fx1_lrg.jpg", "compound_count": 46, "compound_name": "18d", "compound_name_drug": "", "compound_smiles": "C1(=C(N=C[C]2(=C1)CCC(/C=C\\CCCCCCCC2)(C)/C=C\\C(N(CC)CC)CCN1CCC1C)N)O[C@@H](c1c(Cl)ccc(F)c1Cl)C", "medicinal_chemistry_metrics": {"Ki": 0.0, "Kd": 0.0, "IC50": 19.0, "selectivity": 0}, "pharm_metrics_vitro": {"Ki": 0.0, "Kd": 0.0, "IC50": 40.0, "EC50": 0.0, "selectivity": 0, "hERG": 0.0, "solubility": 0.0}, "pharm_metrics_vivo": {"ED50": 0.0, "AUC": 0.0, "solubility": 0.0, "t_half": 0.0, "bioavailability": 0.0}, "clinical_statistics": {}}, {"id": 45, "paper_title": "Design, synthesis and biological evaluations of 2-amino-4-(1-piperidine) pyridine derivatives as novel anti crizotinib-resistant ALK/ROS1 dual inhibitors", "paper_author": ["Siming Liu", "Ying Jiang", "Ruohong Yan", "Zhonghuang Li", "Shanhe Wan", "Tingting Zhang", "Xiaoyun Wu", "Ju Hou", "Zhengguang Zhu", "Yuanxin Tian", "Jiajie Zhang"], "paper_year": 2019, "paper_institution": "Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Science, Southern Medical University, Guangzhou, 510515, PR China", "paper_cited": 4, "doi": "10.1016/j.ejmech.2019.06.043", "paper_journal": "European Journal of Medicinal Chemistry", "paper_abstract_image": "https://api.elsevier.com/content/object/eid/1-s2.0-S0223523419305690-fx1_lrg.jpg", "compound_count": 23, "compound_name": "2e", "compound_name_drug": "", "compound_smiles": "", "medicinal_chemistry_metrics": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "selectivity": 0}, "pharm_metrics_vitro": {"Ki": 0.0, "Kd": 0.0, "IC50": 174.0, "EC50": 0.0, "selectivity": 0, "hERG": 0.0, "solubility": 0.0}, "pharm_metrics_vivo": {"ED50": 0.0, "AUC": 0.0, "solubility": 0.0, "t_half": 0.0, "bioavailability": 0.0}, "clinical_statistics": {}}, {"id": 46, "paper_title": "Discovery of novel mutant-combating ALK and ROS1 dual inhibitors bearing imidazolidin-2-one moiety with reasonable PK properties", "paper_author": ["Hongrui Lei", "Nan Jiang", "Xiuqi Miao", "Lingyun Xing", "Ming Guo", "Yang Liu", "Haowen Xu", "Ping Gong", "Daiying Zuo", "Xin Zhai"], "paper_year": 2019, "paper_institution": "Key Laboratory of Structure-Based Drug Design and Discovery, Ministry of Education, Shenyang Pharmaceutical University, Shenyang, 110016, China", "paper_cited": 6, "doi": "10.1016/j.ejmech.2019.03.038", "paper_journal": "European Journal of Medicinal Chemistry", "paper_abstract_image": "https://api.elsevier.com/content/object/eid/1-s2.0-S0223523419302569-fx1_lrg.jpg", "compound_count": 30, "compound_name": "15", "compound_name_drug": "", "compound_smiles": "", "medicinal_chemistry_metrics": {"Ki": 0.0, "Kd": 0.0, "IC50": 213.0, "selectivity": 0}, "pharm_metrics_vitro": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "EC50": 0.0, "selectivity": 0, "hERG": 0.0, "solubility": 0.0}, "pharm_metrics_vivo": {"ED50": 0.0, "AUC": 0.0, "solubility": 0.0, "t_half": 0.0, "bioavailability": 0.0}, "clinical_statistics": {}}, {"id": 47, "paper_title": "Dual potent ALK and ROS1 inhibitors combating drug-resistant mutants: Synthesis and biological evaluation of aminopyridine-containing diarylaminopyrimidine derivatives", "paper_author": ["Ming Guo", "Daiying Zuo", "Junlong Zhang", "Lingyun Xing", "Wenfeng Gou", "Feng Jiang", "Nan Jiang", "Dajun Zhang", "Xin Zhai"], "paper_year": 2018, "paper_institution": "Key Laboratory of Structure-Based Drug Design and Discovery, Ministry of Education, Shenyang Pharmaceutical University, Shenyang, 110016, China", "paper_cited": 11, "doi": "10.1016/j.ejmech.2018.09.012", "paper_journal": "European Journal of Medicinal Chemistry", "paper_abstract_image": "https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418307840-fx1_lrg.jpg", "compound_count": 33, "compound_name": "F-1", "compound_name_drug": "", "compound_smiles": "", "medicinal_chemistry_metrics": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "selectivity": 0}, "pharm_metrics_vitro": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "EC50": 0.0, "selectivity": 0, "hERG": 0.0, "solubility": 0.0}, "pharm_metrics_vivo": {"ED50": 0.0, "AUC": 0.0, "solubility": 0.0, "t_half": 0.0, "bioavailability": 0.0}, "clinical_statistics": {"p1_company_num": 77, "p1_stat_company_num": [2, 3, 1, 0, 0, 2, 68, 0, 1], "p1_company": [["Chungnam National University Hospital", "H Plus Yangji Hospital"], ["University Hospital Inselspital, Berne", "Center for Immunization Research (CIR), Johns Hopkins Bloomberg School of Public Health (JHSPH)", "Janssen Research & Development, LLC"], ["CMAX Clinical Research Pty Ltd"], [], [], ["Univ of Kentucky", "EMD Serono Inc., a business of Merck KGaA, Darmstadt, Germany"], ["Mclean Hospital", "Icahn School of Medicine at Mount Sinai", "Syneos Health", "IDRI", "Medical College of Wisconsin", "Shionogi", "Hoffmann-La Roche", "Janssen R&D Ireland", "Takeda", "University of Kentucky Department of Neurological Surgery", "University of Kentucky", "Amgen", "Universitaire Ziekenhuizen Leuven", "Rehabilitation Hospital of Indiana", "Bristol-Myers Squibb", "Pfizer", "University of Michigan", "Hopital Foch", "Policlinico Hospital of Milan", "Neuropsychiatric Research Institute and University of North Dakota", "Mayo Clinic", "Eil Lilly and Company", "George Washington University", "University of Oxford", "San Diego Veterans Healthcare System", "Case Western Reserve University / University Hospitals of Cleveland", "Novartis Pharmaceuticals", "Division of Geriatric, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia, Cipto Mangunkusumo General Hospital", "Teva Neuroscience, Inc.", "University Hospital, Basel, Switzerland", "Medical University of Vienna", "Department of surgical, Faculty Hospital Bulovka, Prague, Czech Republic", "Benchmark Research", "Second Genome", "Novo Nordisk A/S", "National Cancer Institute (NCI)", "Octapharma", "Eli Lilly and Company", "Hammersmith Medicines Research", "Markey Cancer Center", "University of Guadalajara", "OHRI", "NRG Oncology", "Columbia University", "National Cardiovascular Center Harapan Kita Jakarta", "Queen's Medical Center", "Xijing Hospital", "AMREP Centre for Clinical Studies, Nucleus Network, 89 Commercial Road, Melbourne, VIC 3004 Australia", "Bioverativ Therapeutics Inc.", "Emory University Winship Cancer Institute", "Service de Pharmacologie (Pr Jaillon) CHU Saint-Antoine 27, rue de Chaligny, 75012 Paris", "University of Cincinnati", "University of Bern", "Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany", "University of North Carolina, Chapel Hill", "Sanofi", "Catalyst Biosciences", "Michael E. DeBakey VA Medical Center, Houston, TX", "Jiangsu Provincial Center for Diseases Control and Prevention", "Uppsala University Hospital", "89bio, Inc.", "Conatus Pharmaceuticals", "GlaxoSmithKline", "Ciusss de L'Est de l'Île de Montréal", "New Mexico VA Healthcare System", "The Lindner Center of HOPE", "Director, Kanto Rosai Hospital; Director, Japanese Red Cross Medical Center", "Mitsubishi Tanabe Pharma Corporation"], [], ["The First Affiliated Hospital with Nanjing Medical University"]], "p1_terminate_reason": {}, "p1_withdraw_reason": {}, "p1_adverse_event": {"GlaxoSmithKline": 0.06666666666666667}, "p2_company_num": 57, "p2_stat_company_num": [0, 4, 0, 5, 0, 3, 44, 1, 0], "p2_company": [[], ["Hoffmann-La Roche", "Novartis Pharmaceuticals", "Icahn School of Medicine at Mount Sinai", "Uppsala University Hospital"], [], ["89bio, Inc.", "Pfizer", "Medical College of Wisconsin", "NRG Oncology", "Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany"], [], ["Emory University Winship Cancer Institute", "Rehabilitation Hospital of Indiana", "Second Genome"], ["Department of surgical, Faculty Hospital Bulovka, Prague, Czech Republic", "Benchmark Research", "Syneos Health", "Novo Nordisk A/S", "National Cancer Institute (NCI)", "Octapharma", "Shionogi", "Eli Lilly and Company", "Markey Cancer Center", "Janssen R&D Ireland", "University of Guadalajara", "OHRI", "Columbia University", "National Cardiovascular Center Harapan Kita Jakarta", "Queen's Medical Center", "Xijing Hospital", "University of Kentucky", "Amgen", "Bioverativ Therapeutics Inc.", "Bristol-Myers Squibb", "University of Michigan", "Hopital Foch", "Service de Pharmacologie (Pr Jaillon) CHU Saint-Antoine 27, rue de Chaligny, 75012 Paris", "University of Cincinnati", "Policlinico Hospital of Milan", "Neuropsychiatric Research Institute and University of North Dakota", "Eil Lilly and Company", "Sanofi", "Catalyst Biosciences", "George Washington University", "University of Oxford", "Jiangsu Provincial Center for Diseases Control and Prevention", "San Diego Veterans Healthcare System", "Conatus Pharmaceuticals", "Case Western Reserve University / University Hospitals of Cleveland", "Division of Geriatric, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia, Cipto Mangunkusumo General Hospital", "GlaxoSmithKline", "Ciusss de L'Est de l'Île de Montréal", "Teva Neuroscience, Inc.", "New Mexico VA Healthcare System", "The Lindner Center of HOPE", "Director, Kanto Rosai Hospital; Director, Japanese Red Cross Medical Center", "Medical University of Vienna", "Mitsubishi Tanabe Pharma Corporation"], ["IDRI"], []], "p2_terminate_reason": {"University of Kentucky": "Withdrawal by Subject", "Novartis Pharmaceuticals": "Administrative Problems"}, "p2_withdraw_reason": {}, "p2_adverse_event": {"Eli Lilly and Company": 0.38461538461538464, "Hoffmann-La Roche": 0.5328947368421053, "GlaxoSmithKline": 0.019230769230769232, "Amgen": 0.0, "University of Kentucky": 0.0, "Markey Cancer Center": 0.03125, "Rehabilitation Hospital of Indiana": 0.0, "OHRI": 0.0, "Janssen R&D Ireland": 0.4, "Conatus Pharmaceuticals": 0.0, "Emory University Winship Cancer Institute": 0.09090909090909091, "National Cancer Institute (NCI)": 0.2, "Novo Nordisk A/S": 0.125, "University of Michigan": 0.0, "Queen's Medical Center": 0.03125, "Novartis Pharmaceuticals": 0.0, "Pfizer": 0.14285714285714285}, "p3_company_num": 26, "p3_stat_company_num": [0, 3, 0, 0, 0, 5, 16, 1, 1], "p3_company": [[], ["Xijing Hospital", "Division of Geriatric, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia, Cipto Mangunkusumo General Hospital", "University of Oxford"], [], [], [], ["Bristol-Myers Squibb", "Service de Pharmacologie (Pr Jaillon) CHU Saint-Antoine 27, rue de Chaligny, 75012 Paris", "Case Western Reserve University / University Hospitals of Cleveland", "GlaxoSmithKline", "Shionogi"], ["Department of surgical, Faculty Hospital Bulovka, Prague, Czech Republic", "San Diego Veterans Healthcare System", "University of Cincinnati", "Syneos Health", "Policlinico Hospital of Milan", "National Cardiovascular Center Harapan Kita Jakarta", "Ciusss de L'Est de l'Île de Montréal", "Neuropsychiatric Research Institute and University of North Dakota", "Teva Neuroscience, Inc.", "Eil Lilly and Company", "Sanofi", "The Lindner Center of HOPE", "Octapharma", "Eli Lilly and Company", "Bioverativ Therapeutics Inc.", "Mitsubishi Tanabe Pharma Corporation"], ["Columbia University"], ["New Mexico VA Healthcare System"]], "p3_terminate_reason": {"Eli Lilly and Company": "Adverse Event", "Shionogi": "Adverse Event", "Bristol-Myers Squibb": "Adverse event unrelated to study drug"}, "p3_withdraw_reason": {}, "p3_adverse_event": {"Eli Lilly and Company": 0.07526881720430108, "Shionogi": 0.02, "GlaxoSmithKline": 0.0, "Bristol-Myers Squibb": 0.3588709677419355}}}, {"id": 48, "paper_title": "Design, synthesis and pharmacological evaluation of ALK and Hsp90 dual inhibitors bearing resorcinol and 2,4-diaminopyrimidine motifs", "paper_author": ["Kaijun Geng", "Hongchun Liu", "Zilan Song", "Chi Zhang", "Minmin Zhang", "Hong Yang", "Jingchen Cao", "Meiyu Geng", "Aijun Shen", "Ao Zhang"], "paper_year": 2018, "paper_institution": "CAS Key Laboratory of Receptor Research and the State Key Laboratory for Drug Research, Shanghai Institute of Materia Medica (SIMM), Chinese Academy of Sciences, Shanghai, 201203, China", "paper_cited": 11, "doi": "10.1016/j.ejmech.2018.04.019", "paper_journal": "European Journal of Medicinal Chemistry", "paper_abstract_image": "https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418303532-fx1_lrg.jpg", "compound_count": 45, "compound_name": "10h", "compound_name_drug": "", "compound_smiles": "", "medicinal_chemistry_metrics": {"Ki": 0.0, "Kd": 0.0, "IC50": 17.3, "selectivity": 0}, "pharm_metrics_vitro": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "EC50": 0.0, "selectivity": 0, "hERG": 0.0, "solubility": 0.0}, "pharm_metrics_vivo": {"ED50": 0.0, "AUC": 0.0, "solubility": 0.0, "t_half": 0.0, "bioavailability": 0.0}, "clinical_statistics": {}}, {"id": 49, "paper_title": "Proteolysis Targeting Chimeras (PROTACs) of Anaplastic Lymphoma Kinase (ALK)", "paper_author": ["Chengwei Zhang", "Xiao-Ran Han", "Xiaobao Yang", "Biao Jiang", "Jing Liu", "Yue Xiong", "Jian Jin"], "paper_year": 2018, "paper_institution": "Center for Chemical Biology and Drug Discovery, Department of Pharmacological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY10029, United States", "paper_cited": 91, "doi": "10.1016/j.ejmech.2018.03.071", "paper_journal": "European Journal of Medicinal Chemistry", "paper_abstract_image": "https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418303143-fx1_lrg.jpg", "compound_count": 17, "compound_name": "5", "compound_name_drug": "", "compound_smiles": "C(S(=O)(=O)c1ccccc1Nc1c(Cl)cnc(Nc2c(OC(C)C)cc(c(C)c2)C2CCN(CC2)CC(=O)NCCOCCOCCOCCOCCOCCNc2c3c(ccc2)C(=O)N(C2C(=O)NC(=O)CC2)C3=O)n1)(C)C", "medicinal_chemistry_metrics": {"Ki": 0.0, "Kd": 0.0, "IC50": 33.0, "selectivity": 0}, "pharm_metrics_vitro": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "EC50": 0.0, "selectivity": 0, "hERG": 0.0, "solubility": 0.0}, "pharm_metrics_vivo": {"ED50": 0.0, "AUC": 0.0, "solubility": 0.0, "t_half": 0.0, "bioavailability": 0.0}, "clinical_statistics": {}}, {"id": 50, "paper_title": "Discovery of 2,4-diarylaminopyrimidines bearing a resorcinol motif as novel ALK inhibitors to overcome the G1202R resistant mutation", "paper_author": ["Kaijun Geng", "Zongjun Xia", "Yinchun Ji", "Ruisi (Ruthy) Zhang", "Deqiao Sun", "Jing Ai", "Zilan Song", "Meiyu Geng", "Ao Zhang"], "paper_year": 2018, "paper_institution": "CAS Key Laboratory of Receptor Research and the State Key Laboratory for Drug Research, Shanghai Institute of Materia Medica (SIMM), Chinese Academy of Sciences, Shanghai 201203, China", "paper_cited": 8, "doi": "10.1016/j.ejmech.2017.12.060", "paper_journal": "European Journal of Medicinal Chemistry", "paper_abstract_image": "https://api.elsevier.com/content/object/eid/1-s2.0-S0223523417310917-fx1_lrg.jpg", "compound_count": 54, "compound_name": "12d", "compound_name_drug": "", "compound_smiles": "S(=O)(=O)(C(C)C)c1c(Nc2nc(Nc3c(ccc(NC(=O)CNC(=O)c4cc(c(O)cc4O)C(C)C)c3)OC)ncc2Cl)cccc1", "medicinal_chemistry_metrics": {"Ki": 0.0, "Kd": 0.0, "IC50": 3.5, "selectivity": 0}, "pharm_metrics_vitro": {"Ki": 0.0, "Kd": 0.0, "IC50": 1.7, "EC50": 0.0, "selectivity": 0, "hERG": 0.0, "solubility": 0.0}, "pharm_metrics_vivo": {"ED50": 0.0, "AUC": 0.0, "solubility": 0.0, "t_half": 0.0, "bioavailability": 0.0}, "clinical_statistics": {}}, {"id": 51, "paper_title": "Discovery of novel 2,4-diarylaminopyrimidine analogues as ALK and ROS1 dual inhibitors to overcome crizotinib-resistant mutants including G1202R", "paper_author": ["Yu Wang", "Shaowei Chen", "Gang Hu", "Jiao Wang", "Wenfeng Gou", "Daiying Zuo", "Yucheng Gu", "Ping Gong", "Xin Zhai"], "paper_year": 2018, "paper_institution": "Key Laboratory of Structure-Based Drug Design and Discovery, Ministry of Education, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenhe District, Shenyang, 110016, China", "paper_cited": 15, "doi": "10.1016/j.ejmech.2017.11.008", "paper_journal": "European Journal of Medicinal Chemistry", "paper_abstract_image": "https://api.elsevier.com/content/object/eid/1-s2.0-S0223523417308930-fx1_lrg.jpg", "compound_count": 37, "compound_name": "34c", "compound_name_drug": "", "compound_smiles": "n1c(CN2CCN(CC2)C)c[nH]n1", "medicinal_chemistry_metrics": {"Ki": 0.0, "Kd": 0.0, "IC50": 3.1, "selectivity": 0}, "pharm_metrics_vitro": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "EC50": 0.0, "selectivity": 0, "hERG": 0.0, "solubility": 0.0}, "pharm_metrics_vivo": {"ED50": 0.0, "AUC": 0.0, "solubility": 0.0, "t_half": 0.0, "bioavailability": 0.0}, "clinical_statistics": {}}, {"id": 52, "paper_title": "-(5-((5-chloro-4-((2-(isopropylsulfonyl)phenyl)amino)pyrimidin-2-yl)amino)-4-methoxy-2-(4-methyl-1,4-diazepan-1-yl)phenyl)acrylamide (CHMFL-ALK/EGFR-050) as a potent ALK/EGFR dual kinase inhibitor capable of overcoming a variety of ALK/EGFR associated drug resistant mutants in NSCLC", "paper_author": ["Yongfei Chen", "Jiaxin Wu", "Aoli Wang", "Ziping Qi", "Taoshan Jiang", "Cheng Chen", "Fengming Zou", "Chen Hu", "Wei Wang", "Hong Wu", "Zhenquan Hu", "Wenchao Wang", "Beilei Wang", "Li Wang", "Tao Ren", "Shanchun Zhang", "Qingsong Liu", "Jing Liu"], "paper_year": 2017, "paper_institution": "High Magnetic Field Laboratory, Chinese Academy of Sciences, Mailbox 1110, 350 Shushanhu Road, Hefei, Anhui 230031, PR China", "paper_cited": 16, "doi": "10.1016/j.ejmech.2017.08.035", "paper_journal": "European Journal of Medicinal Chemistry", "paper_abstract_image": "https://api.elsevier.com/content/object/eid/1-s2.0-S0223523417306384-fx1_lrg.jpg", "compound_count": 53, "compound_name": "14", "compound_name_drug": "", "compound_smiles": "", "medicinal_chemistry_metrics": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "selectivity": 0}, "pharm_metrics_vitro": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "EC50": 0.0, "selectivity": 0, "hERG": 0.0, "solubility": 0.0}, "pharm_metrics_vivo": {"ED50": 0.0, "AUC": 0.0, "solubility": 0.0, "t_half": 0.0, "bioavailability": 0.0}, "clinical_statistics": {}}, {"id": 53, "paper_title": "-generation ALK inhibitor for treatment of ALK/ROS1 cancer: Clinical and designing strategy update of lorlatinib", "paper_author": ["Sulman Basit", "Zaman Ashraf", "Kwangho Lee", "Muhammad Latif"], "paper_year": 2017, "paper_institution": "Centre for Genetics and Inherited Diseases, Taibah University, Al-Madinah Al-Munawwarah, Kingdom of Saudi Arabia", "paper_cited": 57, "doi": "10.1016/j.ejmech.2017.04.032", "paper_journal": "European Journal of Medicinal Chemistry", "paper_abstract_image": "https://api.elsevier.com/content/object/eid/1-s2.0-S0223523417302878-fx1_lrg.jpg", "compound_count": 12, "compound_name": "6", "compound_name_drug": "", "compound_smiles": "", "medicinal_chemistry_metrics": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "selectivity": 0}, "pharm_metrics_vitro": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "EC50": 0.0, "selectivity": 0, "hERG": 0.0, "solubility": 0.0}, "pharm_metrics_vivo": {"ED50": 0.0, "AUC": 0.0, "solubility": 0.0, "t_half": 0.0, "bioavailability": 0.0}, "clinical_statistics": {}}, {"id": 54, "paper_title": "Discovery of a potent dual ALK and EGFR T790M inhibitor", "paper_author": ["Jaebong Jang", "Jung Beom Son", "Ciric To", "Magda Bahcall", "So Young Kim", "Seock Yong Kang", "Mierzhati Mushajiang", "Younho Lee", "Pasi A. Jänne", "Hwan Geun Choi", "Nathanael S. Gray"], "paper_year": 2017, "paper_institution": "Department of Biological Chemistry & Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, United States", "paper_cited": 15, "doi": "10.1016/j.ejmech.2017.04.079", "paper_journal": "European Journal of Medicinal Chemistry", "paper_abstract_image": "https://api.elsevier.com/content/object/eid/1-s2.0-S0223523417303616-fx1_lrg.jpg", "compound_count": 52, "compound_name": "7c", "compound_name_drug": "", "compound_smiles": "C(N(c1c(NC(=O)C=C)cc(c(OC)c1)Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1)C)CN(C)C", "medicinal_chemistry_metrics": {"Ki": 0.0, "Kd": 0.0, "IC50": 18.0, "selectivity": 0}, "pharm_metrics_vitro": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "EC50": 0.0, "selectivity": 0, "hERG": 0.0, "solubility": 0.0}, "pharm_metrics_vivo": {"ED50": 0.0, "AUC": 0.0, "solubility": 0.0, "t_half": 0.0, "bioavailability": 0.0}, "clinical_statistics": {}}, {"id": 55, "paper_title": "]carbazolone core", "paper_author": ["Zilan Song", "Zongjun Xia", "Yinchun Ji", "Li Xing", "Yinglei Gao", "Jing Ai", "Meiyu Geng", "Ao Zhang"], "paper_year": 2016, "paper_institution": "CAS Key Laboratory of Receptor Research, Synthetic Organic & Medicinal Chemistry Laboratory, Shanghai Institute of Materia Medica (SIMM), Chinese Academy of Sciences, Shanghai, 201203, China", "paper_cited": 8, "doi": "10.1016/j.ejmech.2016.04.046", "paper_journal": "European Journal of Medicinal Chemistry", "paper_abstract_image": "https://api.elsevier.com/content/object/eid/1-s2.0-S0223523416303397-fx1_lrg.jpg", "compound_count": 5, "compound_name": "6", "compound_name_drug": "", "compound_smiles": "C(#N)c1cc2[nH]c3c(C(=O)c4c(C3(C)C)cc(C3CCN(CC3)CC3CCOCC3)cc4)c2cc1", "medicinal_chemistry_metrics": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "selectivity": 0}, "pharm_metrics_vitro": {"Ki": 0.0, "Kd": 0.0, "IC50": 3.4, "EC50": 0.0, "selectivity": 0, "hERG": 0.0, "solubility": 0.0}, "pharm_metrics_vivo": {"ED50": 0.0, "AUC": 0.0, "solubility": 0.0, "t_half": 0.0, "bioavailability": 0.0}, "clinical_statistics": {}}, {"id": 56, "paper_title": "Design, synthesis and biological evaluation of novel 4-arylaminopyrimidine derivatives possessing a hydrazone moiety as dual inhibitors of L1196M ALK and ROS1", "paper_author": ["Yu Wang", "Guogang Zhang", "Gang Hu", "Yanxin Bu", "Hongrui Lei", "Daiying Zuo", "Mengting Han", "Xin Zhai", "Ping Gong"], "paper_year": 2016, "paper_institution": "Key Laboratory of Structure-Based Drug Design and Discovery, Shenyang Pharmaceutical University, Ministry of Education, 103 Wenhua Road, Shenhe District, Shenyang 110016, PR China", "paper_cited": 17, "doi": "10.1016/j.ejmech.2016.06.056", "paper_journal": "European Journal of Medicinal Chemistry", "paper_abstract_image": "https://api.elsevier.com/content/object/eid/1-s2.0-S0223523416305463-fx1_lrg.jpg", "compound_count": 28, "compound_name": "7b", "compound_name_drug": "", "compound_smiles": "N(=C(\\c1ccc(F)cc1)/C)/N", "medicinal_chemistry_metrics": {"Ki": 0.0, "Kd": 0.0, "IC50": 28.0, "selectivity": 0}, "pharm_metrics_vitro": {"Ki": 0.0, "Kd": 0.0, "IC50": 20.0, "EC50": 0.0, "selectivity": 0, "hERG": 0.0, "solubility": 0.0}, "pharm_metrics_vivo": {"ED50": 0.0, "AUC": 0.0, "solubility": 0.0, "t_half": 0.0, "bioavailability": 0.0}, "clinical_statistics": {}}, {"id": 57, "paper_title": "Novel derivatives of anaplastic lymphoma kinase inhibitors: Synthesis, radiolabeling, and preliminary biological studies of fluoroethyl analogues of crizotinib, alectinib, and ceritinib", "paper_author": ["Bhasker Radaram", "Federica Pisaneschi", "Yi Rao", "Ping Yang", "David Piwnica-Worms", "Mian M. Alauddin"], "paper_year": 2019, "paper_institution": "Department of Cancer Systems Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA", "paper_cited": 3, "doi": "10.1016/j.ejmech.2019.111571", "paper_journal": "European Journal of Medicinal Chemistry", "paper_abstract_image": "https://api.elsevier.com/content/object/eid/1-s2.0-S0223523419307019-fx1_lrg.jpg", "compound_count": 19, "compound_name": "1", "compound_name_drug": "", "compound_smiles": "CC(C1CCC(C$CC(C2CC3C2C3)(CC)C)CC1)(C=C)C", "medicinal_chemistry_metrics": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "selectivity": 0}, "pharm_metrics_vitro": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "EC50": 0.0, "selectivity": 0, "hERG": 0.0, "solubility": 0.0}, "pharm_metrics_vivo": {"ED50": 0.0, "AUC": 0.0, "solubility": 0.0, "t_half": 0.0, "bioavailability": 0.0}, "clinical_statistics": {}}, {"id": 58, "paper_title": "Synthesis and anti-tumor efficacy of novel 2, 4-diarylaminopyrimidine derivatives bearing N-(3-pyridinylmethyl) urea moiety as anaplastic lymphoma kinase inhibitors", "paper_author": ["Hong Chen", "Ridong Li", "Xianling Ning", "Xuyang Zhao", "Yan Jin", "Yuxin Yin"], "paper_year": 2019, "paper_institution": "Institute of Systems Biomedicine, School of Basic Medical Sciences, Beijing Key Laboratory of Tumor Systems Biology, Peking University Health Science Center, Beijing, China", "paper_cited": 3, "doi": "10.1016/j.ejmech.2019.05.060", "paper_journal": "European Journal of Medicinal Chemistry", "paper_abstract_image": "https://api.elsevier.com/content/object/eid/1-s2.0-S0223523419304763-fx1_lrg.jpg", "compound_count": 40, "compound_name": "5m", "compound_name_drug": "", "compound_smiles": "C/C=C(/OC)\\C(=C/C)\\N1CCOCC1", "medicinal_chemistry_metrics": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "selectivity": 0}, "pharm_metrics_vitro": {"Ki": 0.0, "Kd": 0.0, "IC50": 10.0, "EC50": 0.0, "selectivity": 0, "hERG": 0.0, "solubility": 0.0}, "pharm_metrics_vivo": {"ED50": 0.0, "AUC": 0.0, "solubility": 0.0, "t_half": 0.0, "bioavailability": 0.0}, "clinical_statistics": {}}, {"id": 59, "paper_title": "Replacing the terminal piperidine in ceritinib with aliphatic amines confers activities against crizotinib-resistant mutants including G1202R", "paper_author": ["Gangadhar Rao Mathi", "Chung Hyo Kang", "Heung Kyoung Lee", "Raghavendra Achary", "Ha-Yeon Lee", "Joo-Youn Lee", "Jae Du Ha", "Sunjoo Ahn", "Chi Hoon Park", "Chong Ock Lee", "Jong Yeon Hwang", "Chang-Soo Yun", "Hee Jung Jung", "Sung Yun Cho", "Hyoung Rae Kim", "Pilho Kim"], "paper_year": 2017, "paper_institution": "Bio & Drug Discovery Division, Korea Research Institute of Chemical Technology, Daejeon 34114, South Korea", "paper_cited": 13, "doi": "10.1016/j.ejmech.2016.11.046", "paper_journal": "European Journal of Medicinal Chemistry", "paper_abstract_image": "https://api.elsevier.com/content/object/eid/1-s2.0-S0223523416309849-fx1_lrg.jpg", "compound_count": 39, "compound_name": "0", "compound_name_drug": "", "compound_smiles": "Cc1c(C)cccc1", "medicinal_chemistry_metrics": {"Ki": 0.0, "Kd": 0.0, "IC50": 1.8, "selectivity": 0}, "pharm_metrics_vitro": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "EC50": 0.0, "selectivity": 0, "hERG": 0.0, "solubility": 0.0}, "pharm_metrics_vivo": {"ED50": 0.0, "AUC": 0.0, "solubility": 0.0, "t_half": 0.0, "bioavailability": 0.0}, "clinical_statistics": {}}, {"id": 60, "paper_title": "Design, synthesis, biological evaluation and molecular modeling of novel 2-amino-4-(1-phenylethoxy) pyridine derivatives as potential ROS1 inhibitors", "paper_author": ["Yuanxin Tian", "Tingting Zhang", "Lifan Long", "Zhonghuang Li", "Shanhe Wan", "Guangfa Wang", "Yonghuan Yu", "Ju Hou", "Xiaoyun Wu", "Jiajie Zhang"], "paper_year": 2018, "paper_institution": "Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Science, Southern Medical University, Guangzhou 510515, PR China", "paper_cited": 8, "doi": "10.1016/j.ejmech.2017.11.002", "paper_journal": "European Journal of Medicinal Chemistry", "paper_abstract_image": "https://api.elsevier.com/content/object/eid/1-s2.0-S0223523417308875-fx1_lrg.jpg", "compound_count": 74, "compound_name": "13d", "compound_name_drug": "", "compound_smiles": "", "medicinal_chemistry_metrics": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "selectivity": 0}, "pharm_metrics_vitro": {"Ki": 0.0, "Kd": 0.0, "IC50": 3100.0, "EC50": 0.0, "selectivity": 0, "hERG": 0.0, "solubility": 0.0}, "pharm_metrics_vivo": {"ED50": 0.0, "AUC": 0.0, "solubility": 0.0, "t_half": 0.0, "bioavailability": 0.0}, "clinical_statistics": {}}, {"id": 61, "paper_title": "Design, synthesis, biological evaluation and pharmacophore model analysis of novel tetrahydropyrrolo[3,4-c]pyrazol derivatives as potential TRKs inhibitors", "paper_author": ["Tianxiao Wu", "Chu Zhang", "Ruicheng Lv", "Qiaohua Qin", "Nian Liu", "Wenbo Yin", "Ruifeng Wang", "Yin Sun", "Xiaoyan Wang", "Yixiang Sun", "Dongmei Zhao", "Maosheng Cheng"], "paper_year": 2021, "paper_institution": "Key Laboratory of Structure-Based Drug Design and Discovery, Ministry of Education, School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenhe District, Shenyang, 110016, PR China", "paper_cited": 0, "doi": "10.1016/j.ejmech.2021.113627", "paper_journal": "European Journal of Medicinal Chemistry", "paper_abstract_image": "https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421004761-ga1_lrg.jpg", "compound_count": 52, "compound_name": "19m", "compound_name_drug": "", "compound_smiles": "", "medicinal_chemistry_metrics": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "selectivity": 0}, "pharm_metrics_vitro": {"Ki": 0.0, "Kd": 0.0, "IC50": 82.0, "EC50": 0.0, "selectivity": 0, "hERG": 0.0, "solubility": 0.0}, "pharm_metrics_vivo": {"ED50": 0.0, "AUC": 0.0, "solubility": 0.0, "t_half": 0.0, "bioavailability": 0.0}, "clinical_statistics": {}}, {"id": 62, "paper_title": "Synthesis and antiproliferative activity of 6,7-disubstituted-4-phenoxyquinoline derivatives bearing the 1,8-naphthyridin-2-one moiety", "paper_author": ["Qidong Tang", "Yongli Duan", "Hehua Xiong", "Ting Chen", "Zhen Xiao", "Linxiao Wang", "Yueyue Xiao", "Shunmin Huang", "Yinhua Xiong", "Wufu Zhu", "Ping Gong", "Pengwu Zheng"], "paper_year": 2018, "paper_institution": "Jiangxi Provincial Key Laboratory of Drug Design and Evaluation, School of Pharmacy, Jiangxi Science & Technology Normal University, Nanchang, 330013, PR China", "paper_cited": 12, "doi": "10.1016/j.ejmech.2018.08.066", "paper_journal": "European Journal of Medicinal Chemistry", "paper_abstract_image": "https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418307384-fx1_lrg.jpg", "compound_count": 32, "compound_name": "33", "compound_name_drug": "", "compound_smiles": "", "medicinal_chemistry_metrics": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "selectivity": 0}, "pharm_metrics_vitro": {"Ki": 0.0, "Kd": 0.0, "IC50": 2.36, "EC50": 0.0, "selectivity": 0, "hERG": 0.0, "solubility": 0.0}, "pharm_metrics_vivo": {"ED50": 0.0, "AUC": 0.0, "solubility": 0.0, "t_half": 0.0, "bioavailability": 0.0}, "clinical_statistics": {}}, {"id": 63, "paper_title": "Recent advances in the discovery of small molecule c-Met Kinase inhibitors", "paper_author": ["Palak K. Parikh", "Manjunath D. Ghate"], "paper_year": 2018, "paper_institution": "Department of Pharmaceutical Chemistry, Institute of Pharmacy, Nirma University, Ahmedabad 382 481, Gujarat, India", "paper_cited": 67, "doi": "10.1016/j.ejmech.2017.08.044", "paper_journal": "European Journal of Medicinal Chemistry", "paper_abstract_image": "https://api.elsevier.com/content/object/eid/1-s2.0-S0223523417306475-fx1_lrg.jpg", "compound_count": 168, "compound_name": "9", "compound_name_drug": "", "compound_smiles": "", "medicinal_chemistry_metrics": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "selectivity": 0}, "pharm_metrics_vitro": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "EC50": 0.0, "selectivity": 0, "hERG": 0.0, "solubility": 0.0}, "pharm_metrics_vivo": {"ED50": 0.0, "AUC": 0.0, "solubility": 0.0, "t_half": 0.0, "bioavailability": 0.0}, "clinical_statistics": {}}, {"id": 64, "paper_title": "]pyrazoles", "paper_author": ["Eva Řezníčková", "Lukáš Tenora", "Pavlína Pospíšilová", "Juraj Galeta", "Radek Jorda", "Karel Berka", "Pavel Majer", "Milan Potáček", "Vladimír Kryštof"], "paper_year": 2017, "paper_institution": "Laboratory of Growth Regulators, Centre of the Region Haná for Biotechnological and Agricultural Research, Palacký University and Institute of Experimental Botany AS CR, Šlechtitelů 27, 783 71 Olomouc, Czech Republic", "paper_cited": 4, "doi": "10.1016/j.ejmech.2017.01.018", "paper_journal": "European Journal of Medicinal Chemistry", "paper_abstract_image": "https://api.elsevier.com/content/object/eid/1-s2.0-S0223523417300260-fx1_lrg.jpg", "compound_count": 52, "compound_name": "4k", "compound_name_drug": "", "compound_smiles": "c1c(ccc(c1)c1c(c2nc(ccc2)C)nn2c1C(C(C2)(C)C)C)O", "medicinal_chemistry_metrics": {"Ki": 0.0, "Kd": 0.0, "IC50": 80.0, "selectivity": 0}, "pharm_metrics_vitro": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "EC50": 0.0, "selectivity": 0, "hERG": 0.0, "solubility": 0.0}, "pharm_metrics_vivo": {"ED50": 0.0, "AUC": 0.0, "solubility": 0.0, "t_half": 0.0, "bioavailability": 0.0}, "clinical_statistics": {}}, {"id": 65, "paper_title": "Novel c-Met inhibitory olive secoiridoid semisynthetic analogs for the control of invasive breast cancer", "paper_author": ["Mohamed M. Mohyeldin", "Belnaser A. Busnena", "Mohamed R. Akl", "Ana Maria Dragoi", "James A. Cardelli", "Khalid A. El Sayed"], "paper_year": 2016, "paper_institution": "Department of Basic Pharmaceutical Sciences, School of Pharmacy, University of Louisiana at Monroe, 1800 Bienville Drive, Monroe, LA, 71201, USA", "paper_cited": 15, "doi": "10.1016/j.ejmech.2016.04.043", "paper_journal": "European Journal of Medicinal Chemistry", "paper_abstract_image": "https://api.elsevier.com/content/object/eid/1-s2.0-S0223523416303361-fx1_lrg.jpg", "compound_count": 54, "compound_name": "4", "compound_name_drug": "", "compound_smiles": "", "medicinal_chemistry_metrics": {"Ki": 0.0, "Kd": 0.0, "IC50": 13700.0, "selectivity": 0}, "pharm_metrics_vitro": {"Ki": 0.0, "Kd": 0.0, "IC50": 19800.0, "EC50": 0.0, "selectivity": 0, "hERG": 0.0, "solubility": 0.0}, "pharm_metrics_vivo": {"ED50": 0.0, "AUC": 0.0, "solubility": 0.0, "t_half": 0.0, "bioavailability": 0.0}, "clinical_statistics": {}}], "medicinal_chemistry_similarity": [{"source": 0, "target": 1, "value": 1.0}, {"source": 0, "target": 2, "value": 1.0}, {"source": 0, "target": 3, "value": 1.0}, {"source": 0, "target": 4, "value": 1.0}, {"source": 0, "target": 5, "value": 1.0}, {"source": 0, "target": 6, "value": 0.0}, {"source": 0, "target": 7, "value": 0.0}, {"source": 0, "target": 8, "value": 0.0}, {"source": 0, "target": 9, "value": 0.0}, {"source": 0, "target": 10, "value": 0.0}, {"source": 0, "target": 11, "value": 1.0}, {"source": 0, "target": 12, "value": 1.0}, {"source": 0, "target": 13, "value": 0.0}, {"source": 0, "target": 14, "value": 0.0}, {"source": 0, "target": 15, "value": 0.0}, {"source": 0, "target": 16, "value": 1.0}, {"source": 0, "target": 17, "value": 0.0}, {"source": 0, "target": 18, "value": 1.0}, {"source": 0, "target": 19, "value": 0.0}, {"source": 0, "target": 20, "value": 0.0}, {"source": 0, "target": 21, "value": 1.0}, {"source": 0, "target": 22, "value": 0.0}, {"source": 0, "target": 23, "value": 1.0}, {"source": 0, "target": 24, "value": 1.0}, {"source": 0, "target": 25, "value": 1.0}, {"source": 0, "target": 26, "value": 1.0}, {"source": 0, "target": 27, "value": 1.0}, {"source": 0, "target": 28, "value": 1.0}, {"source": 0, "target": 29, "value": 1.0}, {"source": 0, "target": 30, "value": 1.0}, {"source": 0, "target": 31, "value": 0.0}, {"source": 0, "target": 32, "value": 1.0}, {"source": 0, "target": 33, "value": 1.0}, {"source": 0, "target": 34, "value": 1.0}, {"source": 0, "target": 35, "value": 1.0}, {"source": 0, "target": 36, "value": 0.0}, {"source": 0, "target": 37, "value": 0.0}, {"source": 0, "target": 38, "value": 0.0}, {"source": 0, "target": 39, "value": 0.0}, {"source": 0, "target": 40, "value": 1.0}, {"source": 0, "target": 41, "value": 0.0}, {"source": 0, "target": 42, "value": 0.0}, {"source": 0, "target": 43, "value": 1.0}, {"source": 0, "target": 44, "value": 0.0}, {"source": 0, "target": 45, "value": 1.0}, {"source": 0, "target": 46, "value": 1.0}, {"source": 0, "target": 47, "value": 1.0}, {"source": 0, "target": 48, "value": 1.0}, {"source": 0, "target": 49, "value": 0.0}, {"source": 0, "target": 50, "value": 0.0}, {"source": 0, "target": 51, "value": 0.0}, {"source": 0, "target": 52, "value": 1.0}, {"source": 0, "target": 53, "value": 1.0}, {"source": 0, "target": 54, "value": 0.0}, {"source": 0, "target": 55, "value": 0.0}, {"source": 0, "target": 56, "value": 0.0}, {"source": 0, "target": 57, "value": 0.0}, {"source": 0, "target": 58, "value": 0.0}, {"source": 0, "target": 59, "value": 0.0}, {"source": 0, "target": 60, "value": 1.0}, {"source": 0, "target": 61, "value": 1.0}, {"source": 0, "target": 62, "value": 1.0}, {"source": 0, "target": 63, "value": 1.0}, {"source": 0, "target": 64, "value": 0.0}, {"source": 0, "target": 65, "value": 1.0}, {"source": 1, "target": 2, "value": 1.0}, {"source": 1, "target": 3, "value": 1.0}, {"source": 1, "target": 4, "value": 1.0}, {"source": 1, "target": 5, "value": 1.0}, {"source": 1, "target": 6, "value": 0.0}, {"source": 1, "target": 7, "value": 0.0}, {"source": 1, "target": 8, "value": 0.0}, {"source": 1, "target": 9, "value": 0.0}, {"source": 1, "target": 10, "value": 0.0}, {"source": 1, "target": 11, "value": 1.0}, {"source": 1, "target": 12, "value": 1.0}, {"source": 1, "target": 13, "value": 0.0}, {"source": 1, "target": 14, "value": 0.0}, {"source": 1, "target": 15, "value": 0.0}, {"source": 1, "target": 16, "value": 1.0}, {"source": 1, "target": 17, "value": 0.0}, {"source": 1, "target": 18, "value": 1.0}, {"source": 1, "target": 19, "value": 0.0}, {"source": 1, "target": 20, "value": 0.0}, {"source": 1, "target": 21, "value": 1.0}, {"source": 1, "target": 22, "value": 0.0}, {"source": 1, "target": 23, "value": 1.0}, {"source": 1, "target": 24, "value": 1.0}, {"source": 1, "target": 25, "value": 1.0}, {"source": 1, "target": 26, "value": 1.0}, {"source": 1, "target": 27, "value": 1.0}, {"source": 1, "target": 28, "value": 1.0}, {"source": 1, "target": 29, "value": 1.0}, {"source": 1, "target": 30, "value": 1.0}, {"source": 1, "target": 31, "value": 0.0}, {"source": 1, "target": 32, "value": 1.0}, {"source": 1, "target": 33, "value": 1.0}, {"source": 1, "target": 34, "value": 1.0}, {"source": 1, "target": 35, "value": 1.0}, {"source": 1, "target": 36, "value": 0.0}, {"source": 1, "target": 37, "value": 0.0}, {"source": 1, "target": 38, "value": 0.0}, {"source": 1, "target": 39, "value": 0.0}, {"source": 1, "target": 40, "value": 1.0}, {"source": 1, "target": 41, "value": 0.0}, {"source": 1, "target": 42, "value": 0.0}, {"source": 1, "target": 43, "value": 1.0}, {"source": 1, "target": 44, "value": 0.0}, {"source": 1, "target": 45, "value": 1.0}, {"source": 1, "target": 46, "value": 1.0}, {"source": 1, "target": 47, "value": 1.0}, {"source": 1, "target": 48, "value": 1.0}, {"source": 1, "target": 49, "value": 0.0}, {"source": 1, "target": 50, "value": 0.0}, {"source": 1, "target": 51, "value": 0.0}, {"source": 1, "target": 52, "value": 1.0}, {"source": 1, "target": 53, "value": 1.0}, {"source": 1, "target": 54, "value": 0.0}, {"source": 1, "target": 55, "value": 0.0}, {"source": 1, "target": 56, "value": 0.0}, {"source": 1, "target": 57, "value": 0.0}, {"source": 1, "target": 58, "value": 0.0}, {"source": 1, "target": 59, "value": 0.0}, {"source": 1, "target": 60, "value": 1.0}, {"source": 1, "target": 61, "value": 1.0}, {"source": 1, "target": 62, "value": 1.0}, {"source": 1, "target": 63, "value": 1.0}, {"source": 1, "target": 64, "value": 0.0}, {"source": 1, "target": 65, "value": 1.0}, {"source": 2, "target": 3, "value": 1.0}, {"source": 2, "target": 4, "value": 1.0}, {"source": 2, "target": 5, "value": 1.0}, {"source": 2, "target": 6, "value": 0.0}, {"source": 2, "target": 7, "value": 0.0}, {"source": 2, "target": 8, "value": 0.0}, {"source": 2, "target": 9, "value": 0.0}, {"source": 2, "target": 10, "value": 0.0}, {"source": 2, "target": 11, "value": 1.0}, {"source": 2, "target": 12, "value": 1.0}, {"source": 2, "target": 13, "value": 0.0}, {"source": 2, "target": 14, "value": 0.0}, {"source": 2, "target": 15, "value": 0.0}, {"source": 2, "target": 16, "value": 1.0}, {"source": 2, "target": 17, "value": 0.0}, {"source": 2, "target": 18, "value": 1.0}, {"source": 2, "target": 19, "value": 0.0}, {"source": 2, "target": 20, "value": 0.0}, {"source": 2, "target": 21, "value": 1.0}, {"source": 2, "target": 22, "value": 0.0}, {"source": 2, "target": 23, "value": 1.0}, {"source": 2, "target": 24, "value": 1.0}, {"source": 2, "target": 25, "value": 1.0}, {"source": 2, "target": 26, "value": 1.0}, {"source": 2, "target": 27, "value": 1.0}, {"source": 2, "target": 28, "value": 1.0}, {"source": 2, "target": 29, "value": 1.0}, {"source": 2, "target": 30, "value": 1.0}, {"source": 2, "target": 31, "value": 0.0}, {"source": 2, "target": 32, "value": 1.0}, {"source": 2, "target": 33, "value": 1.0}, {"source": 2, "target": 34, "value": 1.0}, {"source": 2, "target": 35, "value": 1.0}, {"source": 2, "target": 36, "value": 0.0}, {"source": 2, "target": 37, "value": 0.0}, {"source": 2, "target": 38, "value": 0.0}, {"source": 2, "target": 39, "value": 0.0}, {"source": 2, "target": 40, "value": 1.0}, {"source": 2, "target": 41, "value": 0.0}, {"source": 2, "target": 42, "value": 0.0}, {"source": 2, "target": 43, "value": 1.0}, {"source": 2, "target": 44, "value": 0.0}, {"source": 2, "target": 45, "value": 1.0}, {"source": 2, "target": 46, "value": 1.0}, {"source": 2, "target": 47, "value": 1.0}, {"source": 2, "target": 48, "value": 1.0}, {"source": 2, "target": 49, "value": 0.0}, {"source": 2, "target": 50, "value": 0.0}, {"source": 2, "target": 51, "value": 0.0}, {"source": 2, "target": 52, "value": 1.0}, {"source": 2, "target": 53, "value": 1.0}, {"source": 2, "target": 54, "value": 0.0}, {"source": 2, "target": 55, "value": 0.0}, {"source": 2, "target": 56, "value": 0.0}, {"source": 2, "target": 57, "value": 0.0}, {"source": 2, "target": 58, "value": 0.0}, {"source": 2, "target": 59, "value": 0.0}, {"source": 2, "target": 60, "value": 1.0}, {"source": 2, "target": 61, "value": 1.0}, {"source": 2, "target": 62, "value": 1.0}, {"source": 2, "target": 63, "value": 1.0}, {"source": 2, "target": 64, "value": 0.0}, {"source": 2, "target": 65, "value": 1.0}, {"source": 3, "target": 4, "value": 1.0}, {"source": 3, "target": 5, "value": 1.0}, {"source": 3, "target": 6, "value": 0.0}, {"source": 3, "target": 7, "value": 0.0}, {"source": 3, "target": 8, "value": 0.0}, {"source": 3, "target": 9, "value": 0.0}, {"source": 3, "target": 10, "value": 0.0}, {"source": 3, "target": 11, "value": 1.0}, {"source": 3, "target": 12, "value": 1.0}, {"source": 3, "target": 13, "value": 0.0}, {"source": 3, "target": 14, "value": 0.0}, {"source": 3, "target": 15, "value": 0.0}, {"source": 3, "target": 16, "value": 1.0}, {"source": 3, "target": 17, "value": 0.0}, {"source": 3, "target": 18, "value": 1.0}, {"source": 3, "target": 19, "value": 0.0}, {"source": 3, "target": 20, "value": 0.0}, {"source": 3, "target": 21, "value": 1.0}, {"source": 3, "target": 22, "value": 0.0}, {"source": 3, "target": 23, "value": 1.0}, {"source": 3, "target": 24, "value": 1.0}, {"source": 3, "target": 25, "value": 1.0}, {"source": 3, "target": 26, "value": 1.0}, {"source": 3, "target": 27, "value": 1.0}, {"source": 3, "target": 28, "value": 1.0}, {"source": 3, "target": 29, "value": 1.0}, {"source": 3, "target": 30, "value": 1.0}, {"source": 3, "target": 31, "value": 0.0}, {"source": 3, "target": 32, "value": 1.0}, {"source": 3, "target": 33, "value": 1.0}, {"source": 3, "target": 34, "value": 1.0}, {"source": 3, "target": 35, "value": 1.0}, {"source": 3, "target": 36, "value": 0.0}, {"source": 3, "target": 37, "value": 0.0}, {"source": 3, "target": 38, "value": 0.0}, {"source": 3, "target": 39, "value": 0.0}, {"source": 3, "target": 40, "value": 1.0}, {"source": 3, "target": 41, "value": 0.0}, {"source": 3, "target": 42, "value": 0.0}, {"source": 3, "target": 43, "value": 1.0}, {"source": 3, "target": 44, "value": 0.0}, {"source": 3, "target": 45, "value": 1.0}, {"source": 3, "target": 46, "value": 1.0}, {"source": 3, "target": 47, "value": 1.0}, {"source": 3, "target": 48, "value": 1.0}, {"source": 3, "target": 49, "value": 0.0}, {"source": 3, "target": 50, "value": 0.0}, {"source": 3, "target": 51, "value": 0.0}, {"source": 3, "target": 52, "value": 1.0}, {"source": 3, "target": 53, "value": 1.0}, {"source": 3, "target": 54, "value": 0.0}, {"source": 3, "target": 55, "value": 0.0}, {"source": 3, "target": 56, "value": 0.0}, {"source": 3, "target": 57, "value": 0.0}, {"source": 3, "target": 58, "value": 0.0}, {"source": 3, "target": 59, "value": 0.0}, {"source": 3, "target": 60, "value": 1.0}, {"source": 3, "target": 61, "value": 1.0}, {"source": 3, "target": 62, "value": 1.0}, {"source": 3, "target": 63, "value": 1.0}, {"source": 3, "target": 64, "value": 0.0}, {"source": 3, "target": 65, "value": 1.0}, {"source": 4, "target": 5, "value": 1.0}, {"source": 4, "target": 6, "value": 0.0}, {"source": 4, "target": 7, "value": 0.0}, {"source": 4, "target": 8, "value": 0.0}, {"source": 4, "target": 9, "value": 0.0}, {"source": 4, "target": 10, "value": 0.0}, {"source": 4, "target": 11, "value": 1.0}, {"source": 4, "target": 12, "value": 1.0}, {"source": 4, "target": 13, "value": 0.0}, {"source": 4, "target": 14, "value": 0.0}, {"source": 4, "target": 15, "value": 0.0}, {"source": 4, "target": 16, "value": 1.0}, {"source": 4, "target": 17, "value": 0.0}, {"source": 4, "target": 18, "value": 1.0}, {"source": 4, "target": 19, "value": 0.0}, {"source": 4, "target": 20, "value": 0.0}, {"source": 4, "target": 21, "value": 1.0}, {"source": 4, "target": 22, "value": 0.0}, {"source": 4, "target": 23, "value": 1.0}, {"source": 4, "target": 24, "value": 1.0}, {"source": 4, "target": 25, "value": 1.0}, {"source": 4, "target": 26, "value": 1.0}, {"source": 4, "target": 27, "value": 1.0}, {"source": 4, "target": 28, "value": 1.0}, {"source": 4, "target": 29, "value": 1.0}, {"source": 4, "target": 30, "value": 1.0}, {"source": 4, "target": 31, "value": 0.0}, {"source": 4, "target": 32, "value": 1.0}, {"source": 4, "target": 33, "value": 1.0}, {"source": 4, "target": 34, "value": 1.0}, {"source": 4, "target": 35, "value": 1.0}, {"source": 4, "target": 36, "value": 0.0}, {"source": 4, "target": 37, "value": 0.0}, {"source": 4, "target": 38, "value": 0.0}, {"source": 4, "target": 39, "value": 0.0}, {"source": 4, "target": 40, "value": 1.0}, {"source": 4, "target": 41, "value": 0.0}, {"source": 4, "target": 42, "value": 0.0}, {"source": 4, "target": 43, "value": 1.0}, {"source": 4, "target": 44, "value": 0.0}, {"source": 4, "target": 45, "value": 1.0}, {"source": 4, "target": 46, "value": 1.0}, {"source": 4, "target": 47, "value": 1.0}, {"source": 4, "target": 48, "value": 1.0}, {"source": 4, "target": 49, "value": 0.0}, {"source": 4, "target": 50, "value": 0.0}, {"source": 4, "target": 51, "value": 0.0}, {"source": 4, "target": 52, "value": 1.0}, {"source": 4, "target": 53, "value": 1.0}, {"source": 4, "target": 54, "value": 0.0}, {"source": 4, "target": 55, "value": 0.0}, {"source": 4, "target": 56, "value": 0.0}, {"source": 4, "target": 57, "value": 0.0}, {"source": 4, "target": 58, "value": 0.0}, {"source": 4, "target": 59, "value": 0.0}, {"source": 4, "target": 60, "value": 1.0}, {"source": 4, "target": 61, "value": 1.0}, {"source": 4, "target": 62, "value": 1.0}, {"source": 4, "target": 63, "value": 1.0}, {"source": 4, "target": 64, "value": 0.0}, {"source": 4, "target": 65, "value": 1.0}, {"source": 5, "target": 6, "value": 0.0}, {"source": 5, "target": 7, "value": 0.0}, {"source": 5, "target": 8, "value": 0.0}, {"source": 5, "target": 9, "value": 0.0}, {"source": 5, "target": 10, "value": 0.0}, {"source": 5, "target": 11, "value": 1.0}, {"source": 5, "target": 12, "value": 1.0}, {"source": 5, "target": 13, "value": 0.0}, {"source": 5, "target": 14, "value": 0.0}, {"source": 5, "target": 15, "value": 0.0}, {"source": 5, "target": 16, "value": 1.0}, {"source": 5, "target": 17, "value": 0.0}, {"source": 5, "target": 18, "value": 1.0}, {"source": 5, "target": 19, "value": 0.0}, {"source": 5, "target": 20, "value": 0.0}, {"source": 5, "target": 21, "value": 1.0}, {"source": 5, "target": 22, "value": 0.0}, {"source": 5, "target": 23, "value": 1.0}, {"source": 5, "target": 24, "value": 1.0}, {"source": 5, "target": 25, "value": 1.0}, {"source": 5, "target": 26, "value": 1.0}, {"source": 5, "target": 27, "value": 1.0}, {"source": 5, "target": 28, "value": 1.0}, {"source": 5, "target": 29, "value": 1.0}, {"source": 5, "target": 30, "value": 1.0}, {"source": 5, "target": 31, "value": 0.0}, {"source": 5, "target": 32, "value": 1.0}, {"source": 5, "target": 33, "value": 1.0}, {"source": 5, "target": 34, "value": 1.0}, {"source": 5, "target": 35, "value": 1.0}, {"source": 5, "target": 36, "value": 0.0}, {"source": 5, "target": 37, "value": 0.0}, {"source": 5, "target": 38, "value": 0.0}, {"source": 5, "target": 39, "value": 0.0}, {"source": 5, "target": 40, "value": 1.0}, {"source": 5, "target": 41, "value": 0.0}, {"source": 5, "target": 42, "value": 0.0}, {"source": 5, "target": 43, "value": 1.0}, {"source": 5, "target": 44, "value": 0.0}, {"source": 5, "target": 45, "value": 1.0}, {"source": 5, "target": 46, "value": 1.0}, {"source": 5, "target": 47, "value": 1.0}, {"source": 5, "target": 48, "value": 1.0}, {"source": 5, "target": 49, "value": 0.0}, {"source": 5, "target": 50, "value": 0.0}, {"source": 5, "target": 51, "value": 0.0}, {"source": 5, "target": 52, "value": 1.0}, {"source": 5, "target": 53, "value": 1.0}, {"source": 5, "target": 54, "value": 0.0}, {"source": 5, "target": 55, "value": 0.0}, {"source": 5, "target": 56, "value": 0.0}, {"source": 5, "target": 57, "value": 0.0}, {"source": 5, "target": 58, "value": 0.0}, {"source": 5, "target": 59, "value": 0.0}, {"source": 5, "target": 60, "value": 1.0}, {"source": 5, "target": 61, "value": 1.0}, {"source": 5, "target": 62, "value": 1.0}, {"source": 5, "target": 63, "value": 1.0}, {"source": 5, "target": 64, "value": 0.0}, {"source": 5, "target": 65, "value": 1.0}, {"source": 6, "target": 7, "value": 0.0}, {"source": 6, "target": 8, "value": 0.12629896083133493}, {"source": 6, "target": 9, "value": 0.1559778305621536}, {"source": 6, "target": 10, "value": 0.4743950478334271}, {"source": 6, "target": 11, "value": 0.0}, {"source": 6, "target": 12, "value": 0.0}, {"source": 6, "target": 13, "value": 0.09090909090909091}, {"source": 6, "target": 14, "value": 0.47669256381798003}, {"source": 6, "target": 15, "value": 0.41857659831121835}, {"source": 6, "target": 16, "value": 0.0}, {"source": 6, "target": 17, "value": 0.44228504122497053}, {"source": 6, "target": 18, "value": 0.0}, {"source": 6, "target": 19, "value": 0.3616042077580539}, {"source": 6, "target": 20, "value": 0.4683760683760684}, {"source": 6, "target": 21, "value": 0.0}, {"source": 6, "target": 22, "value": 0.3689080814312153}, {"source": 6, "target": 23, "value": 0.0}, {"source": 6, "target": 24, "value": 0.0}, {"source": 6, "target": 25, "value": 0.0}, {"source": 6, "target": 26, "value": 0.0}, {"source": 6, "target": 27, "value": 0.0}, {"source": 6, "target": 28, "value": 0.0}, {"source": 6, "target": 29, "value": 0.0}, {"source": 6, "target": 30, "value": 0.0}, {"source": 6, "target": 31, "value": 0.3369987063389392}, {"source": 6, "target": 32, "value": 0.0}, {"source": 6, "target": 33, "value": 0.0}, {"source": 6, "target": 34, "value": 0.0}, {"source": 6, "target": 35, "value": 0.0}, {"source": 6, "target": 36, "value": 0.3822476735862563}, {"source": 6, "target": 37, "value": 0.30459363957597174}, {"source": 6, "target": 38, "value": 0.0}, {"source": 6, "target": 39, "value": 0.4256716417910448}, {"source": 6, "target": 40, "value": 0.0}, {"source": 6, "target": 41, "value": 0.5024390243902439}, {"source": 6, "target": 42, "value": 0.011854360711261643}, {"source": 6, "target": 43, "value": 0.0}, {"source": 6, "target": 44, "value": 0.0}, {"source": 6, "target": 45, "value": 0.0}, {"source": 6, "target": 46, "value": 0.0}, {"source": 6, "target": 47, "value": 0.0}, {"source": 6, "target": 48, "value": 0.0}, {"source": 6, "target": 49, "value": 0.501085776330076}, {"source": 6, "target": 50, "value": 0.4512485136741974}, {"source": 6, "target": 51, "value": 0.11483253588516747}, {"source": 6, "target": 52, "value": 0.0}, {"source": 6, "target": 53, "value": 0.0}, {"source": 6, "target": 54, "value": 0.41477949940405245}, {"source": 6, "target": 55, "value": 0.43437316068275456}, {"source": 6, "target": 56, "value": 0.11818181818181818}, {"source": 6, "target": 57, "value": 0.0}, {"source": 6, "target": 58, "value": 0.14407436096049575}, {"source": 6, "target": 59, "value": 0.04448246364414029}, {"source": 6, "target": 60, "value": 0.0}, {"source": 6, "target": 61, "value": 0.0}, {"source": 6, "target": 62, "value": 0.0}, {"source": 6, "target": 63, "value": 0.0}, {"source": 6, "target": 64, "value": 0.48990498812351546}, {"source": 6, "target": 65, "value": 0.0}, {"source": 7, "target": 8, "value": 0.0}, {"source": 7, "target": 9, "value": 0.0}, {"source": 7, "target": 10, "value": 0.0}, {"source": 7, "target": 11, "value": 0.0}, {"source": 7, "target": 12, "value": 0.0}, {"source": 7, "target": 13, "value": 0.0}, {"source": 7, "target": 14, "value": 0.0}, {"source": 7, "target": 15, "value": 0.0}, {"source": 7, "target": 16, "value": 0.0}, {"source": 7, "target": 17, "value": 0.0}, {"source": 7, "target": 18, "value": 0.0}, {"source": 7, "target": 19, "value": 0.0}, {"source": 7, "target": 20, "value": 0.0}, {"source": 7, "target": 21, "value": 0.0}, {"source": 7, "target": 22, "value": 0.0}, {"source": 7, "target": 23, "value": 0.0}, {"source": 7, "target": 24, "value": 0.0}, {"source": 7, "target": 25, "value": 0.0}, {"source": 7, "target": 26, "value": 0.0}, {"source": 7, "target": 27, "value": 0.0}, {"source": 7, "target": 28, "value": 0.0}, {"source": 7, "target": 29, "value": 0.0}, {"source": 7, "target": 30, "value": 0.0}, {"source": 7, "target": 31, "value": 0.0}, {"source": 7, "target": 32, "value": 0.0}, {"source": 7, "target": 33, "value": 0.0}, {"source": 7, "target": 34, "value": 0.0}, {"source": 7, "target": 35, "value": 0.0}, {"source": 7, "target": 36, "value": 0.0}, {"source": 7, "target": 37, "value": 0.0}, {"source": 7, "target": 38, "value": 0.0}, {"source": 7, "target": 39, "value": 0.0}, {"source": 7, "target": 40, "value": 0.0}, {"source": 7, "target": 41, "value": 0.0}, {"source": 7, "target": 42, "value": 0.0}, {"source": 7, "target": 43, "value": 0.0}, {"source": 7, "target": 44, "value": 0.0}, {"source": 7, "target": 45, "value": 0.0}, {"source": 7, "target": 46, "value": 0.0}, {"source": 7, "target": 47, "value": 0.0}, {"source": 7, "target": 48, "value": 0.0}, {"source": 7, "target": 49, "value": 0.0}, {"source": 7, "target": 50, "value": 0.0}, {"source": 7, "target": 51, "value": 0.0}, {"source": 7, "target": 52, "value": 0.0}, {"source": 7, "target": 53, "value": 0.0}, {"source": 7, "target": 54, "value": 0.0}, {"source": 7, "target": 55, "value": 0.0}, {"source": 7, "target": 56, "value": 0.0}, {"source": 7, "target": 57, "value": 0.0}, {"source": 7, "target": 58, "value": 0.0}, {"source": 7, "target": 59, "value": 0.0}, {"source": 7, "target": 60, "value": 0.0}, {"source": 7, "target": 61, "value": 0.0}, {"source": 7, "target": 62, "value": 0.0}, {"source": 7, "target": 63, "value": 0.0}, {"source": 7, "target": 64, "value": 0.0}, {"source": 7, "target": 65, "value": 0.0}, {"source": 8, "target": 9, "value": 0.2564102564102564}, {"source": 8, "target": 10, "value": 0.13040585495675316}, {"source": 8, "target": 11, "value": 0.0}, {"source": 8, "target": 12, "value": 0.0}, {"source": 8, "target": 13, "value": 0.13352272727272727}, {"source": 8, "target": 14, "value": 0.11969111969111969}, {"source": 8, "target": 15, "value": 0.15589660743134087}, {"source": 8, "target": 16, "value": 0.0}, {"source": 8, "target": 17, "value": 0.16109422492401215}, {"source": 8, "target": 18, "value": 0.0}, {"source": 8, "target": 19, "value": 0.12745098039215685}, {"source": 8, "target": 20, "value": 0.13037542662116042}, {"source": 8, "target": 21, "value": 0.0}, {"source": 8, "target": 22, "value": 0.12186689714779603}, {"source": 8, "target": 23, "value": 0.0}, {"source": 8, "target": 24, "value": 0.0}, {"source": 8, "target": 25, "value": 0.0}, {"source": 8, "target": 26, "value": 0.0}, {"source": 8, "target": 27, "value": 0.0}, {"source": 8, "target": 28, "value": 0.0}, {"source": 8, "target": 29, "value": 0.0}, {"source": 8, "target": 30, "value": 0.0}, {"source": 8, "target": 31, "value": 0.12463199214916584}, {"source": 8, "target": 32, "value": 0.0}, {"source": 8, "target": 33, "value": 0.0}, {"source": 8, "target": 34, "value": 0.0}, {"source": 8, "target": 35, "value": 0.0}, {"source": 8, "target": 36, "value": 0.15825688073394495}, {"source": 8, "target": 37, "value": 0.11177884615384616}, {"source": 8, "target": 38, "value": 0.0}, {"source": 8, "target": 39, "value": 0.15239591516103693}, {"source": 8, "target": 40, "value": 0.0}, {"source": 8, "target": 41, "value": 0.13003663003663005}, {"source": 8, "target": 42, "value": 0.04182509505703422}, {"source": 8, "target": 43, "value": 0.0}, {"source": 8, "target": 44, "value": 0.0}, {"source": 8, "target": 45, "value": 0.0}, {"source": 8, "target": 46, "value": 0.0}, {"source": 8, "target": 47, "value": 0.0}, {"source": 8, "target": 48, "value": 0.0}, {"source": 8, "target": 49, "value": 0.129210042865891}, {"source": 8, "target": 50, "value": 0.13602391629297458}, {"source": 8, "target": 51, "value": 0.07191011235955057}, {"source": 8, "target": 52, "value": 0.0}, {"source": 8, "target": 53, "value": 0.0}, {"source": 8, "target": 54, "value": 0.11000763941940413}, {"source": 8, "target": 55, "value": 0.16705157813702848}, {"source": 8, "target": 56, "value": 0.21008403361344538}, {"source": 8, "target": 57, "value": 0.0}, {"source": 8, "target": 58, "value": 0.07961165048543689}, {"source": 8, "target": 59, "value": 0.22950819672131148}, {"source": 8, "target": 60, "value": 0.0}, {"source": 8, "target": 61, "value": 0.0}, {"source": 8, "target": 62, "value": 0.0}, {"source": 8, "target": 63, "value": 0.0}, {"source": 8, "target": 64, "value": 0.12624113475177304}, {"source": 8, "target": 65, "value": 0.0}, {"source": 9, "target": 10, "value": 0.19699042407660738}, {"source": 9, "target": 11, "value": 0.0}, {"source": 9, "target": 12, "value": 0.0}, {"source": 9, "target": 13, "value": 0.5254237288135594}, {"source": 9, "target": 14, "value": 0.14221938775510204}, {"source": 9, "target": 15, "value": 0.2370617696160267}, {"source": 9, "target": 16, "value": 0.0}, {"source": 9, "target": 17, "value": 0.20626432391138275}, {"source": 9, "target": 18, "value": 0.0}, {"source": 9, "target": 19, "value": 0.18208661417322836}, {"source": 9, "target": 20, "value": 0.16439290586630287}, {"source": 9, "target": 21, "value": 0.0}, {"source": 9, "target": 22, "value": 0.16999132697311362}, {"source": 9, "target": 23, "value": 0.0}, {"source": 9, "target": 24, "value": 0.0}, {"source": 9, "target": 25, "value": 0.0}, {"source": 9, "target": 26, "value": 0.0}, {"source": 9, "target": 27, "value": 0.0}, {"source": 9, "target": 28, "value": 0.0}, {"source": 9, "target": 29, "value": 0.0}, {"source": 9, "target": 30, "value": 0.0}, {"source": 9, "target": 31, "value": 0.15876089060987417}, {"source": 9, "target": 32, "value": 0.0}, {"source": 9, "target": 33, "value": 0.0}, {"source": 9, "target": 34, "value": 0.0}, {"source": 9, "target": 35, "value": 0.0}, {"source": 9, "target": 36, "value": 0.1685022026431718}, {"source": 9, "target": 37, "value": 0.1619047619047619}, {"source": 9, "target": 38, "value": 0.0}, {"source": 9, "target": 39, "value": 0.23014586709886548}, {"source": 9, "target": 40, "value": 0.0}, {"source": 9, "target": 41, "value": 0.17770897832817337}, {"source": 9, "target": 42, "value": 0.041666666666666664}, {"source": 9, "target": 43, "value": 0.0}, {"source": 9, "target": 44, "value": 0.0}, {"source": 9, "target": 45, "value": 0.0}, {"source": 9, "target": 46, "value": 0.0}, {"source": 9, "target": 47, "value": 0.0}, {"source": 9, "target": 48, "value": 0.0}, {"source": 9, "target": 49, "value": 0.17848258706467662}, {"source": 9, "target": 50, "value": 0.18925056775170326}, {"source": 9, "target": 51, "value": 0.06882591093117409}, {"source": 9, "target": 52, "value": 0.0}, {"source": 9, "target": 53, "value": 0.0}, {"source": 9, "target": 54, "value": 0.16318638824439288}, {"source": 9, "target": 55, "value": 0.1711509715994021}, {"source": 9, "target": 56, "value": 0.17518248175182483}, {"source": 9, "target": 57, "value": 0.0}, {"source": 9, "target": 58, "value": 0.07815275310834814}, {"source": 9, "target": 59, "value": 0.125}, {"source": 9, "target": 60, "value": 0.0}, {"source": 9, "target": 61, "value": 0.0}, {"source": 9, "target": 62, "value": 0.0}, {"source": 9, "target": 63, "value": 0.0}, {"source": 9, "target": 64, "value": 0.15098314606741572}, {"source": 9, "target": 65, "value": 0.0}, {"source": 10, "target": 11, "value": 0.0}, {"source": 10, "target": 12, "value": 0.0}, {"source": 10, "target": 13, "value": 0.10652920962199312}, {"source": 10, "target": 14, "value": 0.5705162320383182}, {"source": 10, "target": 15, "value": 0.5633136094674556}, {"source": 10, "target": 16, "value": 0.0}, {"source": 10, "target": 17, "value": 0.5915165601394538}, {"source": 10, "target": 18, "value": 0.0}, {"source": 10, "target": 19, "value": 0.4821092278719397}, {"source": 10, "target": 20, "value": 0.5649563318777293}, {"source": 10, "target": 21, "value": 0.0}, {"source": 10, "target": 22, "value": 0.493452380952381}, {"source": 10, "target": 23, "value": 0.0}, {"source": 10, "target": 24, "value": 0.0}, {"source": 10, "target": 25, "value": 0.0}, {"source": 10, "target": 26, "value": 0.0}, {"source": 10, "target": 27, "value": 0.0}, {"source": 10, "target": 28, "value": 0.0}, {"source": 10, "target": 29, "value": 0.0}, {"source": 10, "target": 30, "value": 0.0}, {"source": 10, "target": 31, "value": 0.3791691047396138}, {"source": 10, "target": 32, "value": 0.0}, {"source": 10, "target": 33, "value": 0.0}, {"source": 10, "target": 34, "value": 0.0}, {"source": 10, "target": 35, "value": 0.0}, {"source": 10, "target": 36, "value": 0.3485124468731026}, {"source": 10, "target": 37, "value": 0.31689272503082616}, {"source": 10, "target": 38, "value": 0.0}, {"source": 10, "target": 39, "value": 0.5762213066509712}, {"source": 10, "target": 40, "value": 0.0}, {"source": 10, "target": 41, "value": 0.6641304347826087}, {"source": 10, "target": 42, "value": 0.015037593984962405}, {"source": 10, "target": 43, "value": 0.0}, {"source": 10, "target": 44, "value": 0.0}, {"source": 10, "target": 45, "value": 0.0}, {"source": 10, "target": 46, "value": 0.0}, {"source": 10, "target": 47, "value": 0.0}, {"source": 10, "target": 48, "value": 0.0}, {"source": 10, "target": 49, "value": 0.6630375612411541}, {"source": 10, "target": 50, "value": 0.5722510074841681}, {"source": 10, "target": 51, "value": 0.12159468438538205}, {"source": 10, "target": 52, "value": 0.0}, {"source": 10, "target": 53, "value": 0.0}, {"source": 10, "target": 54, "value": 0.5497382198952879}, {"source": 10, "target": 55, "value": 0.5346088913899831}, {"source": 10, "target": 56, "value": 0.10046885465505694}, {"source": 10, "target": 57, "value": 0.0}, {"source": 10, "target": 58, "value": 0.1429495472186287}, {"source": 10, "target": 59, "value": 0.03564084989718986}, {"source": 10, "target": 60, "value": 0.0}, {"source": 10, "target": 61, "value": 0.0}, {"source": 10, "target": 62, "value": 0.0}, {"source": 10, "target": 63, "value": 0.0}, {"source": 10, "target": 64, "value": 0.5295081967213114}, {"source": 10, "target": 65, "value": 0.0}, {"source": 11, "target": 12, "value": 1.0}, {"source": 11, "target": 13, "value": 0.0}, {"source": 11, "target": 14, "value": 0.0}, {"source": 11, "target": 15, "value": 0.0}, {"source": 11, "target": 16, "value": 1.0}, {"source": 11, "target": 17, "value": 0.0}, {"source": 11, "target": 18, "value": 1.0}, {"source": 11, "target": 19, "value": 0.0}, {"source": 11, "target": 20, "value": 0.0}, {"source": 11, "target": 21, "value": 1.0}, {"source": 11, "target": 22, "value": 0.0}, {"source": 11, "target": 23, "value": 1.0}, {"source": 11, "target": 24, "value": 1.0}, {"source": 11, "target": 25, "value": 1.0}, {"source": 11, "target": 26, "value": 1.0}, {"source": 11, "target": 27, "value": 1.0}, {"source": 11, "target": 28, "value": 1.0}, {"source": 11, "target": 29, "value": 1.0}, {"source": 11, "target": 30, "value": 1.0}, {"source": 11, "target": 31, "value": 0.0}, {"source": 11, "target": 32, "value": 1.0}, {"source": 11, "target": 33, "value": 1.0}, {"source": 11, "target": 34, "value": 1.0}, {"source": 11, "target": 35, "value": 1.0}, {"source": 11, "target": 36, "value": 0.0}, {"source": 11, "target": 37, "value": 0.0}, {"source": 11, "target": 38, "value": 0.0}, {"source": 11, "target": 39, "value": 0.0}, {"source": 11, "target": 40, "value": 1.0}, {"source": 11, "target": 41, "value": 0.0}, {"source": 11, "target": 42, "value": 0.0}, {"source": 11, "target": 43, "value": 1.0}, {"source": 11, "target": 44, "value": 0.0}, {"source": 11, "target": 45, "value": 1.0}, {"source": 11, "target": 46, "value": 1.0}, {"source": 11, "target": 47, "value": 1.0}, {"source": 11, "target": 48, "value": 1.0}, {"source": 11, "target": 49, "value": 0.0}, {"source": 11, "target": 50, "value": 0.0}, {"source": 11, "target": 51, "value": 0.0}, {"source": 11, "target": 52, "value": 1.0}, {"source": 11, "target": 53, "value": 1.0}, {"source": 11, "target": 54, "value": 0.0}, {"source": 11, "target": 55, "value": 0.0}, {"source": 11, "target": 56, "value": 0.0}, {"source": 11, "target": 57, "value": 0.0}, {"source": 11, "target": 58, "value": 0.0}, {"source": 11, "target": 59, "value": 0.0}, {"source": 11, "target": 60, "value": 1.0}, {"source": 11, "target": 61, "value": 1.0}, {"source": 11, "target": 62, "value": 1.0}, {"source": 11, "target": 63, "value": 1.0}, {"source": 11, "target": 64, "value": 0.0}, {"source": 11, "target": 65, "value": 1.0}, {"source": 12, "target": 13, "value": 0.0}, {"source": 12, "target": 14, "value": 0.0}, {"source": 12, "target": 15, "value": 0.0}, {"source": 12, "target": 16, "value": 1.0}, {"source": 12, "target": 17, "value": 0.0}, {"source": 12, "target": 18, "value": 1.0}, {"source": 12, "target": 19, "value": 0.0}, {"source": 12, "target": 20, "value": 0.0}, {"source": 12, "target": 21, "value": 1.0}, {"source": 12, "target": 22, "value": 0.0}, {"source": 12, "target": 23, "value": 1.0}, {"source": 12, "target": 24, "value": 1.0}, {"source": 12, "target": 25, "value": 1.0}, {"source": 12, "target": 26, "value": 1.0}, {"source": 12, "target": 27, "value": 1.0}, {"source": 12, "target": 28, "value": 1.0}, {"source": 12, "target": 29, "value": 1.0}, {"source": 12, "target": 30, "value": 1.0}, {"source": 12, "target": 31, "value": 0.0}, {"source": 12, "target": 32, "value": 1.0}, {"source": 12, "target": 33, "value": 1.0}, {"source": 12, "target": 34, "value": 1.0}, {"source": 12, "target": 35, "value": 1.0}, {"source": 12, "target": 36, "value": 0.0}, {"source": 12, "target": 37, "value": 0.0}, {"source": 12, "target": 38, "value": 0.0}, {"source": 12, "target": 39, "value": 0.0}, {"source": 12, "target": 40, "value": 1.0}, {"source": 12, "target": 41, "value": 0.0}, {"source": 12, "target": 42, "value": 0.0}, {"source": 12, "target": 43, "value": 1.0}, {"source": 12, "target": 44, "value": 0.0}, {"source": 12, "target": 45, "value": 1.0}, {"source": 12, "target": 46, "value": 1.0}, {"source": 12, "target": 47, "value": 1.0}, {"source": 12, "target": 48, "value": 1.0}, {"source": 12, "target": 49, "value": 0.0}, {"source": 12, "target": 50, "value": 0.0}, {"source": 12, "target": 51, "value": 0.0}, {"source": 12, "target": 52, "value": 1.0}, {"source": 12, "target": 53, "value": 1.0}, {"source": 12, "target": 54, "value": 0.0}, {"source": 12, "target": 55, "value": 0.0}, {"source": 12, "target": 56, "value": 0.0}, {"source": 12, "target": 57, "value": 0.0}, {"source": 12, "target": 58, "value": 0.0}, {"source": 12, "target": 59, "value": 0.0}, {"source": 12, "target": 60, "value": 1.0}, {"source": 12, "target": 61, "value": 1.0}, {"source": 12, "target": 62, "value": 1.0}, {"source": 12, "target": 63, "value": 1.0}, {"source": 12, "target": 64, "value": 0.0}, {"source": 12, "target": 65, "value": 1.0}, {"source": 13, "target": 14, "value": 0.07979071288423806}, {"source": 13, "target": 15, "value": 0.13058129738837404}, {"source": 13, "target": 16, "value": 0.0}, {"source": 13, "target": 17, "value": 0.12071651090342679}, {"source": 13, "target": 18, "value": 0.0}, {"source": 13, "target": 19, "value": 0.12632696390658174}, {"source": 13, "target": 20, "value": 0.10274454609429978}, {"source": 13, "target": 21, "value": 0.0}, {"source": 13, "target": 22, "value": 0.11531365313653137}, {"source": 13, "target": 23, "value": 0.0}, {"source": 13, "target": 24, "value": 0.0}, {"source": 13, "target": 25, "value": 0.0}, {"source": 13, "target": 26, "value": 0.0}, {"source": 13, "target": 27, "value": 0.0}, {"source": 13, "target": 28, "value": 0.0}, {"source": 13, "target": 29, "value": 0.0}, {"source": 13, "target": 30, "value": 0.0}, {"source": 13, "target": 31, "value": 0.09420289855072464}, {"source": 13, "target": 32, "value": 0.0}, {"source": 13, "target": 33, "value": 0.0}, {"source": 13, "target": 34, "value": 0.0}, {"source": 13, "target": 35, "value": 0.0}, {"source": 13, "target": 36, "value": 0.11097708082026538}, {"source": 13, "target": 37, "value": 0.13279132791327913}, {"source": 13, "target": 38, "value": 0.0}, {"source": 13, "target": 39, "value": 0.1267375306623058}, {"source": 13, "target": 40, "value": 0.0}, {"source": 13, "target": 41, "value": 0.09645301804604854}, {"source": 13, "target": 42, "value": 0.005434782608695652}, {"source": 13, "target": 43, "value": 0.0}, {"source": 13, "target": 44, "value": 0.0}, {"source": 13, "target": 45, "value": 0.0}, {"source": 13, "target": 46, "value": 0.0}, {"source": 13, "target": 47, "value": 0.0}, {"source": 13, "target": 48, "value": 0.0}, {"source": 13, "target": 49, "value": 0.096875}, {"source": 13, "target": 50, "value": 0.11448598130841121}, {"source": 13, "target": 51, "value": 0.04582210242587601}, {"source": 13, "target": 52, "value": 0.0}, {"source": 13, "target": 53, "value": 0.0}, {"source": 13, "target": 54, "value": 0.10804224207961008}, {"source": 13, "target": 55, "value": 0.08352315869400152}, {"source": 13, "target": 56, "value": 0.15100671140939598}, {"source": 13, "target": 57, "value": 0.0}, {"source": 13, "target": 58, "value": 0.04943820224719101}, {"source": 13, "target": 59, "value": 0.21965317919075145}, {"source": 13, "target": 60, "value": 0.0}, {"source": 13, "target": 61, "value": 0.0}, {"source": 13, "target": 62, "value": 0.0}, {"source": 13, "target": 63, "value": 0.0}, {"source": 13, "target": 64, "value": 0.08465991316931983}, {"source": 13, "target": 65, "value": 0.0}, {"source": 14, "target": 15, "value": 0.5073033707865169}, {"source": 14, "target": 16, "value": 0.0}, {"source": 14, "target": 17, "value": 0.5257958287596048}, {"source": 14, "target": 18, "value": 0.0}, {"source": 14, "target": 19, "value": 0.4096244131455399}, {"source": 14, "target": 20, "value": 0.5727420227149811}, {"source": 14, "target": 21, "value": 0.0}, {"source": 14, "target": 22, "value": 0.45381984036488027}, {"source": 14, "target": 23, "value": 0.0}, {"source": 14, "target": 24, "value": 0.0}, {"source": 14, "target": 25, "value": 0.0}, {"source": 14, "target": 26, "value": 0.0}, {"source": 14, "target": 27, "value": 0.0}, {"source": 14, "target": 28, "value": 0.0}, {"source": 14, "target": 29, "value": 0.0}, {"source": 14, "target": 30, "value": 0.0}, {"source": 14, "target": 31, "value": 0.40480374926772117}, {"source": 14, "target": 32, "value": 0.0}, {"source": 14, "target": 33, "value": 0.0}, {"source": 14, "target": 34, "value": 0.0}, {"source": 14, "target": 35, "value": 0.0}, {"source": 14, "target": 36, "value": 0.35855855855855856}, {"source": 14, "target": 37, "value": 0.31223628691983124}, {"source": 14, "target": 38, "value": 0.0}, {"source": 14, "target": 39, "value": 0.5172991071428571}, {"source": 14, "target": 40, "value": 0.0}, {"source": 14, "target": 41, "value": 0.661134903640257}, {"source": 14, "target": 42, "value": 0.015978695073235686}, {"source": 14, "target": 43, "value": 0.0}, {"source": 14, "target": 44, "value": 0.0}, {"source": 14, "target": 45, "value": 0.0}, {"source": 14, "target": 46, "value": 0.0}, {"source": 14, "target": 47, "value": 0.0}, {"source": 14, "target": 48, "value": 0.0}, {"source": 14, "target": 49, "value": 0.6591639871382636}, {"source": 14, "target": 50, "value": 0.5503355704697986}, {"source": 14, "target": 51, "value": 0.12199870214146658}, {"source": 14, "target": 52, "value": 0.0}, {"source": 14, "target": 53, "value": 0.0}, {"source": 14, "target": 54, "value": 0.517106001121705}, {"source": 14, "target": 55, "value": 0.5267512410369554}, {"source": 14, "target": 56, "value": 0.09849967384213959}, {"source": 14, "target": 57, "value": 0.0}, {"source": 14, "target": 58, "value": 0.14285714285714285}, {"source": 14, "target": 59, "value": 0.034666666666666665}, {"source": 14, "target": 60, "value": 0.0}, {"source": 14, "target": 61, "value": 0.0}, {"source": 14, "target": 62, "value": 0.0}, {"source": 14, "target": 63, "value": 0.0}, {"source": 14, "target": 64, "value": 0.5301724137931034}, {"source": 14, "target": 65, "value": 0.0}, {"source": 15, "target": 16, "value": 0.0}, {"source": 15, "target": 17, "value": 0.6003886010362695}, {"source": 15, "target": 18, "value": 0.0}, {"source": 15, "target": 19, "value": 0.4267211997273347}, {"source": 15, "target": 20, "value": 0.4988465974625144}, {"source": 15, "target": 21, "value": 0.0}, {"source": 15, "target": 22, "value": 0.5402061855670103}, {"source": 15, "target": 23, "value": 0.0}, {"source": 15, "target": 24, "value": 0.0}, {"source": 15, "target": 25, "value": 0.0}, {"source": 15, "target": 26, "value": 0.0}, {"source": 15, "target": 27, "value": 0.0}, {"source": 15, "target": 28, "value": 0.0}, {"source": 15, "target": 29, "value": 0.0}, {"source": 15, "target": 30, "value": 0.0}, {"source": 15, "target": 31, "value": 0.34600515463917525}, {"source": 15, "target": 32, "value": 0.0}, {"source": 15, "target": 33, "value": 0.0}, {"source": 15, "target": 34, "value": 0.0}, {"source": 15, "target": 35, "value": 0.0}, {"source": 15, "target": 36, "value": 0.3089812332439678}, {"source": 15, "target": 37, "value": 0.2963219986120749}, {"source": 15, "target": 38, "value": 0.0}, {"source": 15, "target": 39, "value": 0.9705641864268193}, {"source": 15, "target": 40, "value": 0.0}, {"source": 15, "target": 41, "value": 0.7386434349719975}, {"source": 15, "target": 42, "value": 0.019262981574539362}, {"source": 15, "target": 43, "value": 0.0}, {"source": 15, "target": 44, "value": 0.0}, {"source": 15, "target": 45, "value": 0.0}, {"source": 15, "target": 46, "value": 0.0}, {"source": 15, "target": 47, "value": 0.0}, {"source": 15, "target": 48, "value": 0.0}, {"source": 15, "target": 49, "value": 0.741875}, {"source": 15, "target": 50, "value": 0.7308503162333099}, {"source": 15, "target": 51, "value": 0.10162916989914662}, {"source": 15, "target": 52, "value": 0.0}, {"source": 15, "target": 53, "value": 0.0}, {"source": 15, "target": 54, "value": 0.7151037938439513}, {"source": 15, "target": 55, "value": 0.4733373277411624}, {"source": 15, "target": 56, "value": 0.10887096774193548}, {"source": 15, "target": 57, "value": 0.0}, {"source": 15, "target": 58, "value": 0.14340198321891687}, {"source": 15, "target": 59, "value": 0.04717775905644482}, {"source": 15, "target": 60, "value": 0.0}, {"source": 15, "target": 61, "value": 0.0}, {"source": 15, "target": 62, "value": 0.0}, {"source": 15, "target": 63, "value": 0.0}, {"source": 15, "target": 64, "value": 0.4413439635535307}, {"source": 15, "target": 65, "value": 0.0}, {"source": 16, "target": 17, "value": 0.0}, {"source": 16, "target": 18, "value": 1.0}, {"source": 16, "target": 19, "value": 0.0}, {"source": 16, "target": 20, "value": 0.0}, {"source": 16, "target": 21, "value": 1.0}, {"source": 16, "target": 22, "value": 0.0}, {"source": 16, "target": 23, "value": 1.0}, {"source": 16, "target": 24, "value": 1.0}, {"source": 16, "target": 25, "value": 1.0}, {"source": 16, "target": 26, "value": 1.0}, {"source": 16, "target": 27, "value": 1.0}, {"source": 16, "target": 28, "value": 1.0}, {"source": 16, "target": 29, "value": 1.0}, {"source": 16, "target": 30, "value": 1.0}, {"source": 16, "target": 31, "value": 0.0}, {"source": 16, "target": 32, "value": 1.0}, {"source": 16, "target": 33, "value": 1.0}, {"source": 16, "target": 34, "value": 1.0}, {"source": 16, "target": 35, "value": 1.0}, {"source": 16, "target": 36, "value": 0.0}, {"source": 16, "target": 37, "value": 0.0}, {"source": 16, "target": 38, "value": 0.0}, {"source": 16, "target": 39, "value": 0.0}, {"source": 16, "target": 40, "value": 1.0}, {"source": 16, "target": 41, "value": 0.0}, {"source": 16, "target": 42, "value": 0.0}, {"source": 16, "target": 43, "value": 1.0}, {"source": 16, "target": 44, "value": 0.0}, {"source": 16, "target": 45, "value": 1.0}, {"source": 16, "target": 46, "value": 1.0}, {"source": 16, "target": 47, "value": 1.0}, {"source": 16, "target": 48, "value": 1.0}, {"source": 16, "target": 49, "value": 0.0}, {"source": 16, "target": 50, "value": 0.0}, {"source": 16, "target": 51, "value": 0.0}, {"source": 16, "target": 52, "value": 1.0}, {"source": 16, "target": 53, "value": 1.0}, {"source": 16, "target": 54, "value": 0.0}, {"source": 16, "target": 55, "value": 0.0}, {"source": 16, "target": 56, "value": 0.0}, {"source": 16, "target": 57, "value": 0.0}, {"source": 16, "target": 58, "value": 0.0}, {"source": 16, "target": 59, "value": 0.0}, {"source": 16, "target": 60, "value": 1.0}, {"source": 16, "target": 61, "value": 1.0}, {"source": 16, "target": 62, "value": 1.0}, {"source": 16, "target": 63, "value": 1.0}, {"source": 16, "target": 64, "value": 0.0}, {"source": 16, "target": 65, "value": 1.0}, {"source": 17, "target": 18, "value": 0.0}, {"source": 17, "target": 19, "value": 0.4897959183673469}, {"source": 17, "target": 20, "value": 0.5112107623318386}, {"source": 17, "target": 21, "value": 0.0}, {"source": 17, "target": 22, "value": 0.5113122171945701}, {"source": 17, "target": 23, "value": 0.0}, {"source": 17, "target": 24, "value": 0.0}, {"source": 17, "target": 25, "value": 0.0}, {"source": 17, "target": 26, "value": 0.0}, {"source": 17, "target": 27, "value": 0.0}, {"source": 17, "target": 28, "value": 0.0}, {"source": 17, "target": 29, "value": 0.0}, {"source": 17, "target": 30, "value": 0.0}, {"source": 17, "target": 31, "value": 0.367104440275172}, {"source": 17, "target": 32, "value": 0.0}, {"source": 17, "target": 33, "value": 0.0}, {"source": 17, "target": 34, "value": 0.0}, {"source": 17, "target": 35, "value": 0.0}, {"source": 17, "target": 36, "value": 0.3251454427925016}, {"source": 17, "target": 37, "value": 0.2996031746031746}, {"source": 17, "target": 38, "value": 0.0}, {"source": 17, "target": 39, "value": 0.6029411764705882}, {"source": 17, "target": 40, "value": 0.0}, {"source": 17, "target": 41, "value": 0.6187010078387458}, {"source": 17, "target": 42, "value": 0.02336448598130841}, {"source": 17, "target": 43, "value": 0.0}, {"source": 17, "target": 44, "value": 0.0}, {"source": 17, "target": 45, "value": 0.0}, {"source": 17, "target": 46, "value": 0.0}, {"source": 17, "target": 47, "value": 0.0}, {"source": 17, "target": 48, "value": 0.0}, {"source": 17, "target": 49, "value": 0.615686274509804}, {"source": 17, "target": 50, "value": 0.554341226472374}, {"source": 17, "target": 51, "value": 0.11135531135531136}, {"source": 17, "target": 52, "value": 0.0}, {"source": 17, "target": 53, "value": 0.0}, {"source": 17, "target": 54, "value": 0.5360443622920518}, {"source": 17, "target": 55, "value": 0.4921190893169877}, {"source": 17, "target": 56, "value": 0.09850746268656717}, {"source": 17, "target": 57, "value": 0.0}, {"source": 17, "target": 58, "value": 0.16496350364963502}, {"source": 17, "target": 59, "value": 0.04361370716510903}, {"source": 17, "target": 60, "value": 0.0}, {"source": 17, "target": 61, "value": 0.0}, {"source": 17, "target": 62, "value": 0.0}, {"source": 17, "target": 63, "value": 0.0}, {"source": 17, "target": 64, "value": 0.4681564245810056}, {"source": 17, "target": 65, "value": 0.0}, {"source": 18, "target": 19, "value": 0.0}, {"source": 18, "target": 20, "value": 0.0}, {"source": 18, "target": 21, "value": 1.0}, {"source": 18, "target": 22, "value": 0.0}, {"source": 18, "target": 23, "value": 1.0}, {"source": 18, "target": 24, "value": 1.0}, {"source": 18, "target": 25, "value": 1.0}, {"source": 18, "target": 26, "value": 1.0}, {"source": 18, "target": 27, "value": 1.0}, {"source": 18, "target": 28, "value": 1.0}, {"source": 18, "target": 29, "value": 1.0}, {"source": 18, "target": 30, "value": 1.0}, {"source": 18, "target": 31, "value": 0.0}, {"source": 18, "target": 32, "value": 1.0}, {"source": 18, "target": 33, "value": 1.0}, {"source": 18, "target": 34, "value": 1.0}, {"source": 18, "target": 35, "value": 1.0}, {"source": 18, "target": 36, "value": 0.0}, {"source": 18, "target": 37, "value": 0.0}, {"source": 18, "target": 38, "value": 0.0}, {"source": 18, "target": 39, "value": 0.0}, {"source": 18, "target": 40, "value": 1.0}, {"source": 18, "target": 41, "value": 0.0}, {"source": 18, "target": 42, "value": 0.0}, {"source": 18, "target": 43, "value": 1.0}, {"source": 18, "target": 44, "value": 0.0}, {"source": 18, "target": 45, "value": 1.0}, {"source": 18, "target": 46, "value": 1.0}, {"source": 18, "target": 47, "value": 1.0}, {"source": 18, "target": 48, "value": 1.0}, {"source": 18, "target": 49, "value": 0.0}, {"source": 18, "target": 50, "value": 0.0}, {"source": 18, "target": 51, "value": 0.0}, {"source": 18, "target": 52, "value": 1.0}, {"source": 18, "target": 53, "value": 1.0}, {"source": 18, "target": 54, "value": 0.0}, {"source": 18, "target": 55, "value": 0.0}, {"source": 18, "target": 56, "value": 0.0}, {"source": 18, "target": 57, "value": 0.0}, {"source": 18, "target": 58, "value": 0.0}, {"source": 18, "target": 59, "value": 0.0}, {"source": 18, "target": 60, "value": 1.0}, {"source": 18, "target": 61, "value": 1.0}, {"source": 18, "target": 62, "value": 1.0}, {"source": 18, "target": 63, "value": 1.0}, {"source": 18, "target": 64, "value": 0.0}, {"source": 18, "target": 65, "value": 1.0}, {"source": 19, "target": 20, "value": 0.40229885057471265}, {"source": 19, "target": 21, "value": 0.0}, {"source": 19, "target": 22, "value": 0.44863266814486324}, {"source": 19, "target": 23, "value": 0.0}, {"source": 19, "target": 24, "value": 0.0}, {"source": 19, "target": 25, "value": 0.0}, {"source": 19, "target": 26, "value": 0.0}, {"source": 19, "target": 27, "value": 0.0}, {"source": 19, "target": 28, "value": 0.0}, {"source": 19, "target": 29, "value": 0.0}, {"source": 19, "target": 30, "value": 0.0}, {"source": 19, "target": 31, "value": 0.3101449275362319}, {"source": 19, "target": 32, "value": 0.0}, {"source": 19, "target": 33, "value": 0.0}, {"source": 19, "target": 34, "value": 0.0}, {"source": 19, "target": 35, "value": 0.0}, {"source": 19, "target": 36, "value": 0.28417818740399386}, {"source": 19, "target": 37, "value": 0.3302598491198659}, {"source": 19, "target": 38, "value": 0.0}, {"source": 19, "target": 39, "value": 0.4279007377598927}, {"source": 19, "target": 40, "value": 0.0}, {"source": 19, "target": 41, "value": 0.4568115942028986}, {"source": 19, "target": 42, "value": 0.017391304347826087}, {"source": 19, "target": 43, "value": 0.0}, {"source": 19, "target": 44, "value": 0.0}, {"source": 19, "target": 45, "value": 0.0}, {"source": 19, "target": 46, "value": 0.0}, {"source": 19, "target": 47, "value": 0.0}, {"source": 19, "target": 48, "value": 0.0}, {"source": 19, "target": 49, "value": 0.4519119351100811}, {"source": 19, "target": 50, "value": 0.45466666666666666}, {"source": 19, "target": 51, "value": 0.11557296767874632}, {"source": 19, "target": 52, "value": 0.0}, {"source": 19, "target": 53, "value": 0.0}, {"source": 19, "target": 54, "value": 0.44368600682593856}, {"source": 19, "target": 55, "value": 0.3819796954314721}, {"source": 19, "target": 56, "value": 0.11291963377416073}, {"source": 19, "target": 57, "value": 0.0}, {"source": 19, "target": 58, "value": 0.1383177570093458}, {"source": 19, "target": 59, "value": 0.04793028322440087}, {"source": 19, "target": 60, "value": 0.0}, {"source": 19, "target": 61, "value": 0.0}, {"source": 19, "target": 62, "value": 0.0}, {"source": 19, "target": 63, "value": 0.0}, {"source": 19, "target": 64, "value": 0.37362637362637363}, {"source": 19, "target": 65, "value": 0.0}, {"source": 20, "target": 21, "value": 0.0}, {"source": 20, "target": 22, "value": 0.4810810810810811}, {"source": 20, "target": 23, "value": 0.0}, {"source": 20, "target": 24, "value": 0.0}, {"source": 20, "target": 25, "value": 0.0}, {"source": 20, "target": 26, "value": 0.0}, {"source": 20, "target": 27, "value": 0.0}, {"source": 20, "target": 28, "value": 0.0}, {"source": 20, "target": 29, "value": 0.0}, {"source": 20, "target": 30, "value": 0.0}, {"source": 20, "target": 31, "value": 0.3931366646598435}, {"source": 20, "target": 32, "value": 0.0}, {"source": 20, "target": 33, "value": 0.0}, {"source": 20, "target": 34, "value": 0.0}, {"source": 20, "target": 35, "value": 0.0}, {"source": 20, "target": 36, "value": 0.3312958435207824}, {"source": 20, "target": 37, "value": 0.3399487836107554}, {"source": 20, "target": 38, "value": 0.0}, {"source": 20, "target": 39, "value": 0.5082999427590155}, {"source": 20, "target": 40, "value": 0.0}, {"source": 20, "target": 41, "value": 0.6135756280064136}, {"source": 20, "target": 42, "value": 0.017642907551164433}, {"source": 20, "target": 43, "value": 0.0}, {"source": 20, "target": 44, "value": 0.0}, {"source": 20, "target": 45, "value": 0.0}, {"source": 20, "target": 46, "value": 0.0}, {"source": 20, "target": 47, "value": 0.0}, {"source": 20, "target": 48, "value": 0.0}, {"source": 20, "target": 49, "value": 0.6106951871657754}, {"source": 20, "target": 50, "value": 0.5135135135135135}, {"source": 20, "target": 51, "value": 0.11676849966055669}, {"source": 20, "target": 52, "value": 0.0}, {"source": 20, "target": 53, "value": 0.0}, {"source": 20, "target": 54, "value": 0.5071880391029328}, {"source": 20, "target": 55, "value": 0.5407577497129736}, {"source": 20, "target": 56, "value": 0.10116999311768754}, {"source": 20, "target": 57, "value": 0.0}, {"source": 20, "target": 58, "value": 0.14323607427055704}, {"source": 20, "target": 59, "value": 0.03599153140437544}, {"source": 20, "target": 60, "value": 0.0}, {"source": 20, "target": 61, "value": 0.0}, {"source": 20, "target": 62, "value": 0.0}, {"source": 20, "target": 63, "value": 0.0}, {"source": 20, "target": 64, "value": 0.5167859108420473}, {"source": 20, "target": 65, "value": 0.0}, {"source": 21, "target": 22, "value": 0.0}, {"source": 21, "target": 23, "value": 1.0}, {"source": 21, "target": 24, "value": 1.0}, {"source": 21, "target": 25, "value": 1.0}, {"source": 21, "target": 26, "value": 1.0}, {"source": 21, "target": 27, "value": 1.0}, {"source": 21, "target": 28, "value": 1.0}, {"source": 21, "target": 29, "value": 1.0}, {"source": 21, "target": 30, "value": 1.0}, {"source": 21, "target": 31, "value": 0.0}, {"source": 21, "target": 32, "value": 1.0}, {"source": 21, "target": 33, "value": 1.0}, {"source": 21, "target": 34, "value": 1.0}, {"source": 21, "target": 35, "value": 1.0}, {"source": 21, "target": 36, "value": 0.0}, {"source": 21, "target": 37, "value": 0.0}, {"source": 21, "target": 38, "value": 0.0}, {"source": 21, "target": 39, "value": 0.0}, {"source": 21, "target": 40, "value": 1.0}, {"source": 21, "target": 41, "value": 0.0}, {"source": 21, "target": 42, "value": 0.0}, {"source": 21, "target": 43, "value": 1.0}, {"source": 21, "target": 44, "value": 0.0}, {"source": 21, "target": 45, "value": 1.0}, {"source": 21, "target": 46, "value": 1.0}, {"source": 21, "target": 47, "value": 1.0}, {"source": 21, "target": 48, "value": 1.0}, {"source": 21, "target": 49, "value": 0.0}, {"source": 21, "target": 50, "value": 0.0}, {"source": 21, "target": 51, "value": 0.0}, {"source": 21, "target": 52, "value": 1.0}, {"source": 21, "target": 53, "value": 1.0}, {"source": 21, "target": 54, "value": 0.0}, {"source": 21, "target": 55, "value": 0.0}, {"source": 21, "target": 56, "value": 0.0}, {"source": 21, "target": 57, "value": 0.0}, {"source": 21, "target": 58, "value": 0.0}, {"source": 21, "target": 59, "value": 0.0}, {"source": 21, "target": 60, "value": 1.0}, {"source": 21, "target": 61, "value": 1.0}, {"source": 21, "target": 62, "value": 1.0}, {"source": 21, "target": 63, "value": 1.0}, {"source": 21, "target": 64, "value": 0.0}, {"source": 21, "target": 65, "value": 1.0}, {"source": 22, "target": 23, "value": 0.0}, {"source": 22, "target": 24, "value": 0.0}, {"source": 22, "target": 25, "value": 0.0}, {"source": 22, "target": 26, "value": 0.0}, {"source": 22, "target": 27, "value": 0.0}, {"source": 22, "target": 28, "value": 0.0}, {"source": 22, "target": 29, "value": 0.0}, {"source": 22, "target": 30, "value": 0.0}, {"source": 22, "target": 31, "value": 0.3225152129817444}, {"source": 22, "target": 32, "value": 0.0}, {"source": 22, "target": 33, "value": 0.0}, {"source": 22, "target": 34, "value": 0.0}, {"source": 22, "target": 35, "value": 0.0}, {"source": 22, "target": 36, "value": 0.2962962962962963}, {"source": 22, "target": 37, "value": 0.3183890577507599}, {"source": 22, "target": 38, "value": 0.0}, {"source": 22, "target": 39, "value": 0.5385135135135135}, {"source": 22, "target": 40, "value": 0.0}, {"source": 22, "target": 41, "value": 0.5354875937680323}, {"source": 22, "target": 42, "value": 0.016885553470919325}, {"source": 22, "target": 43, "value": 0.0}, {"source": 22, "target": 44, "value": 0.0}, {"source": 22, "target": 45, "value": 0.0}, {"source": 22, "target": 46, "value": 0.0}, {"source": 22, "target": 47, "value": 0.0}, {"source": 22, "target": 48, "value": 0.0}, {"source": 22, "target": 49, "value": 0.5341040462427745}, {"source": 22, "target": 50, "value": 0.5389696169088507}, {"source": 22, "target": 51, "value": 0.12010443864229765}, {"source": 22, "target": 52, "value": 0.0}, {"source": 22, "target": 53, "value": 0.0}, {"source": 22, "target": 54, "value": 0.5936619718309859}, {"source": 22, "target": 55, "value": 0.41226472374013357}, {"source": 22, "target": 56, "value": 0.08756567425569177}, {"source": 22, "target": 57, "value": 0.0}, {"source": 22, "target": 58, "value": 0.14693534844668346}, {"source": 22, "target": 59, "value": 0.034482758620689655}, {"source": 22, "target": 60, "value": 0.0}, {"source": 22, "target": 61, "value": 0.0}, {"source": 22, "target": 62, "value": 0.0}, {"source": 22, "target": 63, "value": 0.0}, {"source": 22, "target": 64, "value": 0.4223013048635824}, {"source": 22, "target": 65, "value": 0.0}, {"source": 23, "target": 24, "value": 1.0}, {"source": 23, "target": 25, "value": 1.0}, {"source": 23, "target": 26, "value": 1.0}, {"source": 23, "target": 27, "value": 1.0}, {"source": 23, "target": 28, "value": 1.0}, {"source": 23, "target": 29, "value": 1.0}, {"source": 23, "target": 30, "value": 1.0}, {"source": 23, "target": 31, "value": 0.0}, {"source": 23, "target": 32, "value": 1.0}, {"source": 23, "target": 33, "value": 1.0}, {"source": 23, "target": 34, "value": 1.0}, {"source": 23, "target": 35, "value": 1.0}, {"source": 23, "target": 36, "value": 0.0}, {"source": 23, "target": 37, "value": 0.0}, {"source": 23, "target": 38, "value": 0.0}, {"source": 23, "target": 39, "value": 0.0}, {"source": 23, "target": 40, "value": 1.0}, {"source": 23, "target": 41, "value": 0.0}, {"source": 23, "target": 42, "value": 0.0}, {"source": 23, "target": 43, "value": 1.0}, {"source": 23, "target": 44, "value": 0.0}, {"source": 23, "target": 45, "value": 1.0}, {"source": 23, "target": 46, "value": 1.0}, {"source": 23, "target": 47, "value": 1.0}, {"source": 23, "target": 48, "value": 1.0}, {"source": 23, "target": 49, "value": 0.0}, {"source": 23, "target": 50, "value": 0.0}, {"source": 23, "target": 51, "value": 0.0}, {"source": 23, "target": 52, "value": 1.0}, {"source": 23, "target": 53, "value": 1.0}, {"source": 23, "target": 54, "value": 0.0}, {"source": 23, "target": 55, "value": 0.0}, {"source": 23, "target": 56, "value": 0.0}, {"source": 23, "target": 57, "value": 0.0}, {"source": 23, "target": 58, "value": 0.0}, {"source": 23, "target": 59, "value": 0.0}, {"source": 23, "target": 60, "value": 1.0}, {"source": 23, "target": 61, "value": 1.0}, {"source": 23, "target": 62, "value": 1.0}, {"source": 23, "target": 63, "value": 1.0}, {"source": 23, "target": 64, "value": 0.0}, {"source": 23, "target": 65, "value": 1.0}, {"source": 24, "target": 25, "value": 1.0}, {"source": 24, "target": 26, "value": 1.0}, {"source": 24, "target": 27, "value": 1.0}, {"source": 24, "target": 28, "value": 1.0}, {"source": 24, "target": 29, "value": 1.0}, {"source": 24, "target": 30, "value": 1.0}, {"source": 24, "target": 31, "value": 0.0}, {"source": 24, "target": 32, "value": 1.0}, {"source": 24, "target": 33, "value": 1.0}, {"source": 24, "target": 34, "value": 1.0}, {"source": 24, "target": 35, "value": 1.0}, {"source": 24, "target": 36, "value": 0.0}, {"source": 24, "target": 37, "value": 0.0}, {"source": 24, "target": 38, "value": 0.0}, {"source": 24, "target": 39, "value": 0.0}, {"source": 24, "target": 40, "value": 1.0}, {"source": 24, "target": 41, "value": 0.0}, {"source": 24, "target": 42, "value": 0.0}, {"source": 24, "target": 43, "value": 1.0}, {"source": 24, "target": 44, "value": 0.0}, {"source": 24, "target": 45, "value": 1.0}, {"source": 24, "target": 46, "value": 1.0}, {"source": 24, "target": 47, "value": 1.0}, {"source": 24, "target": 48, "value": 1.0}, {"source": 24, "target": 49, "value": 0.0}, {"source": 24, "target": 50, "value": 0.0}, {"source": 24, "target": 51, "value": 0.0}, {"source": 24, "target": 52, "value": 1.0}, {"source": 24, "target": 53, "value": 1.0}, {"source": 24, "target": 54, "value": 0.0}, {"source": 24, "target": 55, "value": 0.0}, {"source": 24, "target": 56, "value": 0.0}, {"source": 24, "target": 57, "value": 0.0}, {"source": 24, "target": 58, "value": 0.0}, {"source": 24, "target": 59, "value": 0.0}, {"source": 24, "target": 60, "value": 1.0}, {"source": 24, "target": 61, "value": 1.0}, {"source": 24, "target": 62, "value": 1.0}, {"source": 24, "target": 63, "value": 1.0}, {"source": 24, "target": 64, "value": 0.0}, {"source": 24, "target": 65, "value": 1.0}, {"source": 25, "target": 26, "value": 1.0}, {"source": 25, "target": 27, "value": 1.0}, {"source": 25, "target": 28, "value": 1.0}, {"source": 25, "target": 29, "value": 1.0}, {"source": 25, "target": 30, "value": 1.0}, {"source": 25, "target": 31, "value": 0.0}, {"source": 25, "target": 32, "value": 1.0}, {"source": 25, "target": 33, "value": 1.0}, {"source": 25, "target": 34, "value": 1.0}, {"source": 25, "target": 35, "value": 1.0}, {"source": 25, "target": 36, "value": 0.0}, {"source": 25, "target": 37, "value": 0.0}, {"source": 25, "target": 38, "value": 0.0}, {"source": 25, "target": 39, "value": 0.0}, {"source": 25, "target": 40, "value": 1.0}, {"source": 25, "target": 41, "value": 0.0}, {"source": 25, "target": 42, "value": 0.0}, {"source": 25, "target": 43, "value": 1.0}, {"source": 25, "target": 44, "value": 0.0}, {"source": 25, "target": 45, "value": 1.0}, {"source": 25, "target": 46, "value": 1.0}, {"source": 25, "target": 47, "value": 1.0}, {"source": 25, "target": 48, "value": 1.0}, {"source": 25, "target": 49, "value": 0.0}, {"source": 25, "target": 50, "value": 0.0}, {"source": 25, "target": 51, "value": 0.0}, {"source": 25, "target": 52, "value": 1.0}, {"source": 25, "target": 53, "value": 1.0}, {"source": 25, "target": 54, "value": 0.0}, {"source": 25, "target": 55, "value": 0.0}, {"source": 25, "target": 56, "value": 0.0}, {"source": 25, "target": 57, "value": 0.0}, {"source": 25, "target": 58, "value": 0.0}, {"source": 25, "target": 59, "value": 0.0}, {"source": 25, "target": 60, "value": 1.0}, {"source": 25, "target": 61, "value": 1.0}, {"source": 25, "target": 62, "value": 1.0}, {"source": 25, "target": 63, "value": 1.0}, {"source": 25, "target": 64, "value": 0.0}, {"source": 25, "target": 65, "value": 1.0}, {"source": 26, "target": 27, "value": 1.0}, {"source": 26, "target": 28, "value": 1.0}, {"source": 26, "target": 29, "value": 1.0}, {"source": 26, "target": 30, "value": 1.0}, {"source": 26, "target": 31, "value": 0.0}, {"source": 26, "target": 32, "value": 1.0}, {"source": 26, "target": 33, "value": 1.0}, {"source": 26, "target": 34, "value": 1.0}, {"source": 26, "target": 35, "value": 1.0}, {"source": 26, "target": 36, "value": 0.0}, {"source": 26, "target": 37, "value": 0.0}, {"source": 26, "target": 38, "value": 0.0}, {"source": 26, "target": 39, "value": 0.0}, {"source": 26, "target": 40, "value": 1.0}, {"source": 26, "target": 41, "value": 0.0}, {"source": 26, "target": 42, "value": 0.0}, {"source": 26, "target": 43, "value": 1.0}, {"source": 26, "target": 44, "value": 0.0}, {"source": 26, "target": 45, "value": 1.0}, {"source": 26, "target": 46, "value": 1.0}, {"source": 26, "target": 47, "value": 1.0}, {"source": 26, "target": 48, "value": 1.0}, {"source": 26, "target": 49, "value": 0.0}, {"source": 26, "target": 50, "value": 0.0}, {"source": 26, "target": 51, "value": 0.0}, {"source": 26, "target": 52, "value": 1.0}, {"source": 26, "target": 53, "value": 1.0}, {"source": 26, "target": 54, "value": 0.0}, {"source": 26, "target": 55, "value": 0.0}, {"source": 26, "target": 56, "value": 0.0}, {"source": 26, "target": 57, "value": 0.0}, {"source": 26, "target": 58, "value": 0.0}, {"source": 26, "target": 59, "value": 0.0}, {"source": 26, "target": 60, "value": 1.0}, {"source": 26, "target": 61, "value": 1.0}, {"source": 26, "target": 62, "value": 1.0}, {"source": 26, "target": 63, "value": 1.0}, {"source": 26, "target": 64, "value": 0.0}, {"source": 26, "target": 65, "value": 1.0}, {"source": 27, "target": 28, "value": 1.0}, {"source": 27, "target": 29, "value": 1.0}, {"source": 27, "target": 30, "value": 1.0}, {"source": 27, "target": 31, "value": 0.0}, {"source": 27, "target": 32, "value": 1.0}, {"source": 27, "target": 33, "value": 1.0}, {"source": 27, "target": 34, "value": 1.0}, {"source": 27, "target": 35, "value": 1.0}, {"source": 27, "target": 36, "value": 0.0}, {"source": 27, "target": 37, "value": 0.0}, {"source": 27, "target": 38, "value": 0.0}, {"source": 27, "target": 39, "value": 0.0}, {"source": 27, "target": 40, "value": 1.0}, {"source": 27, "target": 41, "value": 0.0}, {"source": 27, "target": 42, "value": 0.0}, {"source": 27, "target": 43, "value": 1.0}, {"source": 27, "target": 44, "value": 0.0}, {"source": 27, "target": 45, "value": 1.0}, {"source": 27, "target": 46, "value": 1.0}, {"source": 27, "target": 47, "value": 1.0}, {"source": 27, "target": 48, "value": 1.0}, {"source": 27, "target": 49, "value": 0.0}, {"source": 27, "target": 50, "value": 0.0}, {"source": 27, "target": 51, "value": 0.0}, {"source": 27, "target": 52, "value": 1.0}, {"source": 27, "target": 53, "value": 1.0}, {"source": 27, "target": 54, "value": 0.0}, {"source": 27, "target": 55, "value": 0.0}, {"source": 27, "target": 56, "value": 0.0}, {"source": 27, "target": 57, "value": 0.0}, {"source": 27, "target": 58, "value": 0.0}, {"source": 27, "target": 59, "value": 0.0}, {"source": 27, "target": 60, "value": 1.0}, {"source": 27, "target": 61, "value": 1.0}, {"source": 27, "target": 62, "value": 1.0}, {"source": 27, "target": 63, "value": 1.0}, {"source": 27, "target": 64, "value": 0.0}, {"source": 27, "target": 65, "value": 1.0}, {"source": 28, "target": 29, "value": 1.0}, {"source": 28, "target": 30, "value": 1.0}, {"source": 28, "target": 31, "value": 0.0}, {"source": 28, "target": 32, "value": 1.0}, {"source": 28, "target": 33, "value": 1.0}, {"source": 28, "target": 34, "value": 1.0}, {"source": 28, "target": 35, "value": 1.0}, {"source": 28, "target": 36, "value": 0.0}, {"source": 28, "target": 37, "value": 0.0}, {"source": 28, "target": 38, "value": 0.0}, {"source": 28, "target": 39, "value": 0.0}, {"source": 28, "target": 40, "value": 1.0}, {"source": 28, "target": 41, "value": 0.0}, {"source": 28, "target": 42, "value": 0.0}, {"source": 28, "target": 43, "value": 1.0}, {"source": 28, "target": 44, "value": 0.0}, {"source": 28, "target": 45, "value": 1.0}, {"source": 28, "target": 46, "value": 1.0}, {"source": 28, "target": 47, "value": 1.0}, {"source": 28, "target": 48, "value": 1.0}, {"source": 28, "target": 49, "value": 0.0}, {"source": 28, "target": 50, "value": 0.0}, {"source": 28, "target": 51, "value": 0.0}, {"source": 28, "target": 52, "value": 1.0}, {"source": 28, "target": 53, "value": 1.0}, {"source": 28, "target": 54, "value": 0.0}, {"source": 28, "target": 55, "value": 0.0}, {"source": 28, "target": 56, "value": 0.0}, {"source": 28, "target": 57, "value": 0.0}, {"source": 28, "target": 58, "value": 0.0}, {"source": 28, "target": 59, "value": 0.0}, {"source": 28, "target": 60, "value": 1.0}, {"source": 28, "target": 61, "value": 1.0}, {"source": 28, "target": 62, "value": 1.0}, {"source": 28, "target": 63, "value": 1.0}, {"source": 28, "target": 64, "value": 0.0}, {"source": 28, "target": 65, "value": 1.0}, {"source": 29, "target": 30, "value": 1.0}, {"source": 29, "target": 31, "value": 0.0}, {"source": 29, "target": 32, "value": 1.0}, {"source": 29, "target": 33, "value": 1.0}, {"source": 29, "target": 34, "value": 1.0}, {"source": 29, "target": 35, "value": 1.0}, {"source": 29, "target": 36, "value": 0.0}, {"source": 29, "target": 37, "value": 0.0}, {"source": 29, "target": 38, "value": 0.0}, {"source": 29, "target": 39, "value": 0.0}, {"source": 29, "target": 40, "value": 1.0}, {"source": 29, "target": 41, "value": 0.0}, {"source": 29, "target": 42, "value": 0.0}, {"source": 29, "target": 43, "value": 1.0}, {"source": 29, "target": 44, "value": 0.0}, {"source": 29, "target": 45, "value": 1.0}, {"source": 29, "target": 46, "value": 1.0}, {"source": 29, "target": 47, "value": 1.0}, {"source": 29, "target": 48, "value": 1.0}, {"source": 29, "target": 49, "value": 0.0}, {"source": 29, "target": 50, "value": 0.0}, {"source": 29, "target": 51, "value": 0.0}, {"source": 29, "target": 52, "value": 1.0}, {"source": 29, "target": 53, "value": 1.0}, {"source": 29, "target": 54, "value": 0.0}, {"source": 29, "target": 55, "value": 0.0}, {"source": 29, "target": 56, "value": 0.0}, {"source": 29, "target": 57, "value": 0.0}, {"source": 29, "target": 58, "value": 0.0}, {"source": 29, "target": 59, "value": 0.0}, {"source": 29, "target": 60, "value": 1.0}, {"source": 29, "target": 61, "value": 1.0}, {"source": 29, "target": 62, "value": 1.0}, {"source": 29, "target": 63, "value": 1.0}, {"source": 29, "target": 64, "value": 0.0}, {"source": 29, "target": 65, "value": 1.0}, {"source": 30, "target": 31, "value": 0.0}, {"source": 30, "target": 32, "value": 1.0}, {"source": 30, "target": 33, "value": 1.0}, {"source": 30, "target": 34, "value": 1.0}, {"source": 30, "target": 35, "value": 1.0}, {"source": 30, "target": 36, "value": 0.0}, {"source": 30, "target": 37, "value": 0.0}, {"source": 30, "target": 38, "value": 0.0}, {"source": 30, "target": 39, "value": 0.0}, {"source": 30, "target": 40, "value": 1.0}, {"source": 30, "target": 41, "value": 0.0}, {"source": 30, "target": 42, "value": 0.0}, {"source": 30, "target": 43, "value": 1.0}, {"source": 30, "target": 44, "value": 0.0}, {"source": 30, "target": 45, "value": 1.0}, {"source": 30, "target": 46, "value": 1.0}, {"source": 30, "target": 47, "value": 1.0}, {"source": 30, "target": 48, "value": 1.0}, {"source": 30, "target": 49, "value": 0.0}, {"source": 30, "target": 50, "value": 0.0}, {"source": 30, "target": 51, "value": 0.0}, {"source": 30, "target": 52, "value": 1.0}, {"source": 30, "target": 53, "value": 1.0}, {"source": 30, "target": 54, "value": 0.0}, {"source": 30, "target": 55, "value": 0.0}, {"source": 30, "target": 56, "value": 0.0}, {"source": 30, "target": 57, "value": 0.0}, {"source": 30, "target": 58, "value": 0.0}, {"source": 30, "target": 59, "value": 0.0}, {"source": 30, "target": 60, "value": 1.0}, {"source": 30, "target": 61, "value": 1.0}, {"source": 30, "target": 62, "value": 1.0}, {"source": 30, "target": 63, "value": 1.0}, {"source": 30, "target": 64, "value": 0.0}, {"source": 30, "target": 65, "value": 1.0}, {"source": 31, "target": 32, "value": 0.0}, {"source": 31, "target": 33, "value": 0.0}, {"source": 31, "target": 34, "value": 0.0}, {"source": 31, "target": 35, "value": 0.0}, {"source": 31, "target": 36, "value": 0.2636363636363636}, {"source": 31, "target": 37, "value": 0.24645669291338582}, {"source": 31, "target": 38, "value": 0.0}, {"source": 31, "target": 39, "value": 0.3526416295353278}, {"source": 31, "target": 40, "value": 0.0}, {"source": 31, "target": 41, "value": 0.40011160714285715}, {"source": 31, "target": 42, "value": 0.015250544662309368}, {"source": 31, "target": 43, "value": 0.0}, {"source": 31, "target": 44, "value": 0.0}, {"source": 31, "target": 45, "value": 0.0}, {"source": 31, "target": 46, "value": 0.0}, {"source": 31, "target": 47, "value": 0.0}, {"source": 31, "target": 48, "value": 0.0}, {"source": 31, "target": 49, "value": 0.39776536312849164}, {"source": 31, "target": 50, "value": 0.3561643835616438}, {"source": 31, "target": 51, "value": 0.11056751467710371}, {"source": 31, "target": 52, "value": 0.0}, {"source": 31, "target": 53, "value": 0.0}, {"source": 31, "target": 54, "value": 0.3506078055022393}, {"source": 31, "target": 55, "value": 0.387364390555201}, {"source": 31, "target": 56, "value": 0.09327983951855567}, {"source": 31, "target": 57, "value": 0.0}, {"source": 31, "target": 58, "value": 0.15950334288443171}, {"source": 31, "target": 59, "value": 0.03791982665222102}, {"source": 31, "target": 60, "value": 0.0}, {"source": 31, "target": 61, "value": 0.0}, {"source": 31, "target": 62, "value": 0.0}, {"source": 31, "target": 63, "value": 0.0}, {"source": 31, "target": 64, "value": 0.3821538461538462}, {"source": 31, "target": 65, "value": 0.0}, {"source": 32, "target": 33, "value": 1.0}, {"source": 32, "target": 34, "value": 1.0}, {"source": 32, "target": 35, "value": 1.0}, {"source": 32, "target": 36, "value": 0.0}, {"source": 32, "target": 37, "value": 0.0}, {"source": 32, "target": 38, "value": 0.0}, {"source": 32, "target": 39, "value": 0.0}, {"source": 32, "target": 40, "value": 1.0}, {"source": 32, "target": 41, "value": 0.0}, {"source": 32, "target": 42, "value": 0.0}, {"source": 32, "target": 43, "value": 1.0}, {"source": 32, "target": 44, "value": 0.0}, {"source": 32, "target": 45, "value": 1.0}, {"source": 32, "target": 46, "value": 1.0}, {"source": 32, "target": 47, "value": 1.0}, {"source": 32, "target": 48, "value": 1.0}, {"source": 32, "target": 49, "value": 0.0}, {"source": 32, "target": 50, "value": 0.0}, {"source": 32, "target": 51, "value": 0.0}, {"source": 32, "target": 52, "value": 1.0}, {"source": 32, "target": 53, "value": 1.0}, {"source": 32, "target": 54, "value": 0.0}, {"source": 32, "target": 55, "value": 0.0}, {"source": 32, "target": 56, "value": 0.0}, {"source": 32, "target": 57, "value": 0.0}, {"source": 32, "target": 58, "value": 0.0}, {"source": 32, "target": 59, "value": 0.0}, {"source": 32, "target": 60, "value": 1.0}, {"source": 32, "target": 61, "value": 1.0}, {"source": 32, "target": 62, "value": 1.0}, {"source": 32, "target": 63, "value": 1.0}, {"source": 32, "target": 64, "value": 0.0}, {"source": 32, "target": 65, "value": 1.0}, {"source": 33, "target": 34, "value": 1.0}, {"source": 33, "target": 35, "value": 1.0}, {"source": 33, "target": 36, "value": 0.0}, {"source": 33, "target": 37, "value": 0.0}, {"source": 33, "target": 38, "value": 0.0}, {"source": 33, "target": 39, "value": 0.0}, {"source": 33, "target": 40, "value": 1.0}, {"source": 33, "target": 41, "value": 0.0}, {"source": 33, "target": 42, "value": 0.0}, {"source": 33, "target": 43, "value": 1.0}, {"source": 33, "target": 44, "value": 0.0}, {"source": 33, "target": 45, "value": 1.0}, {"source": 33, "target": 46, "value": 1.0}, {"source": 33, "target": 47, "value": 1.0}, {"source": 33, "target": 48, "value": 1.0}, {"source": 33, "target": 49, "value": 0.0}, {"source": 33, "target": 50, "value": 0.0}, {"source": 33, "target": 51, "value": 0.0}, {"source": 33, "target": 52, "value": 1.0}, {"source": 33, "target": 53, "value": 1.0}, {"source": 33, "target": 54, "value": 0.0}, {"source": 33, "target": 55, "value": 0.0}, {"source": 33, "target": 56, "value": 0.0}, {"source": 33, "target": 57, "value": 0.0}, {"source": 33, "target": 58, "value": 0.0}, {"source": 33, "target": 59, "value": 0.0}, {"source": 33, "target": 60, "value": 1.0}, {"source": 33, "target": 61, "value": 1.0}, {"source": 33, "target": 62, "value": 1.0}, {"source": 33, "target": 63, "value": 1.0}, {"source": 33, "target": 64, "value": 0.0}, {"source": 33, "target": 65, "value": 1.0}, {"source": 34, "target": 35, "value": 1.0}, {"source": 34, "target": 36, "value": 0.0}, {"source": 34, "target": 37, "value": 0.0}, {"source": 34, "target": 38, "value": 0.0}, {"source": 34, "target": 39, "value": 0.0}, {"source": 34, "target": 40, "value": 1.0}, {"source": 34, "target": 41, "value": 0.0}, {"source": 34, "target": 42, "value": 0.0}, {"source": 34, "target": 43, "value": 1.0}, {"source": 34, "target": 44, "value": 0.0}, {"source": 34, "target": 45, "value": 1.0}, {"source": 34, "target": 46, "value": 1.0}, {"source": 34, "target": 47, "value": 1.0}, {"source": 34, "target": 48, "value": 1.0}, {"source": 34, "target": 49, "value": 0.0}, {"source": 34, "target": 50, "value": 0.0}, {"source": 34, "target": 51, "value": 0.0}, {"source": 34, "target": 52, "value": 1.0}, {"source": 34, "target": 53, "value": 1.0}, {"source": 34, "target": 54, "value": 0.0}, {"source": 34, "target": 55, "value": 0.0}, {"source": 34, "target": 56, "value": 0.0}, {"source": 34, "target": 57, "value": 0.0}, {"source": 34, "target": 58, "value": 0.0}, {"source": 34, "target": 59, "value": 0.0}, {"source": 34, "target": 60, "value": 1.0}, {"source": 34, "target": 61, "value": 1.0}, {"source": 34, "target": 62, "value": 1.0}, {"source": 34, "target": 63, "value": 1.0}, {"source": 34, "target": 64, "value": 0.0}, {"source": 34, "target": 65, "value": 1.0}, {"source": 35, "target": 36, "value": 0.0}, {"source": 35, "target": 37, "value": 0.0}, {"source": 35, "target": 38, "value": 0.0}, {"source": 35, "target": 39, "value": 0.0}, {"source": 35, "target": 40, "value": 1.0}, {"source": 35, "target": 41, "value": 0.0}, {"source": 35, "target": 42, "value": 0.0}, {"source": 35, "target": 43, "value": 1.0}, {"source": 35, "target": 44, "value": 0.0}, {"source": 35, "target": 45, "value": 1.0}, {"source": 35, "target": 46, "value": 1.0}, {"source": 35, "target": 47, "value": 1.0}, {"source": 35, "target": 48, "value": 1.0}, {"source": 35, "target": 49, "value": 0.0}, {"source": 35, "target": 50, "value": 0.0}, {"source": 35, "target": 51, "value": 0.0}, {"source": 35, "target": 52, "value": 1.0}, {"source": 35, "target": 53, "value": 1.0}, {"source": 35, "target": 54, "value": 0.0}, {"source": 35, "target": 55, "value": 0.0}, {"source": 35, "target": 56, "value": 0.0}, {"source": 35, "target": 57, "value": 0.0}, {"source": 35, "target": 58, "value": 0.0}, {"source": 35, "target": 59, "value": 0.0}, {"source": 35, "target": 60, "value": 1.0}, {"source": 35, "target": 61, "value": 1.0}, {"source": 35, "target": 62, "value": 1.0}, {"source": 35, "target": 63, "value": 1.0}, {"source": 35, "target": 64, "value": 0.0}, {"source": 35, "target": 65, "value": 1.0}, {"source": 36, "target": 37, "value": 0.34604651162790695}, {"source": 36, "target": 38, "value": 0.0}, {"source": 36, "target": 39, "value": 0.31287128712871287}, {"source": 36, "target": 40, "value": 0.0}, {"source": 36, "target": 41, "value": 0.3437146092865232}, {"source": 36, "target": 42, "value": 0.014012738853503185}, {"source": 36, "target": 43, "value": 0.0}, {"source": 36, "target": 44, "value": 0.0}, {"source": 36, "target": 45, "value": 0.0}, {"source": 36, "target": 46, "value": 0.0}, {"source": 36, "target": 47, "value": 0.0}, {"source": 36, "target": 48, "value": 0.0}, {"source": 36, "target": 49, "value": 0.3435547984099943}, {"source": 36, "target": 50, "value": 0.32597402597402597}, {"source": 36, "target": 51, "value": 0.10264900662251655}, {"source": 36, "target": 52, "value": 0.0}, {"source": 36, "target": 53, "value": 0.0}, {"source": 36, "target": 54, "value": 0.3019116677653263}, {"source": 36, "target": 55, "value": 0.3285528031290743}, {"source": 36, "target": 56, "value": 0.13842482100238662}, {"source": 36, "target": 57, "value": 0.0}, {"source": 36, "target": 58, "value": 0.12174817898022892}, {"source": 36, "target": 59, "value": 0.06064516129032258}, {"source": 36, "target": 60, "value": 0.0}, {"source": 36, "target": 61, "value": 0.0}, {"source": 36, "target": 62, "value": 0.0}, {"source": 36, "target": 63, "value": 0.0}, {"source": 36, "target": 64, "value": 0.45919778699861685}, {"source": 36, "target": 65, "value": 0.0}, {"source": 37, "target": 38, "value": 0.0}, {"source": 37, "target": 39, "value": 0.29611980939414567}, {"source": 37, "target": 40, "value": 0.0}, {"source": 37, "target": 41, "value": 0.31569867740080504}, {"source": 37, "target": 42, "value": 0.00851063829787234}, {"source": 37, "target": 43, "value": 0.0}, {"source": 37, "target": 44, "value": 0.0}, {"source": 37, "target": 45, "value": 0.0}, {"source": 37, "target": 46, "value": 0.0}, {"source": 37, "target": 47, "value": 0.0}, {"source": 37, "target": 48, "value": 0.0}, {"source": 37, "target": 49, "value": 0.31621465666474324}, {"source": 37, "target": 50, "value": 0.3196223870532704}, {"source": 37, "target": 51, "value": 0.11463414634146342}, {"source": 37, "target": 52, "value": 0.0}, {"source": 37, "target": 53, "value": 0.0}, {"source": 37, "target": 54, "value": 0.33192389006342493}, {"source": 37, "target": 55, "value": 0.2994011976047904}, {"source": 37, "target": 56, "value": 0.11125319693094629}, {"source": 37, "target": 57, "value": 0.0}, {"source": 37, "target": 58, "value": 0.10702341137123746}, {"source": 37, "target": 59, "value": 0.04985754985754986}, {"source": 37, "target": 60, "value": 0.0}, {"source": 37, "target": 61, "value": 0.0}, {"source": 37, "target": 62, "value": 0.0}, {"source": 37, "target": 63, "value": 0.0}, {"source": 37, "target": 64, "value": 0.32786885245901637}, {"source": 37, "target": 65, "value": 0.0}, {"source": 38, "target": 39, "value": 0.0}, {"source": 38, "target": 40, "value": 0.0}, {"source": 38, "target": 41, "value": 0.0}, {"source": 38, "target": 42, "value": 0.0}, {"source": 38, "target": 43, "value": 0.0}, {"source": 38, "target": 44, "value": 0.0}, {"source": 38, "target": 45, "value": 0.0}, {"source": 38, "target": 46, "value": 0.0}, {"source": 38, "target": 47, "value": 0.0}, {"source": 38, "target": 48, "value": 0.0}, {"source": 38, "target": 49, "value": 0.0}, {"source": 38, "target": 50, "value": 0.0}, {"source": 38, "target": 51, "value": 0.0}, {"source": 38, "target": 52, "value": 0.0}, {"source": 38, "target": 53, "value": 0.0}, {"source": 38, "target": 54, "value": 0.0}, {"source": 38, "target": 55, "value": 0.0}, {"source": 38, "target": 56, "value": 0.0}, {"source": 38, "target": 57, "value": 0.0}, {"source": 38, "target": 58, "value": 0.0}, {"source": 38, "target": 59, "value": 0.0}, {"source": 38, "target": 60, "value": 0.0}, {"source": 38, "target": 61, "value": 0.0}, {"source": 38, "target": 62, "value": 0.0}, {"source": 38, "target": 63, "value": 0.0}, {"source": 38, "target": 64, "value": 0.0}, {"source": 38, "target": 65, "value": 0.0}, {"source": 39, "target": 40, "value": 0.0}, {"source": 39, "target": 41, "value": 0.7404674046740467}, {"source": 39, "target": 42, "value": 0.01869918699186992}, {"source": 39, "target": 43, "value": 0.0}, {"source": 39, "target": 44, "value": 0.0}, {"source": 39, "target": 45, "value": 0.0}, {"source": 39, "target": 46, "value": 0.0}, {"source": 39, "target": 47, "value": 0.0}, {"source": 39, "target": 48, "value": 0.0}, {"source": 39, "target": 49, "value": 0.7425925925925926}, {"source": 39, "target": 50, "value": 0.7222605099931082}, {"source": 39, "target": 51, "value": 0.09969788519637462}, {"source": 39, "target": 52, "value": 0.0}, {"source": 39, "target": 53, "value": 0.0}, {"source": 39, "target": 54, "value": 0.7054698457223001}, {"source": 39, "target": 55, "value": 0.4772054470100651}, {"source": 39, "target": 56, "value": 0.10927672955974843}, {"source": 39, "target": 57, "value": 0.0}, {"source": 39, "target": 58, "value": 0.14296351451973194}, {"source": 39, "target": 59, "value": 0.04578904333605887}, {"source": 39, "target": 60, "value": 0.0}, {"source": 39, "target": 61, "value": 0.0}, {"source": 39, "target": 62, "value": 0.0}, {"source": 39, "target": 63, "value": 0.0}, {"source": 39, "target": 64, "value": 0.45028248587570624}, {"source": 39, "target": 65, "value": 0.0}, {"source": 40, "target": 41, "value": 0.0}, {"source": 40, "target": 42, "value": 0.0}, {"source": 40, "target": 43, "value": 1.0}, {"source": 40, "target": 44, "value": 0.0}, {"source": 40, "target": 45, "value": 1.0}, {"source": 40, "target": 46, "value": 1.0}, {"source": 40, "target": 47, "value": 1.0}, {"source": 40, "target": 48, "value": 1.0}, {"source": 40, "target": 49, "value": 0.0}, {"source": 40, "target": 50, "value": 0.0}, {"source": 40, "target": 51, "value": 0.0}, {"source": 40, "target": 52, "value": 1.0}, {"source": 40, "target": 53, "value": 1.0}, {"source": 40, "target": 54, "value": 0.0}, {"source": 40, "target": 55, "value": 0.0}, {"source": 40, "target": 56, "value": 0.0}, {"source": 40, "target": 57, "value": 0.0}, {"source": 40, "target": 58, "value": 0.0}, {"source": 40, "target": 59, "value": 0.0}, {"source": 40, "target": 60, "value": 1.0}, {"source": 40, "target": 61, "value": 1.0}, {"source": 40, "target": 62, "value": 1.0}, {"source": 40, "target": 63, "value": 1.0}, {"source": 40, "target": 64, "value": 0.0}, {"source": 40, "target": 65, "value": 1.0}, {"source": 41, "target": 42, "value": 0.016139044072004966}, {"source": 41, "target": 43, "value": 0.0}, {"source": 41, "target": 44, "value": 0.0}, {"source": 41, "target": 45, "value": 0.0}, {"source": 41, "target": 46, "value": 0.0}, {"source": 41, "target": 47, "value": 0.0}, {"source": 41, "target": 48, "value": 0.0}, {"source": 41, "target": 49, "value": 0.9919254658385093}, {"source": 41, "target": 50, "value": 0.7059171597633136}, {"source": 41, "target": 51, "value": 0.1199026171637249}, {"source": 41, "target": 52, "value": 0.0}, {"source": 41, "target": 53, "value": 0.0}, {"source": 41, "target": 54, "value": 0.6643026004728132}, {"source": 41, "target": 55, "value": 0.5655247417074497}, {"source": 41, "target": 56, "value": 0.09853121175030599}, {"source": 41, "target": 57, "value": 0.0}, {"source": 41, "target": 58, "value": 0.15116976604679064}, {"source": 41, "target": 59, "value": 0.03484754200373367}, {"source": 41, "target": 60, "value": 0.0}, {"source": 41, "target": 61, "value": 0.0}, {"source": 41, "target": 62, "value": 0.0}, {"source": 41, "target": 63, "value": 0.0}, {"source": 41, "target": 64, "value": 0.5622022233986236}, {"source": 41, "target": 65, "value": 0.0}, {"source": 42, "target": 43, "value": 0.0}, {"source": 42, "target": 44, "value": 0.0}, {"source": 42, "target": 45, "value": 0.0}, {"source": 42, "target": 46, "value": 0.0}, {"source": 42, "target": 47, "value": 0.0}, {"source": 42, "target": 48, "value": 0.0}, {"source": 42, "target": 49, "value": 0.016209476309226933}, {"source": 42, "target": 50, "value": 0.015552099533437015}, {"source": 42, "target": 51, "value": 0.015444015444015444}, {"source": 42, "target": 52, "value": 0.0}, {"source": 42, "target": 53, "value": 0.0}, {"source": 42, "target": 54, "value": 0.01557377049180328}, {"source": 42, "target": 55, "value": 0.02037617554858934}, {"source": 42, "target": 56, "value": 0.018691588785046728}, {"source": 42, "target": 57, "value": 0.0}, {"source": 42, "target": 58, "value": 0.023952095808383235}, {"source": 42, "target": 59, "value": 0.011764705882352941}, {"source": 42, "target": 60, "value": 0.0}, {"source": 42, "target": 61, "value": 0.0}, {"source": 42, "target": 62, "value": 0.0}, {"source": 42, "target": 63, "value": 0.0}, {"source": 42, "target": 64, "value": 0.016272189349112426}, {"source": 42, "target": 65, "value": 0.0}, {"source": 43, "target": 44, "value": 0.0}, {"source": 43, "target": 45, "value": 1.0}, {"source": 43, "target": 46, "value": 1.0}, {"source": 43, "target": 47, "value": 1.0}, {"source": 43, "target": 48, "value": 1.0}, {"source": 43, "target": 49, "value": 0.0}, {"source": 43, "target": 50, "value": 0.0}, {"source": 43, "target": 51, "value": 0.0}, {"source": 43, "target": 52, "value": 1.0}, {"source": 43, "target": 53, "value": 1.0}, {"source": 43, "target": 54, "value": 0.0}, {"source": 43, "target": 55, "value": 0.0}, {"source": 43, "target": 56, "value": 0.0}, {"source": 43, "target": 57, "value": 0.0}, {"source": 43, "target": 58, "value": 0.0}, {"source": 43, "target": 59, "value": 0.0}, {"source": 43, "target": 60, "value": 1.0}, {"source": 43, "target": 61, "value": 1.0}, {"source": 43, "target": 62, "value": 1.0}, {"source": 43, "target": 63, "value": 1.0}, {"source": 43, "target": 64, "value": 0.0}, {"source": 43, "target": 65, "value": 1.0}, {"source": 44, "target": 45, "value": 0.0}, {"source": 44, "target": 46, "value": 0.0}, {"source": 44, "target": 47, "value": 0.0}, {"source": 44, "target": 48, "value": 0.0}, {"source": 44, "target": 49, "value": 0.0}, {"source": 44, "target": 50, "value": 0.0}, {"source": 44, "target": 51, "value": 0.0}, {"source": 44, "target": 52, "value": 0.0}, {"source": 44, "target": 53, "value": 0.0}, {"source": 44, "target": 54, "value": 0.0}, {"source": 44, "target": 55, "value": 0.0}, {"source": 44, "target": 56, "value": 0.0}, {"source": 44, "target": 57, "value": 0.0}, {"source": 44, "target": 58, "value": 0.0}, {"source": 44, "target": 59, "value": 0.0}, {"source": 44, "target": 60, "value": 0.0}, {"source": 44, "target": 61, "value": 0.0}, {"source": 44, "target": 62, "value": 0.0}, {"source": 44, "target": 63, "value": 0.0}, {"source": 44, "target": 64, "value": 0.0}, {"source": 44, "target": 65, "value": 0.0}, {"source": 45, "target": 46, "value": 1.0}, {"source": 45, "target": 47, "value": 1.0}, {"source": 45, "target": 48, "value": 1.0}, {"source": 45, "target": 49, "value": 0.0}, {"source": 45, "target": 50, "value": 0.0}, {"source": 45, "target": 51, "value": 0.0}, {"source": 45, "target": 52, "value": 1.0}, {"source": 45, "target": 53, "value": 1.0}, {"source": 45, "target": 54, "value": 0.0}, {"source": 45, "target": 55, "value": 0.0}, {"source": 45, "target": 56, "value": 0.0}, {"source": 45, "target": 57, "value": 0.0}, {"source": 45, "target": 58, "value": 0.0}, {"source": 45, "target": 59, "value": 0.0}, {"source": 45, "target": 60, "value": 1.0}, {"source": 45, "target": 61, "value": 1.0}, {"source": 45, "target": 62, "value": 1.0}, {"source": 45, "target": 63, "value": 1.0}, {"source": 45, "target": 64, "value": 0.0}, {"source": 45, "target": 65, "value": 1.0}, {"source": 46, "target": 47, "value": 1.0}, {"source": 46, "target": 48, "value": 1.0}, {"source": 46, "target": 49, "value": 0.0}, {"source": 46, "target": 50, "value": 0.0}, {"source": 46, "target": 51, "value": 0.0}, {"source": 46, "target": 52, "value": 1.0}, {"source": 46, "target": 53, "value": 1.0}, {"source": 46, "target": 54, "value": 0.0}, {"source": 46, "target": 55, "value": 0.0}, {"source": 46, "target": 56, "value": 0.0}, {"source": 46, "target": 57, "value": 0.0}, {"source": 46, "target": 58, "value": 0.0}, {"source": 46, "target": 59, "value": 0.0}, {"source": 46, "target": 60, "value": 1.0}, {"source": 46, "target": 61, "value": 1.0}, {"source": 46, "target": 62, "value": 1.0}, {"source": 46, "target": 63, "value": 1.0}, {"source": 46, "target": 64, "value": 0.0}, {"source": 46, "target": 65, "value": 1.0}, {"source": 47, "target": 48, "value": 1.0}, {"source": 47, "target": 49, "value": 0.0}, {"source": 47, "target": 50, "value": 0.0}, {"source": 47, "target": 51, "value": 0.0}, {"source": 47, "target": 52, "value": 1.0}, {"source": 47, "target": 53, "value": 1.0}, {"source": 47, "target": 54, "value": 0.0}, {"source": 47, "target": 55, "value": 0.0}, {"source": 47, "target": 56, "value": 0.0}, {"source": 47, "target": 57, "value": 0.0}, {"source": 47, "target": 58, "value": 0.0}, {"source": 47, "target": 59, "value": 0.0}, {"source": 47, "target": 60, "value": 1.0}, {"source": 47, "target": 61, "value": 1.0}, {"source": 47, "target": 62, "value": 1.0}, {"source": 47, "target": 63, "value": 1.0}, {"source": 47, "target": 64, "value": 0.0}, {"source": 47, "target": 65, "value": 1.0}, {"source": 48, "target": 49, "value": 0.0}, {"source": 48, "target": 50, "value": 0.0}, {"source": 48, "target": 51, "value": 0.0}, {"source": 48, "target": 52, "value": 1.0}, {"source": 48, "target": 53, "value": 1.0}, {"source": 48, "target": 54, "value": 0.0}, {"source": 48, "target": 55, "value": 0.0}, {"source": 48, "target": 56, "value": 0.0}, {"source": 48, "target": 57, "value": 0.0}, {"source": 48, "target": 58, "value": 0.0}, {"source": 48, "target": 59, "value": 0.0}, {"source": 48, "target": 60, "value": 1.0}, {"source": 48, "target": 61, "value": 1.0}, {"source": 48, "target": 62, "value": 1.0}, {"source": 48, "target": 63, "value": 1.0}, {"source": 48, "target": 64, "value": 0.0}, {"source": 48, "target": 65, "value": 1.0}, {"source": 49, "target": 50, "value": 0.7068249258160237}, {"source": 49, "target": 51, "value": 0.11904761904761904}, {"source": 49, "target": 52, "value": 0.0}, {"source": 49, "target": 53, "value": 0.0}, {"source": 49, "target": 54, "value": 0.6631142687981054}, {"source": 49, "target": 55, "value": 0.5642701525054467}, {"source": 49, "target": 56, "value": 0.09828009828009827}, {"source": 49, "target": 57, "value": 0.0}, {"source": 49, "target": 58, "value": 0.15042117930204574}, {"source": 49, "target": 59, "value": 0.035}, {"source": 49, "target": 60, "value": 0.0}, {"source": 49, "target": 61, "value": 0.0}, {"source": 49, "target": 62, "value": 0.0}, {"source": 49, "target": 63, "value": 0.0}, {"source": 49, "target": 64, "value": 0.559322033898305}, {"source": 49, "target": 65, "value": 0.0}, {"source": 50, "target": 51, "value": 0.11119293078055964}, {"source": 50, "target": 52, "value": 0.0}, {"source": 50, "target": 53, "value": 0.0}, {"source": 50, "target": 54, "value": 0.7561837455830389}, {"source": 50, "target": 55, "value": 0.4762456546929316}, {"source": 50, "target": 56, "value": 0.11077389984825493}, {"source": 50, "target": 57, "value": 0.0}, {"source": 50, "target": 58, "value": 0.13672154617036505}, {"source": 50, "target": 59, "value": 0.03981264637002342}, {"source": 50, "target": 60, "value": 0.0}, {"source": 50, "target": 61, "value": 0.0}, {"source": 50, "target": 62, "value": 0.0}, {"source": 50, "target": 63, "value": 0.0}, {"source": 50, "target": 64, "value": 0.46943353897924844}, {"source": 50, "target": 65, "value": 0.0}, {"source": 51, "target": 52, "value": 0.0}, {"source": 51, "target": 53, "value": 0.0}, {"source": 51, "target": 54, "value": 0.1117964533538936}, {"source": 51, "target": 55, "value": 0.11481481481481481}, {"source": 51, "target": 56, "value": 0.08505154639175258}, {"source": 51, "target": 57, "value": 0.0}, {"source": 51, "target": 58, "value": 0.07920792079207921}, {"source": 51, "target": 59, "value": 0.039568345323741004}, {"source": 51, "target": 60, "value": 0.0}, {"source": 51, "target": 61, "value": 0.0}, {"source": 51, "target": 62, "value": 0.0}, {"source": 51, "target": 63, "value": 0.0}, {"source": 51, "target": 64, "value": 0.12082444918265814}, {"source": 51, "target": 65, "value": 0.0}, {"source": 52, "target": 53, "value": 1.0}, {"source": 52, "target": 54, "value": 0.0}, {"source": 52, "target": 55, "value": 0.0}, {"source": 52, "target": 56, "value": 0.0}, {"source": 52, "target": 57, "value": 0.0}, {"source": 52, "target": 58, "value": 0.0}, {"source": 52, "target": 59, "value": 0.0}, {"source": 52, "target": 60, "value": 1.0}, {"source": 52, "target": 61, "value": 1.0}, {"source": 52, "target": 62, "value": 1.0}, {"source": 52, "target": 63, "value": 1.0}, {"source": 52, "target": 64, "value": 0.0}, {"source": 52, "target": 65, "value": 1.0}, {"source": 53, "target": 54, "value": 0.0}, {"source": 53, "target": 55, "value": 0.0}, {"source": 53, "target": 56, "value": 0.0}, {"source": 53, "target": 57, "value": 0.0}, {"source": 53, "target": 58, "value": 0.0}, {"source": 53, "target": 59, "value": 0.0}, {"source": 53, "target": 60, "value": 1.0}, {"source": 53, "target": 61, "value": 1.0}, {"source": 53, "target": 62, "value": 1.0}, {"source": 53, "target": 63, "value": 1.0}, {"source": 53, "target": 64, "value": 0.0}, {"source": 53, "target": 65, "value": 1.0}, {"source": 54, "target": 55, "value": 0.4491822429906542}, {"source": 54, "target": 56, "value": 0.09654631083202511}, {"source": 54, "target": 57, "value": 0.0}, {"source": 54, "target": 58, "value": 0.1393258426966292}, {"source": 54, "target": 59, "value": 0.03434178250204415}, {"source": 54, "target": 60, "value": 0.0}, {"source": 54, "target": 61, "value": 0.0}, {"source": 54, "target": 62, "value": 0.0}, {"source": 54, "target": 63, "value": 0.0}, {"source": 54, "target": 64, "value": 0.453872437357631}, {"source": 54, "target": 65, "value": 0.0}, {"source": 55, "target": 56, "value": 0.1094224924012158}, {"source": 55, "target": 57, "value": 0.0}, {"source": 55, "target": 58, "value": 0.14782608695652175}, {"source": 55, "target": 59, "value": 0.0440251572327044}, {"source": 55, "target": 60, "value": 0.0}, {"source": 55, "target": 61, "value": 0.0}, {"source": 55, "target": 62, "value": 0.0}, {"source": 55, "target": 63, "value": 0.0}, {"source": 55, "target": 64, "value": 0.5043128234617597}, {"source": 55, "target": 65, "value": 0.0}, {"source": 56, "target": 57, "value": 0.0}, {"source": 56, "target": 58, "value": 0.059322033898305086}, {"source": 56, "target": 59, "value": 0.1902439024390244}, {"source": 56, "target": 60, "value": 0.0}, {"source": 56, "target": 61, "value": 0.0}, {"source": 56, "target": 62, "value": 0.0}, {"source": 56, "target": 63, "value": 0.0}, {"source": 56, "target": 64, "value": 0.09428571428571429}, {"source": 56, "target": 65, "value": 0.0}, {"source": 57, "target": 58, "value": 0.0}, {"source": 57, "target": 59, "value": 0.0}, {"source": 57, "target": 60, "value": 0.0}, {"source": 57, "target": 61, "value": 0.0}, {"source": 57, "target": 62, "value": 0.0}, {"source": 57, "target": 63, "value": 0.0}, {"source": 57, "target": 64, "value": 0.0}, {"source": 57, "target": 65, "value": 0.0}, {"source": 58, "target": 59, "value": 0.027932960893854747}, {"source": 58, "target": 60, "value": 0.0}, {"source": 58, "target": 61, "value": 0.0}, {"source": 58, "target": 62, "value": 0.0}, {"source": 58, "target": 63, "value": 0.0}, {"source": 58, "target": 64, "value": 0.14285714285714285}, {"source": 58, "target": 65, "value": 0.0}, {"source": 59, "target": 60, "value": 0.0}, {"source": 59, "target": 61, "value": 0.0}, {"source": 59, "target": 62, "value": 0.0}, {"source": 59, "target": 63, "value": 0.0}, {"source": 59, "target": 64, "value": 0.033973412112259974}, {"source": 59, "target": 65, "value": 0.0}, {"source": 60, "target": 61, "value": 1.0}, {"source": 60, "target": 62, "value": 1.0}, {"source": 60, "target": 63, "value": 1.0}, {"source": 60, "target": 64, "value": 0.0}, {"source": 60, "target": 65, "value": 1.0}, {"source": 61, "target": 62, "value": 1.0}, {"source": 61, "target": 63, "value": 1.0}, {"source": 61, "target": 64, "value": 0.0}, {"source": 61, "target": 65, "value": 1.0}, {"source": 62, "target": 63, "value": 1.0}, {"source": 62, "target": 64, "value": 0.0}, {"source": 62, "target": 65, "value": 1.0}, {"source": 63, "target": 64, "value": 0.0}, {"source": 63, "target": 65, "value": 1.0}, {"source": 64, "target": 65, "value": 0.0}], "metrics_paper_count": {"IC50_MC": 30, "Ki_MC": 0, "Kd_MC": 0, "Selectivity_MC": 1, "IC50_Ph": 15, "Ki_Ph": 0, "Kd_Ph": 0, "EC50_Ph": 0, "Selectivity_Ph": 1, "hERG_Ph": 0, "solubility_Ph": 0, "ED50_Cl": 0, "thalf_Cl": 4, "AUC_Cl": 6, "bio_Cl": 2, "solubility_Cl": 0, "adverse_1": 287, "adverse_2": 209, "adverse_3": 60}, "metrics_distribution": {"IC50_MC": [1.3, 12.0, 3.1, 6.0, 510.0, 1.9, 174.0, 2.2, 370.0, 5000.0, 800.0, 7.1000000000000005, 9.0, 72.0, 19.0, 7.9, 2.8, 900.0, 1.7, 19.0, 213.0, 17.3, 33.0, 3.5, 3.1, 18.0, 28.0, 1.8, 80.0, 13700.0], "Ki_MC": [], "Kd_MC": [], "Selectivity_MC": [1], "IC50_Ph": [13.63, 15300.0, 21.3, 31040.0, 640.0, 40.0, 174.0, 1.7, 3.4, 20.0, 10.0, 3100.0, 82.0, 2.36, 19800.0], "Ki_Ph": [], "Kd_Ph": [], "EC50_Ph": [], "Selectivity_Ph": [20], "hERG_Ph": [], "solubility_Ph": [], "ED50_Cl": [], "thalf_Cl": [3.01, 4.8, 3.5, 0.42], "AUC_Cl": [13.1, 150478.0, 2268.0, 155.1, 75.0, 205.1], "bio_Cl": [7.3, 52.0], "solubility_Cl": [], "adverse_1": [0.0, 0.0, 0.06666666666666667], "adverse_2": [0.5056285178236398, 0.5, 0.3333333333333333, 0.07142857142857142, 0.4032258064516129, 0.5321100917431193, 0.2826086956521739, 0.3333333333333333, 0.46153846153846156, 1.0, 0.5321100917431193, 0.0, 0.0, 0.65, 0.0, 0.4666666666666667, 0.3055555555555556, 0.1, 0.25, 0.14285714285714285, 0.0, 0.0, 0.0, 0.03333333333333333, 0.0967741935483871, 0.0, 0.13725490196078433, 0.058823529411764705, 0.0, 0.043478260869565216, 0.38461538461538464, 0.5328947368421053, 0.019230769230769232, 0.0, 0.0, 0.03125, 0.0, 0.0, 0.4, 0.0, 0.09090909090909091, 0.2, 0.125, 0.0, 0.03125, 0.0, 0.14285714285714285], "adverse_3": [0.4423076923076923, 0.17942583732057416, 0.015503875968992248, 0.1, 0.1298283261802575, 0.07526881720430108, 0.02, 0.0, 0.3588709677419355]}}